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Abstract
Regulation of gene expression under stress conditions involves chromatin remodeling
through post-translational modification of histones. One of these modifications, acetylation
of lysine residues, regulates transcription initiation and is linked to a variety of essential
cellular processes including cell cycle control, DNA repair, and importantly, activation of
cellular stress response pathways. Dysregulation of histone acetylation has been observed in
many stress-related diseases such as inflammatory diseases, cancer, neurodegenerative
disorders, and fungal infections. Tra1 is the only essential component of both the highly
conserved SAGA and NuA4 histone acetyltransferase (HAT) complexes that are responsible
for acetylation of histones and other proteins. Tra1 has been shown to be involved in the
regulation of stress response pathways; however, the underlying mechanisms remain unclear.
Huntington’s disease (HD) is a neurodegenerative disease caused by the aberrantly expanded
polyglutamine (polyQ) repeats within the gene encoding the Huntingtin protein (Htt), leading
to misfolding and aggregation of the mutant Htt. Defect in misfolded protein stress responses
is a hallmark of HD. Thus, I sought to investigate how Tra1 orchestrates the transcriptional
responses to toxic misfolded polyQ expansions. First, I developed an optimized yeast model
of HD to study the effects of Tra1 on polyQ toxicity. I found that polyQ expansions impair
the assembly of the Tra1-containing SAGA HAT complex. This correlates with loss of
Tra1/SAGA function that exacerbates polyQ toxicity. Furthermore, polyQ expansions lead to
increased expression of TRA1, revealing a compensatory feedback mechanism. Interestingly,
deletion of SFP1, a transcription regulator downstream of TORC1, abolished TRA1
upregulation upon polyQ expression. Thus, I identified a novel link between Tra1 and
TORC1 signaling. Moreover, I showed that the increased sensitivity to heat stress in cells
expressing expanded polyQ is rescued by an osmotic stabilizer sorbitol, suggesting that the
defect can be traced back to the cell wall integrity. Considering that Tra1 is vital to maintain
cell wall integrity and activation of the heat shock response, it appears that impaired
Tra1/SAGA functions could underlie the dysregulation of these stress responses in the yeast
model of HD. Finally, because of its essential role in cell wall maintenance and calcium
homeostasis (two targets of antifungal drugs), Tra1 emerges as a rational target for
pathological yeast infections. Indeed, I found that cells expressing a mutant tra1 allele
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showed increased sensitivity to antifungal drugs. Overall, my graduate work helps
characterize the global role of Tra1 in protein homeostasis and define its potential as a
therapeutic target for stress-related human diseases.

Keywords
Stress response, histone acetyltransferase complex, Huntington’s disease, polyglutamine,
fluorescent proteins, aggregation, heat shock response, cell wall integrity, calcineurin
pathway, antifungal resistance, Tra1, TORC1, Sfp1.
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Summary for lay audience
Cells respond to environmental insults by remodeling their genome. Cells require critical
transcriptional machinery to regulate the expression of specific genes in response to different
stressors. Impaired cellular stress response pathways can lead to accumulation of toxic
misfolded proteins and major cellular dysfunctions, which are hallmarks of several human
disorders from neurodegeneration to our ability to fight fungal infections. Hyperactivation of
cellular stress responses, on the other hand, can cause drug resistance in cancer therapy and
lead to emergence of drug resistant microorganisms. Therefore, it is crucial to investigate the
regulation of cellular stress responses and their implication in stress-related diseases. Using
the budding yeast as an experimental model, my thesis explores how cells respond to stress in
two major health problems: Huntington’s Disease and yeast resistance to antifungal drugs.
While these two issues appear quite distinct, my work established that a single protein, Tra1,
plays a pivotal role in controlling how cells modulate gene expressions under stress
conditions linked to these pathologies. Therefore, understanding the crucial role of Tra1 in
cellular stress responses will provide better insights into the pathogenesis and therapies of
stress-related disorders.
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Chapter 1

1

Introduction

In the first chapter, I will review literature pertinent to the subject of my thesis project.
Specifically, I will focus on studies that define the role of Tra1 in gene expression,
transcriptional regulation, and histone modification. Then, I will provide background
information on cellular stress response pathways including TORC1 signaling, the heat
shock response (HSR), the cell wall integrity (CWI) pathway, and the calcineurin
pathway. Furthermore, I will emphasize the importance of the dysregulation of these
cellular stress responses in human diseases, especially in Huntington’s disease (HD) and
fungal infections.

1.1 Cellular stress responses and stress-induced gene
transcription
A key aspect of cellular physiology is maintaining homeostasis, a dynamic state of
equilibrium of the physiological and chemical conditions within our cells and our body
(Keener and Sneyd, 2009). Many extracellular and intracellular factors, such as
temperature and pH changes, hypoxia, genetic mutations, and protein misfolding can
perturb protein homeostasis (or proteostasis) and cause cell stress. To cope with different
environmental and genetic insults and restore homeostasis, cells adjust the expression of
specific genes encoding stress response proteins through activation of multiple stress
response pathways (Fulda et al., 2010). These stress response pathways include the
unfolded protein response (UPR), the HSR, several MAPK pathways, the TORC1
pathway, and the calcineurin pathway. The transcriptional regulation of stress-induced
genes is critical for stress response activation. When increasing yeast incubation
temperature from 25 to 38 °C, 52 proteins were induced in response to heat shock (BoyMarcotte et al., 1999). Upregulation of at least 115 genes was identified during H202
treatment in response to oxidative stress (Godon et al., 1998). During osmotic stress, the
mRNA level of 186 genes raised over 3-fold (Rep et al., 2000). Dysregulation of cellular
stress responses has been found in various diseases including inflammatory diseases,
cancer, and neurodegenerative disorders (Chen and Xie, 2018; Leak, 2014; Lindholm et
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al., 2006). Understanding the regulation of gene transcription under specific disease
conditions provides insights into the fundamental mechanisms of stress-related diseases.
My thesis focuses on using the budding yeast Saccharomyces cerevisiae as a model
organism to study transcriptional regulation in cellular stress responses in two distinct
major health problems, HD, an inherited neurodegenerative disease, and pathological
yeast infection and antifungal drug resistance.
Stress-induced genes have specific sequences within their respective promoter that can be
recognized by specific transcription factors. An example of such elements is the stress
responsive element (STRE) which has a core sequence AGGGG (Ruis and Schüller,
1995). STRE is the binding site of transcription factors Msn2/4 (Görner et al., 1998;
Martínez-Pastor et al., 1996). A computer search in the yeast genome predicted that 186
genes are potentially regulated through STRE (Moskvina et al., 1998). Other examples of
stress response elements within gene promoters include the heat shock element (HSE),
which is recognized by heat shock factors, the unfolded protein response element (UPRE),
which is the binding sequence of Hac1/Xbp1 during ER stress, and the calcineurin
dependent reporter element (CDRE), which is controlled by Crz1 to maintain calcium
homeostasis (Morimoto and Westerheide, 2010; Stathopoulos and Cyert, 1997;
Takayanagi et al., 2013). Importantly, some genes may contain both STRE and other
stress response elements that can be induced by different stress-response transcription
factors, such as HSP104 which encodes a heat shock protein, and an essential osmotic
stress response gene GPD1 (Rep et al., 1999).
Transcription initiation requires the binding of transcription factors and co-activators to
the DNA regulatory regions. In eukaryotes, DNA is packed with histones to form
nucleosomes, the fundamental subunit of chromatin (Kornberg and Lorch, 1999). The
condensed chromatin structure and interaction between DNA and histones inhibit the
binding of the transcriptional machinery (Grunstein, 1990). Specific enzymes can change
the state of chromatin to start gene transcription. A major class of these histonemodifying enzymes is the histone acetyltransferases (HAT) and associated complexes
(Sterner and Berger, 2000). By transferring an acetyl group to certain lysine sites within
histones in chromatin, HAT complexes weaken the interaction between DNA and
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histones and/or change the chromatin to a more relaxed structure that allows the binding
of transcription factors (Norton et al., 1989). Therefore, histone acetylation plays a vital
role in gene transcription. Furthermore, many proteins of the HAT complexes have been
reported as transcription co-activators (Bonnet et al., 2014). How HAT complexes
regulate specific stress-induced gene transcriptions and their roles in cellular stress
responses need further investigation. My thesis focuses on the role of Tra1, an essential
component of two highly conserved HAT complexes, in cellular stress responses and its
implication for stress-related diseases.

1.2 Tra1 and transcription initiation
Two major HAT complexes, which are highly conserved from yeast to humans, are the
SAGA (Spt-Ada-Gcn5-Acetyltransferase) and NuA4 (Nucleosome acetyltransferase of
H4) complexes. They respectively contain the Gcn5 and Esa1 lysine acetyltransferases,
both of which have histones as a major substrate (Allard et al., 1999; Auger et al., 2008;
Grant et al., 1997) (Figure 1.1A). In addition, SAGA and NuA4 have a number of nonhistone target proteins with roles likely unrelated to chromatin and gene regulation
(Choudhary et al., 2009; Downey et al., 2015; Henriksen et al., 2012; Mitchell et al.,
2013). The SAGA complex also possesses a ubiquitin protease activity specific for
monoubiquitinated histone H2B that is involved in the regulation of gene expression
(Henry et al., 2003). A genome-wide microarray study first showed that SAGA
contributes to the expression of about 10% of all yeast genes. Interestingly, a large
amount of SAGA dependent transcripts are involved in cellular stress responses
(Huisinga and Pugh, 2004). Furthermore, subsequent studies identified SAGA as a global
transcription regulator that maps to the promoters of most genes (Baptista et al., 2018).
The transcription-associated protein 1 (Tra1) is homologous to the mammalian TRRAP
(McMahon et al., 1998) and was first identified within the purified SAGA complex
(Grant et al., 1998). Tra1 is also an essential component of the NuA4 complex (Allard et
al., 1999). It is a member of the phosphoinositide-3-kinase-related kinase (PIKK) family
that also includes Tor1, DNA-PKcs, ATM, ATR and SMG-1 (Lovejoy and Cortez, 2009).
The PIKK proteins play multiple vital roles in maintaining cell viability, especially stressinduced signaling pathways such as DNA repair, ribosome biogenesis, and apoptosis
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(Abraham, 2004). Recent structural studies using cryo-electron microscopy revealed the
structure of Tra1 strikingly resembles another PIKK, DNA-PKcs, thus arguing in favor of
a role for Tra1 in DNA repair (Díaz-Santín et al., 2017). As opposed to other PIKK
proteins such as ATM and mTOR, Tra1 is not found to have catalytic activity due to the
lack of signature motifs of kinases within the PI3K domain (Mutiu et al., 2007). The
function of different Tra1 domains (Figure 1.1B) was investigated in a sequence-based
study (Knutson and Hahn, 2011). Similar to other PIKK family proteins, there are five
different domains in Tra1 and all are essential for viability. The long N-terminal HEAT
(Huntingtin, elongation factor 3, PR65/A, and TOR) domain represents about 70% of the
length of Tra1, which interact with transcription activators and other subunits of the HAT
complexes, followed by the FAT (FRAP, ATM, and TRRAP) and FRB (FKBP12
rapamycin binding) domains. After the PI3K domain, PIKK proteins have a small FAT
C-terminal domain which is vital for the integrity of PIKK-containing complexes (Jiang
et al., 2006). The authors reported the critical role of Tra1 in associating other subunits
and contributing to the acetylation activity of the HAT complexes (Knutson and Hahn,
2011). Previous studies identified Tra1 as a transcription co-activator that can recruit coactivator complexes and directly interact with transcription activators during transcription
initiation (Brown et al., 2001). Studies also showed that Tra1 has multiple transactivation
domain binding sites within its HEAT region which allow its interaction with activators
including yeast Gal4, Gcn4 or human c-myc (Lin et al., 2012; Park et al., 2001). Like
Tra1 in S. cerevisiae, TRRAP in mice is essential for viability (Herceg et al., 2001).
However, there are two paralogous proteins in S. pombe, Tra1 and Tra2 (Hayashi et al.,
2007). Tra1 in S. pombe is not essential and associates with SAGA, while Tra2 is
essential and associates with NuA4 (Helmlinger et al. 2011). The fact that only S. pombe
Tra2 is essential suggests that, in other organisms, NuA4 associated function of Tra1 is
essential for viability (Helmlinger et al., 2011). Thus, it may not be a coincidence that
depletion of Tra1 using the anchor-away system in S. cerevisiae recapitulates with higher
fidelity the transcriptional profile of esa1Δ cells (a NuA4 component) and not gcn5Δ cells
(a SAGA component) (Bruzzone et al., 2018). The requirement for Tra1, therefore,
appears different for SAGA and NuA4 functions.
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Figure 1.1 Tra1 is an essential component of both the SAGA and NuA4 HAT
complexes.
(A) Subunits of the SAGA and NuA4 HAT complexes. SAGA contains four modules,
the HAT module, TAF module, deubiquitination (DUB) module, and TATA binding
protein (TBP) module. The catalytic subunit of SAGA is Gcn5, whereas the
acetyltransferase in NuA4 is Esa1. (B) The modular structure of Tra1 protein. Tra1 is
a PIKK family protein which consists of five domains. Figure B adapted from Wang
et al., 2018.
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1.3 Yeast as a model organism
Since first used in the early 1900s, the budding yeast S. cerevisiae has become a
compelling model organism to build the fundamental understanding of eukaryotic cell
biology (Mortimer and Johnston, 1986). The advantages of employing yeast include its
short life cycle, simple growth requirements, and stable expression of plasmids. Yeast
also allows the possibility of extensive and relatively easy genetic manipulations (Duina
et al., 2014). Since the exciting publication of the first fully sequenced eukaryotic
genome database came out in 1996, S. cerevisiae continues to offer new information on
eukaryotic genome organization, basic cellular mechanisms, and evolution (Goffeau et al.,
1996). Numerous screening tools have been established including yeast genome-wide
libraries carrying deletions of all non-essential genes and genomic plasmid banks for
overexpression screen (Gelperin et al., 2005; Rose et al., 1987; Winzeler et al., 1999).
These tools allow researchers to conduct high-throughput analysis of genetic interactions
and protein functions. One example is the synthetic genetic array where a query mutation
is crossed with the yeast deletion library. Spore inviability or growth defect of the double
mutant indicates a genetic interaction between the two genes (Tong et al., 2001). More
than 30% of all yeast genes have clear homologs in mammals (Botstein et al., 1997).
Benefitting from the ease and rapidity of genetic screening, the yeast model is
particularly amenable for genome-wide study on gene expression and signaling cascades.
Most of the basic cellular mechanisms, such as the TORC1 signaling, the HSR, the
MAPK pathways, and the calcineurin pathway, that I will discuss in subsequent sections,
are conserved in human and widely studied in yeast.
Due to the relatively short generation time, yeast is also used for aging research (Gershon
and Gershon, 2000; Kaeberlein et al., 2007). The replicative as well as chronological life
span allows researchers to investigate the aging processes of proliferating and
nonproliferating cells respectively. Furthermore, yeast also provides an excellent platform
for assessing cellular functions affected by disease-causing proteins (Smith and Snyder,
2006). Making human point mutations in yeast orthologs, expressing human proteins in
yeast, or humanizing yeast, i.e. replacing the yeast gene with its human homolog,
successfully mimic human diseases’ phenotypes in S. cerevisiae (Laurent et al., 2016).
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The yeast model has helped scientists gain a better understanding of different disease
mechanisms such as neurodegenerations and cancer (Guaragnella et al., 2014; MillerFleming et al., 2008). Researchers also exploit the yeast model for large-scale drug tests.
Yeast has become a powerful in vivo tool for high throughput screens to identify drug
targets and demonstrate the mechanisms of action (Couplan et al., 2011; Ohnuki et al.,
2010).
Similarly to other model organisms, the yeast model is not perfect. Higher eukaryotes
have more complex mechanisms that are difficult to study in yeast. Because yeast is a
single cell organism, tissue studies and behavioral approaches are not feasible.
Nevertheless, the use of this simple organism has become widespread, especially in
combination with tools available in other model organisms such as C.elegans, Drosophila,
rodents, and tissue culture cell lines established from patient samples. The simple yeast
model not only enables a better understanding of the fundamental mechanisms of cellular
functions but also contributes to accelerating the development of therapeutic agents for
human diseases. In my thesis, I used S. cerevisiae to investigate the role of Tra1 in
cellular stress responses and implications for Huntington’s disease and fungal infections.
In the following sections, I will review the major stress responses pathways pertinent to
my thesis project.

1.4 TORC1 signaling pathway
The Target of Rapamycin (TOR) is a widely conserved serine/threonine kinase that
functions in two different complexes named TORC1 and TORC2, each of which plays
vital roles in various aspects of eukaryote cell growth (Loewith and Hall, 2011). TORC1
is activated under many stress conditions i.e. nutrient starvation and well studied for its
role in regulating ribosome biogenesis, cell cycle, autophagy, and promoting cell growth
during stress conditions (Barbet et al., 1996; Kawai et al., 2001; Noda and Ohsumi, 1998;
Urban et al., 2007). TORC2, meanwhile, controls cell growth by regulating the
polarization of the actin cytoskeleton (Schmidt et al., 1996). TORC2 has also been shown
to regulate endocytosis and sphingolipid biosynthesis; however, the underlying
mechanisms have yet to be elucidated (Tabuchi et al., 2006).
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S. cerevisiae has two TOR genes encoding Tor1 and Tor2, which redundantly regulate
growth (Loewith et al., 2002). Tor proteins are PIKK family proteins which contain a
HEAT domain, binding targets for subunits of the TOR complexes; a core FAT domain,
clamping onto the kinase domain and required for partners binding; an FRB domain,
which contains the rapamycin binding region; and a PI3K kinase domain and FATC
domain, which play critical roles in regulating protein kinase activity (Adami et al., 2007;
Yang et al., 2013). The yeast TORC1 complex is formed by the proteins Kog1, Lst8,
Tco89, and TOR1 or TOR2 (Loewith et al., 2002). Through fluorescence microscopy and
fractionation experiments, TORC1 was found to localize to the vacuolar membrane
(Reinke et al., 2004; Sturgill et al., 2008). Besides its known inhibition by rapamycin,
many factors have been found to regulate TORC1 signaling including nutrient starvation,
oxidative stress, heat shock, and cell wall stress (Beck and Hall, 1999; Gasch and
Werner-Washburne, 2002). A yeast global protein kinase and phosphatase interaction
network study identified downstream targets of TORC1 (Figure 1.2), revealing the
critical role of the TORC1 signaling as described below (Breitkreutz et al., 2010).
Ribosomes play a pivotal role in protein translation and cell growth. Actively dividing
yeast cells allocate up to 85% of their transcriptional activity to ribosome biogenesis
(Warner, 1999). TORC1 is a vital regulator of ribosome biogenesis through
phosphorylation of the transcription factors Sch9 and Sfp1 (Lempiäinen and Shore, 2009).
TORC1 directly binds and phosphorylates Sch9. Sch9 supports ribosome biogenesis and
ribosomal protein gene transcription by inhibiting transcriptional repressor Dot6 and its
homolog Tod6 (Huber et al., 2011; Lippman and Broach, 2009). Importantly, this
phosphorylation is abolished during stress conditions (Urban et al., 2007). The activation
of Sch9 also leads to the inhibition of Maf1, an RNA polymerase III repressor (Vannini et
al., 2010). The phosphorylation of Sfp1 by TORC1 promotes Sfp1 binding to the
promoters of genes encoding ribosomal proteins and thus regulates transcription
activation (Fingerman et al., 2003). Mrs6, a protein involved in ER to Golgi trafficking,
directly binds Sfp1 and regulates its cellular localization. Under stress conditions, Sfp1
re-localizes from the nucleus to the cytoplasm that causes downregulation of ribosome
biogenesis (Lempiäinen et al., 2009; Marion et al., 2004). Furthermore, Sfp1 or Sch9
deletion leads to reduced cell size (Jorgensen et al., 2004), suggesting that ribosome
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biogenesis regulated by the TORC1 signaling pathway is critical for cell size
determination.
TORC1 is essential for cell cycle regulation and growth. Treating yeast cells with
rapamycin causes G1 arrest (Barbet et al., 1996). Previous literature showed that TORC1
activates G1 cyclin-dependent protein kinases (CDKs) through destabilizing the CDK
inhibitor Sic1 (Moreno-Torres et al., 2015). Furthermore, TORC1 is also involved in the
G2/M transition through the interaction between Kog1 and a polo-like kinase Cdc5
(Nakashima et al., 2008). Under stress or starvation conditions, cells undergo autophagy
to degrade damaged proteins and organelles in order to generate biomaterials and ATP
for essential protein synthesis (Reggiori and Klionsky, 2013). TORC1 has been shown to
negatively regulate autophagy through the phosphorylation of autophagy-related genes
(ATGs). Atg13 phosphorylation by TORC1 prevents its binding to Atg1 in yeast. The
dephosphorylation and disassociation of the Atg1 mammalian homolog Ulk1 from
mTORC1 increases its activity during starvation (Kamada et al., 2010; Noda, 2017;
Yorimitsu et al., 2009).
The TORC1 pathway has been linked to other cellular stress response pathways.
mTORC1 is crucial for HSF1 activation in HeLa cells (Chou et al., 2012). Yeast cells
carrying an Hsp90 mutation, which leads to overactivation of HSF1, are more sensitive to
rapamycin, suggesting that inhibition of TORC1 signaling is involved in the process
(Chou et al., 2012; Millson and Piper, 2014). Rapamycin treatment has also been shown
to activate the CWI pathway, suggesting the negative regulation by TORC1 on cell wall
integrity (Torres et al., 2002). Therefore, it is crucial to understand the multifunctional
TORC1 regulation during stress and its connection with other stress response pathways.
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Figure 1.2 Model of the TORC1 signaling pathway in S. cerevisiae.
TORC1 is regulated by nutrients and cell stress. TORC1 level is inhibited by
rapamycin. TORC1 controls ribosome biogenesis (Ribi) through phosphorylation of
Sfp1 and Sch9. TORC1 negatively regulates autophagy by phosphorylating Atg13 and
prevents the formation of Atg1 complex. TORC1 is also involved in cell cycle
regulation.
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1.5 Heat shock response
The HSR is a well-conserved transcriptional program activated when cells are exposed to
stresses which induces the expression of many heat shock proteins (HSPs) (Lindquist,
1986; Richter et al., 2010). Many factors can lead to cell stress and activate the HSR
including temperature changes, nutrient starvation, hypoxia, aging, and genetic mutations
(Kalmar and Greensmith, 2009; Marambio et al., 2010; Murshid et al., 2013). Under
stress conditions, an increased amount of misfolded or unfolded proteins accumulate
within the cell, requiring a consequential increase in protein folding and quality control
capacity to maintain protein homeostasis (Gidalevitz et al., 2011). The majority of HSPs
function as molecular chaperones to unfold aggregated proteins, refold misfolded proteins,
and target damaged proteins for degradation processes (Feder and Hofmann, 1999).
Physiological changes such as the osmolyte synthesis and import, cytoskeleton
remodeling, and interruption of the cell cycle regulated by HSPs also contribute to
cellular survival during stress (Helmbrecht et al., 2000; Wettstein et al., 2012). Much of
what we know about the HSR in eukaryotic cells has been elucidated in S. cerevisiae
(Figure 1.3), supporting its use for investigating the underlying mechanisms of
transcriptional regulation and effects during misfolded protein stress in my thesis.
The key regulators of the HSR are heat shock factors (Akerfelt et al., 2010). Although
mammals have multiple heat shock factors providing redundancy and specialization of
the stress signals, Heat shock factor 1 (HSF1) is the main heat shock factor and is well
conserved from yeast to human (Morimoto, 1998). During stress, HSF1 binds to a
specific domain (nGAAn) termed the heat shock element (HSE) within the promoter of
its targets, thereby regulating downstream gene transcription. The initial activation of the
HSR requires HSF1 trimerization, phosphorylation at specific sites, and other posttranslational modifications (Chu et al., 1996; Holmberg et al., 2001; Westerheide et al.,
2009). As previously mentioned, the transcriptional regulation of HSPs also depends on
co-activators. Tra1 has been shown to be involved in HSP activations (Lebedeva et al.,
2005). In addition, two other transcription factors, Msn2 and Msn4, were also found to be
activated by heat shock in S. cerevisiae, mainly targeting enzymes involved in carbon
metabolism and anti-oxidants (Boy-Marcotte et al., 1999).
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HSF1 regulates the activation of HSPs which are critical for protein quality control. Wellcharacterized HSPs include Hsp70, Hsp90, Hsp104, and small heat shock proteins
(sHSPs) family. Hsp70 chaperones support about 30% of proteins to maintain their
correct folding by binding transiently to hydrophobic polypeptides of unfolded proteins
to prevent non-specific interactions that may cause misfolding and aggregation (Sharma
and Masison, 2009). Compared to Hsp70, Hsp90 tends to interact with its clients at later
and more mature folding stages (Taipale et al., 2010). Targets of Hsp90 are mainly
transcription factors and protein kinases (Karagöz and Rüdiger, 2015). The binding of
Hsp70 and Hsp90 to Carboxyl terminus of Hsc70-interacting protein (CHIP) leads to
unfolded protein degradation (Kundrat and Regan, 2010). Hsp104 promotes damaged
protein refolding by solubilizing protein aggregates in cooperation with Hsp70 and Hsp40
(Glover and Lindquist, 1998; Okuda et al., 2015). The sHSPs are usually 12-43kDa and
are also essential for cell survival under stress due to their chaperone activity and antiapoptotic effects (Bakthisaran et al., 2015). HSP26 and HSP42 deletion strains can
survive under heat shock but displayed a significant cell morphology change and cell wall
damage (Haslbeck et al., 2004). Furthermore, HSPs, such as Hsp70 and Hsp90, can
directly interact with HSF1 and repress its activation (Abravaya et al., 1992; Zou et al.,
1998). The feedback mechanism provides an autoregulatory system that controls the
extent of the HSR. In S. cerevisiae, HSF1 C-terminal domain deletion has been shown to
increase cell sensitivity to high temperature. Notably, the growth defect at a high
temperature can be rescued by treating the cells with an osmotic stabilizer, sorbitol. This
phenotype is further linked to the interaction between Hsp90 and Slt2, the mitogenactivated protein kinase (MAPK) required for cell integrity (Truman et al., 2007).
Moreover, inhibiting Hsp90 led to increased sensitivity to cell wall stressor caspofungin
in another yeast species Aspergillus fumigatus (Lamoth et al., 2012) These results
demonstrate the crosstalk between the HSR and the cell wall integrity (CWI) pathway in
regulating cell survival during stress.
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Figure 1.3 Model of the heat shock response pathway in S. cerevisiae.
The HSR is crucial for proteostasis. HSF1 is phosphorylated and forms a trimer
during stress. Then HSF1 translocates into the nucleus and binds to the HSE of its
downstream targets to activate transcription. HSPs assist with protein refolding or
target damaged proteins for degradation through the interaction with CHIP ubiquitin
ligase. Overexpression of HSPs inhibits HSF1 activation to reduce the level of HSR.
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1.6 Cell wall integrity
The yeast cell wall is a layered dynamic structure outside of the cell membrane which
occupies more than 20% of a yeast cell’s dry weight (Orlean, 1997). The outer layer of
the yeast cell wall is comprised of glycoproteins protecting the inner layer from walldegrading enzymes (Zlotnik et al., 1984), whereas the inner layer is mainly made of
glucan polymers and chitin that regulate cell wall elasticity and remodeling (Smits et al.,
1999). In S. cerevisiae, the cell wall is critical for budding and cell division, response to
environmental stress, and cell-cell contact (Cid et al., 1995; Hohmann, 2002; Reynolds
and Fink, 2001).
The CWI pathway is a MAPK signaling cascade that maintains cell shape and cell wall
integrity during various cellular stresses (Levin, 2011). Briefly, cell surface sensor
proteins transmit stress signals to the Rho1 GTPase, the master regulator of the CWI
pathway. During stress, Rho1 interacts with Pkc1 and activates the MAPK cascade: Bck1
(MEKK), Mkk1/2 (MEKs), and Slt2 (MAPK) (Figure 1.4). Deletion of any CWI kinase
causes cell growth defects at 37 °C and also increases cell sensitivity to cell wall stressors
and mating pheromone (Gustin et al., 1998; Kirchrath et al., 2000; Martín et al., 2000).
These results indicate the essential role of the MAPK signaling in regulating cellular
stress responses.
Cell surface sensors Wsc1/2/3 and Mid2 located on the plasma membrane recruit Rom1/2,
the guanine nucleotide exchange factor of Rho1, to activate its GTPase activity. The yeast
Pkc1 is homologous to the mammalian protein kinase C (Levin et al., 1990). Deletion of
PKC1 is lethal but cells can grow with the support of sorbitol. The cell walls were found
to be thinner in the pkc1Δ strain (Roemer et al., 1994). When Pkc1 is activated by Rho1,
it phosphorylates specific residues of Bck1, leading to the phosphorylation of Mkk1/2
and Slt2, which is functionally homologous to human ERK5 (Truman et al., 2006). The
ERK5 signaling is crucial for oxidative stress and environmental stress through regulation
of the serum and glucocorticoid-induced kinase (SGK) (Chao et al., 1999; Wang and
Tournier, 2006). Downstream targets of the MAPK cascade include transcription
regulators Rlm1 and Swi4/6. Rlm1 target genes are involved in cell wall synthesis (Jung
et al., 2002). Meanwhile, Swi4/6 mainly regulate transcription of genes required for cell
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G1 to S phase (Harrington and Andrews, 1996). Swi4/6 are also found to activate FKS1/2
transcription, which encode proteins regulating β-glucan and chitin synthesis (Roemer et
al., 1994)
The CWI pathway is shown to be activated during heat shock stress to regulate cell
survival (Truman et al., 2007). Previous literature indicated that Tra1 is involved in the
CWI activation. However, the underlying mechanisms are not fully understood (Hoke et
al., 2008). Thus, it will be interesting to investigate how Tra1 regulates cellular stress
response to high temperature. Furthermore, high calcium concentration can also activate
Slt2 phosphorylation (Mizunuma et al., 1998). In parallel with the CWI pathway, Fks2 is
also regulated by Crz1, a transcription activator controlled by the calcium-calcineurin
signaling (Stathopoulos and Cyert, 1997). All evidence suggests a connection between
the CWI pathway and regulation of calcium homeostasis.
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Figure 1.4 Model of the cell wall integrity pathway in S. cerevisiae.
The CWI pathway is a MAPK signaling pathway in response to cell wall stress.
Sensors on the plasma membrane transmit the signal to Rho1 GTPase and activate the
MAPK Slt2. Downstream targets of Slt2 are transcriptional regulators Swi4/6 and
Rlm1 which activate the transcription of gene involved in cell wall synthesis and cell
cycle. Figure modified from Levin, 2005.
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1.7 Calcium-calcineurin pathway
Calcium ions play a vital role in cell signal transduction pathways. The regulation of
calcium is crucial for cell survival, membrane fusion, cytoskeleton organization, and cell
polarization (Cao et al., 2012; Foskett and Spring, 1985; Portis et al., 1979; Shirayoshi et
al., 1983). Under normal growth condition, the level of the yeast cytosolic Ca2+ is
between 50 to 200 nM (Miseta et al., 1999) and maintained stably by pumping Ca2+ into
vacuoles through a vacuolar calcium ATPase Pmc1. Part of the cytosolic Ca2+ is
transported into ER and Golgi through Pmr1, a secretory pathway calcium ATPase,
which also helps pump extra Ca2+ out of the cells (Cunningham and Fink, 1994).
However, calcium concentration can be abnormally increased resulting from
environmental changes as well as intracellular stresses such as cell wall stress or ER
stress (Bonilla et al., 2002; Chen et al., 2012). To maintain calcium homeostasis, the
calcium-calcineurin pathway is activated (Crabtree, 2001) (Figure 1.5).
Calcineurin is a highly conserved protein phosphatase in eukaryotes (Aramburu et al.,
2000). Calcineurin is a heterodimeric protein containing a catalytic subunit calcineurin A
together with a Ca2+ binding and regulatory subunit calcineurin B (Rusnak and Mertz,
2000). In S. cerevisiae, CNA1 and CNA2 encode calcineurin A, whereas CNB1 encodes
calcineurin B. Deletion of each component is viable but cells displayed growth defect
under stress conditions. Double deletion of CNA1 and CNA2 show increased cell
sensitivity to mating pheromone (Cyert et al., 1991). Furthermore, deletion of CNB1
leads to no detectable calcineurin activity, even though Cna1 and Cna2 protein levels
remain unchanged, indicating that the essential role of subunit B on enzymatic activity
(Cyert and Thorner, 1992). Under stress conditions, a rapid influx of Ca2+ into the cytosol
through the high affinity Ca2+ influx system (HACS) and low affinity Ca2+ influx system
of the plasma membrane is sensed by calmodulin (Muller et al., 2001). External calcium
ions and calmodulin then bind to calcineurin and activates its phosphatase activity.
Next, the critical target Crz1, a transcriptional regulator, gets dephosphorylated and
translocates to the nucleus to activate the transcription of downstream targets including
PMC1 and PMR1 (Cyert, 2003; Li et al., 2011). The localization of Crz1 is dependent on
its phosphorylation state. Nuclear import of Crz1 requires binding to Nmd5p. Only
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dephosphorylated Crz1 can bind to Nmd5p in vitro (Polizotto and Cyert, 2001).
Moreover, the export to the cytoplasm is achieved by Msn5p that exclusively recognize
phosphorylated proteins (Boustany and Cyert, 2002). Calcineurin is shown to bind Crz1
in a PIISIQ sequence and regulates its dephosphorylation (Kim et al., 2003).
When imported into the nucleus, Crz1 recognizes and binds to the calcineurin-dependent
response elements (CDRE), a unique 24 bp sequence, within the target gene promoters
and regulates transcription (Stathopoulos and Cyert, 1997). A genome-wide microarray
has identified 163 genes which are directly regulated by Crz1, mainly involved in ion
transport (e.g. PMC1), vesicle transport (e.g. CVT19), cell wall synthesis (e.g. FKS2),
lipid synthesis (e.g. SUR1), protein degradation (e.g. APG5), and transcription (e.g. RCN1)
(Cyert, 2003; Yoshimoto et al., 2002). These results suggest the cross-talk between the
calcineurin signaling and other cellular processes such as plasma membrane synthesis,
the CWI pathway, and autophagy besides modulating ion homeostasis.
The calcineurin signaling has been studied as a new target for antifungal drugs through its
essential role in regulating fungal cell survival and virulence (Karababa et al., 2006;
Soriani et al., 2008). Thus, it is crucial to understand the cellular mechanisms that
regulate the calcineurin pathway. Histone acetylation has been linked to the regulation of
the calcineurin pathway in fungi. Researchers observed that the C. neoformans gcn5Δ
mutant strain is more sensitive to calcineurin inhibitors (O’Meara et al., 2010). As
mentioned previously, Tra1 is vital for histone acetylation. Accordingly, a synthetic
genetic array showed that cells with tra1SRR3413 and cnb1Δ double mutation showed a slow
growth phenotype (Hoke et al., 2008). Cells carrying a mutant Tra1 allele displayed a
growth defect under conditions of high calcium, indicating that calcium homeostasis
pathways are impaired (Berg et al., 2018). These results suggest that functional Tra1 is
required for the calcium-calcineurin pathway activation. Chapter 6 of my thesis will study
the role of Tra1 in regulating the calcineurin pathway and the effects on antifungal
resistance.
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Figure 1.5 Model of the calcium-calcineurin pathway in S. cerevisiae.
Calcineurin is activated by the binding of calmodulin and Ca2+. Calcineurin
dephosphorylates Crz1 which controls its nucleus localization. Crz1 binds to CDRE
of its target genes and activates transcription of genes involved in the transport of
calcium. Figure modified from Liu et al., 2015.
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1.8 Tra1 and cellular stress responses
The nature of the Tra1 protein and its critical role within the SAGA/NuA4 complexes
indicate that Tra1 may be involved in the regulation of cellular stress responses.
Systematic genetic array analysis of tra1SRR3413 identified 114 negative genetic
interactions where 30 interacting genes directly play a role in stress responses, with some
genes implicated in stress-related signaling pathways (Hoke et al., 2008). Moreover, Tra1
incorporation into the SAGA complex requires Tti2, a subunit of the Triple T complex
responsible for PIKK family protein stabilization (Elias-Villalobos et al., 2019;
Genereaux et al., 2012). Loss of Tti2 function leads to defect in SAGA-dependent
transcription that correlates with increased sensitivity to various stresses (Genereaux et al.,
2012; Hoffman et al., 2016). Interestingly, the addition of an osmotic stabilizer sorbitol
ameliorates the growth defect, suggesting that Tra1 is involved in cell wall function.
Indeed, proper SAGA function through Gcn5 is required for the cell wall integrity
transcriptional program (Sanz et al., 2016) and Tra1 mutants are hypersensitive to cell
wall perturbing agents such as caffeine and calcofluor white (Berg et al., 2018;
Helmlinger et al., 2011; Hoke et al., 2008; Mutiu et al., 2007). Studies of Tra1 deletions
in S. pombe showed that Tra1 recruits SAGA to a subset of promoters, mainly controlling
genes involved in stress response (Helmlinger et al., 2011). Also, NuA4 was shown to
directly interact with the stress-induced transcription factors Msn4, supporting a role for
the complex in the general stress response pathway (Mitchell et al., 2008). The link
between Tra1 and cellular stress response pathways is summarized in Figure 1.6.
One of the most characterized roles of Tra1 in the response to stress is its role in the
activation of the HSR in response to heat shock. The HSR is an evolutionary conserved
stress response pathway to maintain protein homeostasis. The transcription of genes
encoding HSPs requires heat shock factor HSF1 as well as co-activators such as SAGA
(Cotto and Morimoto, 1999; Lindquist, 1986; Vinayachandran et al., 2018; Zanton and
Pugh, 2004). Acetylation and displacement of histone H3 is observed at the promoters of
HSPs during heat stress (Erkina and Erkine, 2006). Moreover, a loss-of-function mutation
within Tra1 leads to growth inhibition at high temperature and in the presence of the cell
wall perturbing agent (Berg et al., 2018; Hoke et al., 2010; Mutiu et al., 2007). These
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phenotypes correlate with a defective activation of the HSR. Similar phenotypes are
observed in cells carrying a mutant HSF1 (1-583) lacking the C-terminal domain
(Truman et al., 2007).

In support of a role for Tra1 in Hsf1 function, a physical

interaction between Hsf1 and Tra1 was observed by mass spectrometry (Breitkreutz et al.,
2010). Moreover, studies in Drosophila found that Hsp70 transcription requires the
recruitment of Tra1 homolog Nipped-A to its promoter (Lebedeva et al., 2005). In
mammals, HSP genes are downregulated in TRRAP deficient cells (Herceg et al., 2003).
Collectively, these results indicate that Tra1 is involved in HSF1-dependent transcription
of HSP genes across species.
Dysregulation of Tra1 has been observed in many stress-related diseases which I will
introduce in the following section. Our recent study reported elevated TRA1 mRNA and
protein levels in a yeast model of HD (Jiang et al., 2019). Increased TRRAP expression
is also observed in a mammalian HD cell line (Kim et al., 2016). Furthermore, TRRAP
has been described as a potential biomarker of Alzheimer’s disease (AD) and is
upregulated in hippocampal tissues of AD patients (Ho Kim et al., 2015). TRRAP also
plays a critical role in cancer. TRRAP was identified to interact with several cancerrelated proteins such as c-Myc, P53, E2F transcription factors, and viral oncoprotein E1A
(Jethwa et al., 2018; Lang and Hearing, 2003; McMahon et al., 1998). Overall,
Tra1/TRRAP could be an important modifier of HD and other stress-related diseases
through its role in regulating cellular stress responses.
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Figure 1.6 Tra1 and cellular stress response pathways.
Under stress conditions, cells activated stress response pathways to retain homeostasis.
The main stress response pathways include in this thesis are the TORC1 signaling
which regulates cell cycle, autophagy, and ribosome biogenesis; the heat shock
response, which assists with protein folding and degradation; the cell wall integrity
pathway that controls cell wall synthesis; and the calcineurin pathway, which
maintains calcium homeostasis. Tra1 is critical for cellular stress response activations.
Direct interaction between Tra1 and transcription regulator Sfp1, and HSF1 has been
reported in yeast. Tra1 mutation leads to increased cell sensitivity to different stressors
such as cell wall stressor caffeine and extra Ca2+.
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1.9 Cellular stress responses and human diseases
Dysregulation of cellular stress responses has been observed in various stress-related
diseases including neurodegenerative disease, cancer and chemotherapy resistance in
cancer therapy, and antifungal resistance (Chen and Xie, 2018; Cowen et al., 2014; Kim
et al., 2015; Leak, 2014; Liu et al., 2017). Insufficient cellular stress responses can lead to
impaired protein homeostasis and defects in multiple cell functions. In contrast, hyperactivated stress responses result in drug resistance and limit disease treatments. Therefore,
investigating the mechanisms of cellular stress responses is crucial for understanding
pathological mechanisms and developing target-specific therapies. My thesis focuses on
the regulation of cellular stress responses in HD and antifungal resistance, which I will
describe in the following sections.

Cellular stress responses in neurodegeneration and cancer
A hallmark of neurodegenerative diseases is protein misfolding (Soto and Estrada, 2008;
Sweeney et al., 2017). Upon accumulation of misfolded proteins, neurons require
increased activity of molecular chaperones, mainly heat shock proteins, to cope with the
protein misfolding defect. In Alzheimer's disease (AD), Hsp70 and Hsp90 overexpression
have been shown to inhibit Aβ formation and ameliorate disease phenotypes (Luo and Le,
2010; Sun et al., 2017). Impaired HSR has been shown in Parkinson’s disease (PD) and
HD, which may explain the mechanism of amyloid-like aggregations formed in neurons
and the toxicity. For example, Hsp70 levels are decreased in Parkinson’s disease brain
sample, suggesting the reduced HSR activation (Alvarez-Erviti et al., 2010). Moreover,
due to the high demand for oxygen, the brain is especially vulnerable to the accumulation
of reactive oxygen species (ROS) and oxidative stress. Increased oxidative stress has
been found in different neurodegenerative disorders that may cause DNA damage and
mitochondria dysregulation (Wang and Patterson, 2015). Literature has reported Aβinduced oxidative stress in AD (Wang et al., 2014). Oxidative imbalance was also shown
to appear at early stage of AD, which could be a leading cause of the disease (Butterfield
et al., 2006). Dysregulation of complex I of the respiratory chain and increased ROS
accumulation has also been observed in PD (Blesa et al., 2015). Overall, impaired cellular
stress responses contribute to neurodegenerative disease pathology and could be potential
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therapeutic targets for drug development. Indeed, several drugs targeting the HSP
proteins or oxidants have been screened for the treatment of AD and PD (Repalli and
Meruelo, 2015; Wojsiat et al., 2018).
Many studies have reported the role of cellular stress responses, especially the HSR, in
cancer development. HSF1 overexpression is observed in a variety of cancer types
(Santagata et al., 2011). It was shown that activation of HSF1 helps maintain the cellular
malignant phenotypes by increasing resistance to apoptosis (Mendillo et al., 2012; Meng
et al., 2010). The HSPs were also shown to promote tumorigenesis and cancer cell
survival by stabilizing oncoprotein mutant p53 and regulating glycolysis (Dai and
Whitesell, 2005; Zhao et al., 2009). Furthermore, activation of the HSR has been linked
to resistance to chemotherapy. Increased expression of HSPs correlated with increased
drug resistance in breast cancer (Vargas-Roig et al., 1998). Importantly, the HSR plays a
critical role in tumor metastasis. Epithelial-mesenchymal transition (EMT) was reduced
when knocking down HSF1 in the ovarian cancer spheroids (Powell et al., 2016).
Furthermore, expression of Hsp10 was found in ascites of ovarian cancer patients which
could be involved in T-lymphocyte inhibition (Akyol et al., 2006). High expression of
Hsp70 correlates with the aggressiveness of ovarian cancer and leads to poor overall
survival (Elstrand et al., 2009). Activation of the HSR provides tumor cells with a
cytoprotective effect to survive in the anoxic, acidotic, and nutrient-deprived
microenvironment. These results delineate the critical role of the HSR in tumor survival
and metastasis, further emphasize the potential to target this pathway for cancer therapy.
As such, HSF1 and HSPs have been studied as targets for drugs and immunotherapy in
cancer treatment. One exciting result showing that inhibiting Hsp90 with a geldanamycin
analog 17AAG43 benefits multiple cancer types in clinical trials (Wang et al., 2016;
Workman, 2002).

Impaired heat shock response in Huntington’s disease
Huntington’s disease (HD) is an autosomal recessive neurodegenerative disorder
associated with mutations in a gene encoding the Huntingtin protein (Htt) (Whalley,
2015). The cause of HD is an abnormal increase of polyglutamine repeats (polyQ) within
a region of Htt encoded by the first exon of HTT (Httex1) (Gusella and MacDonald, 2009).
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Normally, the HTT gene encodes less than 35 CAG repeats. However, an increased
number of polyQ leads to the appearance of HD symptoms in patients, such as chorea,
cognitive loss, involuntary movements, and diminished coordination (Roos, 2010). The
disease is inherited, and the length of polyQ repeats can increase over consecutive
generations. Physical symptoms usually occur at around 40 years of age. However, a
higher number of CAG repeats leads to a juvenile HD in which symptoms start before the
age of 20 (Ghosh and Tabrizi, 2015).
At the cellular level, increased PolyQ expansions cause the Htt protein to incorrectly fold,
and aggregate into cytoplasmic, non-soluble, amyloid-like fibrils termed inclusion bodies
(IB) (Arrasate and Finkbeiner, 2012). While most studies focus on how polyQ toxicity
leads to neuronal cell death, the effects at early time points have not been well established.
A series of cellular processes have been found to be impaired in HD, including
dysfunctional ER stress response, protein degradation pathways, transcription activation,
mitochondrial activity, and calcium signaling (Duennwald and Lindquist, 2008; Jiang et
al., 2016; Kumar et al., 2014; Papsdorf et al., 2015). Thus, expression of mutant Htt
impairs normal cellular functions, especially the ability of cells to properly regulate stress
response pathways.
The principal regulator of proteostasis, the HSR, is impaired during polyQ expansion.
Reduced HSF1 activation and HSPs expression were observed in striatal cells expressing
full-length polyQ-expanded Htt and HD knock-in mice (Chafekar and Duennwald, 2012).
Overexpressing Hsp26, Hsp42, and Hsp104 attenuated polyQ toxicity in the yeast HD
model (Cashikar et al., 2005). To study the mechanisms by which polyQ expansions
affect the HSR, a chromatin immunoprecipitation sequencing (ChIP-Seq) assay was
performed to identify changes in HSF1 targets during expanded polyQ expression. About
30% of genes binding to HSF1 during heat shock lost the interaction in the presence of
polyQ. Surprisingly, genes identified were not enriched in classical HSF1 targets but
involved in other functions such as GTPase regulation, cytoskeleton remodeling, focal
adhesion, and cell proliferation (Riva et al., 2012). These results suggest that polyQ may
also impair non-canonical HSR targets.
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Compounds that induce HSR activation have shown therapeutic effects against HD.
Treating PC12 cells expressing 81Q with celastrol, which upregulates HSPs, significantly
reduced the neuronal death rate. Another drug, geldanamycin, which can activate the
HSR, was shown to inhibit Htt aggregation in COS-1 cell line (Sittler et al., 2001).
Furthermore, a study in an HD mice model demonstrated that the beneficial effects of the
HSR activation were transient and diminished during disease progression (Labbadia et al.,
2011). The same study also found that the impairment may result from histone H4
hypoacetylation which reduces chromatin accessibility and ability of HSF1 to bind to the
HSP promoters. This result further links impaired the HSR in HD to histone acetylation.
In the fifth chapter of my thesis, I will study the role of Tra1 in regulating the HSR in the
presence of toxic polyQ. Investigating how polyQ expansions impair the HSR will
provide us a better insight into the molecular pathogenesis of HD and help identify
potential therapeutic targets.

Cellular stress responses in antifungal resistance
The ability for fungi to survive and adapt to a variety of environmental stressors is
formidable. Nowadays, fungal infection has become a huge problem for human health.
Around 20 to 25% of the world’s population has skin fungal infections (Havlickova et al.,
2008). Due to the lack of understanding of fungal stress responses, the development of
effective and target-specific antifungal reagents is still challenging. Approximately 300
fungal species have been found to be pathogenic to humans (Casadevall,
2018). Candida, Aspergillus, Pneumocystis, and Cryptococcus are the most common
fungi that have been found to cause human diseases such as chronic skin infections
including athlete’s foot and ringworm. Severe infection may cause death especially in
people with immune diseases (Brown et al., 2012; Johnson, 2018). The widely used
antifungal drugs are mainly azoles, polyenes, and echinocandins. Azoles and polyenes
target ergosterol that leads to plasma membrane defects in fungi. Echinocandins
(caspofungin and anidulafungin), on the other hand, blocks the synthesis of β(1,3)-dglucan, a major component of the fungal cell wall (Groll et al., 1998; Kathiravan et al.,
2012). The mechanisms of action of common antifungal agents are shown in figure 1.7.
Resistance to common drugs has been observed in many fungal pathogens, specifically
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among Candida species. Patients also suffer from strong side effects (Cowen, 2008;
Cowen et al., 2014). Therefore, it is crucial to understand the mechanism of antifungal
resistance and identify new targets for fungal infection therapy.
The cell wall is a promising target in the study of antifungal drugs for many reasons. First,
cell walls are unique structures in fungi so targeting cell wall synthesis can avoid side
effects to human and animal host cells. Furthermore, as mentioned previously, cell wall
integrity is vital for fungi survival under stress conditions (Levin, 2005). Thus, the CWI
pathway may be a novel target for killing the fungal pathogens. Mutant Aspergillus
strains with defects in the cell wall have shown reduced virulence in mouse infection
models (Valiante et al., 2015). Moreover, AfMKK2 deletion leads to increased sensitivity
to antifungals (Dirr et al., 2010). In Candida albicans, mutations in CaCAS5, a
transcriptional regulator of CWI targets, made cells more sensitive to caspofungin (Bruno
et al., 2006). These findings suggest that the CWI pathway is critical for fungal virulence
and antifungal resistance. Since Tra1 may be required for the CWI pathway activation
(Berg et al., 2018), it could be a potential target for antifungal drug development.
Another cellular stress response pathway that has been found relevant to pathogen
virulence and drug resistance is the calcineurin pathway. Calcineurin is vital for fungal
virulence and survival in the host environment. A cna1 mutation Cryptococcus
neoformans strain is viable but cannot survive at 37 °C or alkaline pH and is not toxic in
a rabbit model (Odom et al., 1997). Reduced virulence of C. albicans carrying a
calcineurin mutation was also seen in a mouse model of systemic infection (Blankenship
et al., 2003). Furthermore, calcineurin inhibitors FK506 and cyclosporine A and their
analogs have been shown to have protective effects against fungal infections (Lee et al.,
2018; Pandit, 2003). Treatment with a calcium channel blocker amlodipine, in
combination with fluconazole, caused significant cell death in fluconazole-resistant C.
albicans strain (Liu et al., 2016). All the evidence indicates that the calcineurin pathway
is critical for antifungal resistance. To further study the mechanism, whole proteomic
analyses were performed in the well-studied S. cerevisiae to identify calcineurin targets.
Seventy candidates were found to interact with the calcineurin signaling pathway,
involved in membrane structure, polarized growth, protein trafficking, and cell wall
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integrity (Goldman et al., 2014), indicating the multifunctional role of calcineurin in
regulating fungal survival. As previously demonstrated, Tra1 has been linked to
calcineurin signaling regulation. Therefore, I will study the mechanisms on how Tra1
regulates the calcineurin pathway activation and its role in antifungal resistance.
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Figure 1.7 Mechanism of action of common antifungal agents.
Azoles inhibit the cytochrome P450 dependent enzyme lanosterol 14α-demethylase,
which interrupt the synthesis of ergosterol, the main sterol in fungal cell membrane.
Polyenes bind to ergosterol, leading to membrane depolarization and leakage of
intracellular cations. Echinocandins inhibit β(1,3)-d-glucan synthesis and cause cell
wall defect. Calcineurin inhibitors which suppress calcineurin activation also prevent
fungal infections. Figure modified from Alzohairy et al., 2014.
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1.10 Fluorescent-tagged yeast model of Huntington’s
Disease
The baker's yeast S. cerevisiae has been widely studied as a model for neurodegeneration
such as AD, PD, ALS, and HD (Bharadwaj et al., 2010; Fushimi et al., 2011; Outeiro and
Lindquist, 2003). Although there is no HTT ortholog in the yeast genome, expressing the
first 17 amino acids of Httex1 followed by different length of polyQ repeat sequences
successfully mimic the toxic phenotype and protein aggregation observed in mammalian
models of HD (Duennwald, 2011; Krobitsch and Lindquist, 2000). Several CAA codons
are interrupted into the CAG repeats to prevent the expansion and contraction of the
accurate number of polyQ repeats. Removal of the proline-rich region and adding a
FLAG-tag is also required for polyQ toxicity in the yeast model (Duennwald et al., 2006).
Furthermore, our study demonstrated that different fluorescent tag can also differentially
affect polyQ toxicity and aggregation morphology in yeast (Jiang et al., 2017). A series of
cellular phenotypes have been reported using the yeast model of HD, including
transcriptional dysregulation, ER stress and ER-associated degradation defects, vesicle
trafficking defects, and impaired mitochondrial function (Duennwald and Lindquist, 2008;
Kumar et al., 2014; Nath et al., 2015; Quintanilla and Johnson, 2009). Overall, yeast
provides us with an excellent model to investigate cellular mechanisms in misfolded
protein stress responses and understand polyQ toxicity in HD.

Yeast model used in this thesis
The yeast model of HD used in this thesis is optimized from previous studies (Duennwald
and Lindquist, 2008; Krobitsch and Lindquist, 2000). Strains used in this thesis are
derivatives of W303a or BY4741/4742. Briefly, the polyQ high expression model uses
the human Httex1 fragment carrying non-pathological 25Q or HD-associated 46Q/72Q
expansion regions designed under a GAL promoter, and tagged with a yeast optimized
fluorescent protein (FP). The high expression model mimics the toxic polyQ condition.
Cells show an obvious growth defect when 72Q is induced by switching the carbon
source from glucose to galactose. Aggregation is observed in cells expressing 46Q and
72Q. The polyQ low expression strain uses the human Httex1 fragment with 25Q/103Q
regions designed under a MET25 promoter. Cells display little growth defect when
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induced in synthetic complete media lacking methionine in standard growth condition.
The model successfully mimics the cellular mechanisms of HD at early time points
before neuronal cell death which provides us a good tool to investigate the underlying
mechanisms to cope with mutant Htt accumulation and polyQ toxicity under stress
conditions.

Flanking sequence affects polyQ toxicity in yeast
Previous literature reported that the endogenous C-terminal polyproline region of Httex1
has profound effects on polyQ toxicity in yeast (Duennwald et al., 2006). PolyQ toxicity
requires the deletion of the proline-rich region. In the presence of the proline-rich region,
polyQ only formed one or two tight fluorescent foci, whereas they displayed multiple
aggregates throughout the cytosol without the proline-rich sequence. The large aggregate
formed by mutant Htt containing proline-rich region was found to co-localize with
aggresome markers (Wang et al., 2009). Chaperones can be recruited to aggresomes to
help with protein refolding and degradation. Autophagy was found to facilitate
aggresome degradation (Johnston et al., 1998). Thus, the proline-rich sequence may
direct Htt into the aggresome to prevent misfolding. Furthermore, many proteins have
been found to interact with proline-rich regions including molecular chaperones and
protein remodeling proteins (Kay et al., 2000), so the mechanism may involve the
recruitment of chaperone proteins that need further investigations. On the other hand, a
FLAG-tag (DYKDDDDK) is critical for mutant Htt toxicity. The hypothesized
mechanism is that FLAG-tag mimics the sumoylation of polyQ proteins because SUMO
proteins are also enriched in negative charged amino acid at the C-terminus. And polyQ
sumoylation has been shown to enhance its toxicity (Steffan et al., 2004).
Previous studies including ours, suggested that the fluorescent tag can alter polyQ
toxicity and aggregation (Duennwald et al., 2006; Jiang et al., 2017). Tagging polyQ with
mCherry and TagBFP significantly reduce its toxicity in yeast. The full results are shown
in chapter two and three of this thesis. Since the first fluorescent protein (FP), wild-type
green fluorescent protein (GFP) discovered in Aequorea Victoria jellyfish, was used to
highlight sensory neurons in C.elegans (Tsien, 1998), FPs have become a powerful tool
in the molecular toolbox in studying protein localization, function, and interactions. A
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series of modified FPs which are brighter, exhibit enhanced photostability and cover a
broader spectral range have come out and provided scientists with better choices in
monitoring different proteins and cellular structures(Chudakov et al., 2010). For instance,
a yeast GFP clone integrated into the yeast chromosome has been made to obtain a better
result when labelling proteins in yeast (Niedenthal et al., 1996).
The most commonly used FPs are enhanced version of wild-type GFP (EGFP) as well as
the original blue (BFP), cyan (CFP) or yellow (YFP) derivatives. Another group is the
red fluorescent proteins (RFP) cloned from corals which have a longer excitation
wavelength. However, choosing which fluorescent tag to use must consider different
experimental conditions and the misfolding of the fusion proteins. Different FPs have
different structures and thus chromophores. The GFP family has a barrel structure where
an alpha-helix runs through eleven beta-sheets (Evdokimov et al., 2006; Henderson and
Remington, 2005). The GFP-like chromophore in Aequorea victoria GFP is achieved by
cyclization at positions 65–67 (Ser-Tyr-Gly) (Barondeau et al., 2003). Although RFPs
have a similar structure with GFP, the post-translational modification is diverse. For
example, the bond between the alpha-carbon and nitrogen of 66 Gln in DsRed is
dehydrogenated, which extends the GFP chromophore by forming C==N==C==O at the
2-position of the imidazolidinone (Gross et al., 2000; Yarbrough et al., 2001). FPs usually
have a tendency to oligomerize, which can interfere with their fusion partners (Loening et
al., 2007; Wall et al., 2000). Through mutation studies and protein engineering techniques,
better FPs have been developed (Table 1.1). However, it also raises the question on which
FPs to use and how to assess their impact on targeted proteins. Most assays available
were performed in vitro or not suitable for large-scale analysis. Therefore, a rapid and
high-throughput assay is imperative to assess the impact of FPs on their fusion partners.
Overall, the ideal FP would have sufficient photostability and brightness to provide a
detectable signal (Shaner et al., 2005). In addition, using monomeric versions of FPs
could avoid aberrant oligomerization and toxicity (Campbell et al., 2002). Erik Snapp and
his group have developed an array of monomeric oxidizing environment-optimized FPs
(moxFPs). These moxFPs could avoid non-native disulphide bond formation between
cysteine residue, providing a brighter signal and more accurate protein localization of ER
and secretory proteins (Costantini et al., 2015). It also needs to be noted that FPs must
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have minimal crosstalk in excitation and emission channels during multiple-labelling
experiments (Lata et al., 2006).
Using modern FPs, we are able to optimize the previous yeast model of HD as a
compelling tool to study cellular functions during polyQ expansion through fluorescence
microscopy techniques. Furthermore, the yeast polyQ model provides researchers a high
throughput tool for assessing the impact of FPs on their target in vivo.
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Table 1.1 Modern fluorescent proteins
FPs

Origin

sfGFP

Aequorea
Victoria
GFP
B.
lanceolatum
LanYFP
Discosoma
DsRed
Synthetic

NeonGreen
mCherry
mScarlet
FusionRed

TagBFP2

moxBFP

Entacmaea
quadricolor
sea anemone
RFP
Entacmaea
quadricolor
sea anemone
RFP
Aequorea
Victoria
GFP

Peak
Excitation
485nm

Advantages

Oligomerization

Reference

High folding
efficiency

Monomer

(Pédelacq et al.,
2006)

506nm

Bright,
monomeric

Monomer

(Shaner et al.,
2013)

587nm

High
photostability
Truly
monomeric
Low toxicity
in vivo

Monomer

(Shaner et al.,
2004)
(Bindels et al.,
2017)
(Shemiakina et
al., 2012)

high pH
stability, fast
chromophore
formation
Optimized
for oxidizing
environments

Oligomer

(Subach et al.,
2011)

Monomer

(Costantini et al.,
2015)

569nm
580nm

399nm

385nm

Monomer
Monomer
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1.11 Objectives and hypothesis
Cellular stress responses are crucial for cell survival and growth under stress conditions.
Dysregulation of cellular stress responses is linked to different diseases including
inflammation (Muralidharan and Mandrekar, 2013), cancer (Herr and Debatin, 2001),
neurodegenerative diseases (Chafekar and Duennwald, 2012; Puspita et al., 2017), and
fungal infections (Brown et al., 2014). The activation of stress response pathways
requires the transcription of stress-induced genes encoding molecular chaperones,
metabolic enzymes, and proteins involved in biomass synthesis (Estruch, 2000). However,
the transcriptional regulations of cellular stress responses, especially the roles of
transcription coactivators and post-translational modifications of histones, remain elusive.
Available high throughput approaches and comparative genomics to human make S.
cerevisiae an excellent model to study the activation of cellular stress response pathways.
The transcriptional co-activator Tra1 within the SAGA and NuA4 HAT complexes has
been found to be critical during cell stress (Hoke et al., 2008). How Tra1 regulates
cellular stress responses and its implication in stress-related diseases is poorly understood.
Therefore, my thesis investigates Tra1-dependent regulation of stress response pathways
in a yeast model of HD, determining its role in cellular stress responses such as the
TORC1 pathway, the HSR, and the CWI pathway, as well as their implications for
antifungal drug resistance.
My overall hypothesis is that Tra1 is a key regulator of cellular stress responses
through its role in the SAGA acetyltransferase complex, activating transcription, and
represents a potential therapeutic target for stress-related human diseases such as
Huntington’s Disease and fungal infections.

Chapter 2. Polyglutamine toxicity in yeast uncovers
phenotypic variations between different fluorescent protein
fusions.
Rationale: Flanking sequences could alter polyQ toxicity in yeast (Duennwald et al.,
2006). FPs differ in their physical properties and can affect protein function of their
fusion partners. Therefore, we provide a novel series of vectors based on the latest yeastoptimized FPs for efficient investigation of polyQ toxicity in yeast. Furthermore, there
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are no rapid and high throughput methods available to assess the effects of FPs on their
fusion partners. We may be able to develop an efficient assay to evaluate new FPs using
the yeast model of HD.
Hypothesis: Different FPs alter the polyQ aggregation morphology and toxicity. The
yeast polyQ model is an ideal in vivo tool to assess the impact of fluorescent tags,
especially on naturally oligomeric or misfolded proteins.

Chapter 3. Polyglutamine toxicity assays highlight the
advantages of mScarlet for imaging in Saccharomyces
cerevisiae.
Rationale: RFPs are the most popular alternatives to GFP in fluorescent imaging.
Different monomeric versions of RFP have been developed over the years that provide a
stable and robust signal. Observed from our polyQ yeast model, unlike what is reported
for green FP variants, yemRFP tagged polyQ expansions show reduced toxicity and a
different pattern of aggregates (Jiang et al., 2017). Thus, it is crucial to test the effect of
two latest versions of RFP, mScarlet, and FusionRed, on their binding partners using the
method we developed.
Hypothesis: The ymScarlet has significant advantages over the previous generation of
red FPs for use in fluorescent fusions in yeast.

Chapter 4. Sfp1 links TORC1 and cell growth regulation to
the yeast SAGA-complex component Tra1 in response to
polyQ proteotoxicity.
Rationale: Acetylation of histones has been shown to be impaired by polyQ expansions
in different HD models (Gray, 2011; Steffan et al., 2001). Tra1 is an essential component
of both the SAGA and NuA4 HAT complexes. Our preliminary data showed that Tra1
mutant cells are more sensitive to polyQ toxicity. Moreover, previous papers have shown
the interaction between Tra1 and Sfp1, linking the regulation of Tra1 to TORC1 pathway
and cell growth (Lempiäinen et al., 2009). Importantly, Tra1 is considered functionally
equivalent to TRRAP in mammals and TRRAP was identified as a cofactor for c-Myc in
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regulating oncogenic transformation (McMahon et al., 1998). Thus, the results may
indicate a novel pathway impaired by polyQ in HD.
Hypothesis: PolyQ impairs Tra1 signaling through dysregulation of the TORC1/Sfp1
pathway, leading to defect in SAGA HAT complex and transcription activation.

Chapter 5. Impaired Tra1-dependent transcription during
heat shock in the presence of polyQ expansions
Rationale: Impaired HSR by expanded polyQ expression has been found in both yeast
and mammalian system (Chafekar and Duennwald, 2012). Importantly, upon exposure to
stress, neuronal cells accumulate damaged proteins and lack a fully functional
proteostasis network to cope with this damage. Therefore, the impaired protein
homeostasis may lead to dysfunction of multiple cellular functions and reveal the
pathological hallmarks of HD and other neurodegenerative diseases.
Hypothesis: Heat shock sensitivity of cells expressing polyQ expansions can be traced
back to the defect of Tra1/SAGA which regulates the activation of the heat shock
response and the cell wall integrity pathway.

Chapter 6. Tra1 is a novel potential target for antifungal
therapy.
Rationale: The calcineurin pathway regulates cell growth and drug resistance in many
fungal pathogens (Juvvadi et al., 2014; Liu et al., 2015). Our preliminary data suggest
that Tra1 plays a vital role in regulating calcineurin signaling and cell sensitivity to
antifungal drugs. Thus, Tra1 could be a new target for antifungal drug development.
Hypothesis: Tra1 mediates cell growth and antifungal drug resistance through the
activation of the calcium-calcineurin pathway in yeast.
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Chapter 2

2

Polyglutamine toxicity in yeast uncovers phenotypic
variations between different fluorescent protein fusions

Fluorescent proteins (FPs) have revolutionized the work of scientists by allowing the
direct visualization of protein trafficking and localization in living cells. However, FPs
are too often seen as interchangeable building blocks than can be easily swapped to
accommodate a specific imaging condition. In this study, we will monitor polyQ toxicity
and aggregation in a yeast model of HD to highlight the differential impact of the most
common FPs on the behavior of fluorescent reporters.

2.1 Abstract
The palette of fluorescent proteins (FPs) available for live-cell imaging contains proteins
that strongly differ in their biophysical properties. FPs cannot be assumed to be
equivalent and in certain cases could significantly perturb the behavior of fluorescent
reporters. We employed Saccharomyces cerevisiae to comprehensively study the impact
of FPs on the toxicity of polyglutamine (polyQ) expansion proteins associated with
Huntington's disease. The toxicity of polyQ fusion constructs is highly dependent on the
sequences flanking the polyQ repeats. Thus, they represent a powerful tool to study the
impact of fluorescent fusion partners. We observed significant differences on polyQ
aggregation and toxicity between commonly used FPs. We generated a novel series of
vectors with latest yeast-optimized FPs for investigation of Htt toxicity, including a
newly optimized blue FP for expression in yeast. Our study highlights the importance of
carefully choosing the optimal FPs when designing tagging strategies.

2.2 Introduction
The ability to visualize protein localization in living cells or whole organisms has been
the driving force behind a myriad of new technological innovations in fluorescence
microscopy that revolutionized our ability to address many biological problems (Betzig,
2015; Sengupta et al., 2014). The engineering of the green fluorescent protein (GFP)
reporter (Chalfie et al., 1994) paved the way for the subsequent discovery and
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optimization of other fluorescent genetically encoded reporters that can be employed to
tag native proteins. Since the pioneer work on GFP, several other FPs have been
characterized, covering the whole ensemble of the light spectrum, from the ultraviolet to
the far red (Miyawaki et al., 2012; Morozova et al., 2010; Rizzo et al., 2009; Shaner et al.,
2004; Shaner et al., 2007; Shaner et al., 2013). FPs vary extensively in their physical
features beyond just their spectral properties. These properties can include brightness,
photostability, maturation time, oligomeric state (monomers, dimers, multimers) and
folding capacity (Suzuki et al., 2012). While these reporter proteins have been
instrumental in several discoveries, the addition of a fluorescent tag can disrupt the
normal function of the protein of interest (Han et al., 2015). First, not all FPs are equally
suitable for every cellular compartment. For example, when using fluorescent fusion
proteins that enter the oxidizing environment of the endoplasmic reticulum, one should
avoid FP containing internal cysteines that may cause creation of aberrant, non-native
disulfide bond resulting in formation of misfolded and non-fluorescent FP oligomers
(Aronson et al., 2011; Costantini and Snapp, 2013; Costantini et al., 2013; Costantini et
al., 2015). Accumulation of a significant pool of such dark misfolded oligomers can not
only lead to a significant underestimation of protein concentrations, but also cause
unwanted protein interactions, especially with the cellular protein quality control
machinery (Aronson et al., 2011). Second, all FPs originally isolated from either corals or
jellyfish exist as oligomers in their environment of origin. For example, GFP forms a
complex with aequorin and the original DsRed is a tetramer. Original studies have shown
that GFP can form dimers in crystals (Yang et al., 1996) and when present at high
concentration in solution (Phillips, 1997). Therefore, efforts were directed into improving
the monomeric status of FPs. Discovery of mutations that improve the monomeric nature
of GFP (Zacharias et al., 2002) and DsRed (Shaner et al., 2004) paved the way for
improvement of the fluorescent protein technology. The tendency of several FPs to
oligomerize has been shown to artificially lead to cellular membrane reorganization
(Costantini et al., 2012; Snapp et al., 2003). Moreover, several studies have shown that
FPs originally characterized as monomers were prone to aberrant protein interactions
(Costantini et al., 2012; Costantini et al., 2015; Lam et al., 2012; Shemiakina et al., 2012).
It was recently shown that the choice of a specific FP can significantly alter the behavior
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of tandem fluorescent protein timers used to measure protein turnover in living cells
(Khmelinskii et al., 2016). The behavior of FP’s can also be potentially affected by
several other factors such as pH and other physical properties (Patterson et al., 1997) and
the size of the linker domain between the fusion partners (Chen et al., 2013). Thus, when
designing strategies to produce FP-tagged proteins, the choice of a specific FP is crucial
in order to minimize the effect on native protein and thus obtain optimal experimental
conditions reflecting untampered functions and properties of the native proteins (Snapp,
2009).
Aberrant expansion of polyglutamine (polyQ) repeats within disease-causing proteins is
at the root of several human neurodegenerative pathologies including Huntington’s
disease (HD) (Macdonald, 1993). In HD, expansion of the polyQ region (typically over
36 repeats) within the N-terminal region of the first exon of the Huntingtin protein (Httex1)
results in its misfolding and increased aggregation into detergent-insoluble, amyloid-like
inclusion bodies (IBs) (Gövert and Schneider, 2013). Several studies showed that polyQ
proteins assembly into toxic intermediate oligomers that preceded accumulation of IBs
represent the most toxic species of the protein which may be associated to HD
pathogenesis (Arrasate et al., 2004; Herrera et al., 2011; Lajoie and Snapp, 2010; Leitman
et al., 2013; Takahashi et al., 2007). Thus, understanding the parameters regulating polyQ
oligomer formation is critical to our understanding of HD. In order to decipher these
mechanisms, a yeast model of HD was developed (Duennwald, 2013; Krobitsch and
Lindquist, 2000; Mason and Giorgini, 2011; Meriin et al., 2002), allowing rapid and
extensive dissection of the genetic mechanisms underlying polyQ aggregation and
toxicity. Over the years, the yeast model of HD has led researchers to identify several
determinants of toxicity in HD, from chaperone proteins that assist protein folding
(Muchowski et al., 2000; Sakahira et al., 2002; Schaffar et al., 2004), to activation of
endoplasmic reticulum stress pathways (Duennwald and Lindquist, 2008), that were
subsequently validated in other models.
In most cases, assessment of polyQ aggregation and toxicity is performed using a
fluorescent fusion protein consisting of Httex1 fused to fluorescent proteins at the Cterminus following the polyQ repeats (Duennwald, 2013; Duennwald et al., 2006a;
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Duennwald et al., 2006b; Meriin et al., 2002). Based on the aforementioned ability of
fluorescent proteins to affect the behavior of the protein of interest, we hypothesized that
various fluorescent proteins could differentially affect the aggregation of toxic
polyglutamine expansion (polyQ). For example, the tendency of certain FPs to
oligomerize could lead to changes in the ability of expanded polyQ proteins to achieve or
maintain their toxic conformation. This assumption was supported by previous studies
showing that the sequences flanking polyQ proteins can alter their ability to oligomerize
into the SDS-insoluble toxic IBs characteristic of HD (Duennwald et al., 2006a).

2.3 Materials and Methods
Yeast strains and culture conditions
All strains are derived from W303 Mat a (Thomas and Rothstein, 1989). In order to
assess polyQ protein aggregation and toxicity, cells expressing the different plasmids
were grown overnight in synthetic complete media using appropriate selection media to
maintain plasmids. Cells were then washed twice with media containing 2% galactose
and resuspended to OD600nm 0.2 and incubated at 30oC in a rotator drum for the indicated
amounts of time to induce polyQ expression. Spot assays were performed by spotting 5X
dilutions of OD600nm 0.2 on agar plates. Plates were photographed using a GelDoc system
(Bio-Rad Laboratories) Liquid growth assays were performed using a Bioscreen C
(Growth Curves USA, Piscataway, NJ) plate reader set at 30oC.

Plasmids
The original 25 and 72Q-CFP lacking the proline rich sequence (ΔPRO) vector were
previously described (Duennwald et al., 2006b; Duennwald et al., 2006a). To generate the
construct without the FP we introduced a stop codon downstream of the polyQ region.
All new vectors were generated by cloning the GAL-polyQ-ΔPRO fragment into the
SacI/SpeI sites of pRS415. The various new fluorescent proteins were subsequently
cloned into the SpeI/SalI sites. All fragments were generated using standard PCR
methods. The yemsfGFP vector was obtained from Erik Snapp (Albert Einstein College
of Medicine) and a monomerizing mutation (V206K) was inserted using site directed
mutagenesis. ymNeonGreen (Shaner et al., 2013) was obtained from Allelebiotech (San
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Diego CA). yemRFP was from Neta Dean (Keppler-Ross et al., 2008). yomTagBFP2
(#44899) was obtained from Addgene and previously characterized (Lee et al., 2013).
ymoxBFP was synthetized by Genscript (Piscataway, NJ) based on the moxBFP
sequence previously published (Costantini et al., 2015). All constructs were validated by
sequencing and are listed in Table 2.1. All primer sequences can be found in Table 2.2.
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Table 2.1 Plasmids used in this study

Plasmids

Number

Vector

Resistance

Reference

Leu+

This study

Ura+

(Duennwald et al.,

Backbone
GAL-FLAG-25QΔPRO-CFP

pPL001

pRS415

GAL-FLAG-72QΔPRO-CFP

pPL002

(CEN/ARS)

GAL-FLAG-25QΔPRO

pPL003

GAL-FLAG-72QΔPRO

pPL004

GAL-FLAG-25QΔPRO-ymsfGFP

pPL005

GAL-FLAG-72QΔPRO-ymsfGFP

pPL006

GAL-FLAG-25QΔPRO-yemRFP

pPL007

GAL-FLAG-72QΔPRO-yemRFP

pPL008

GAL-FLAG-25QΔPRO-

pPL009

ymNeonGreen
GAL-FLAG-72QΔPRO-

pPL010

ymNeonGreen
GAL-FLAG-25QΔPRO-

pPL011

yomTagBFP2
GAL-FLAG-72QΔPRO-

pPL012

yomTagBFP2
GAL-FLAG-25QΔPRO-ymoxBFP

pPL013

GAL-FLAG-72QΔPRO-ymoxBFP

pPL014

GAL-FLAG-103Q ΔPRO-

pPL015

yomTagBFP2

pPL016

GPD-yomTagBFP2

pPL017

GPD-ymoxBFP
GPD-FLAG-103Q+PRO-GFP

-

pRS416
(CEN/ARS)

GAL-FLAG-25QΔPRO

pPL018

pRS424

GAL-FLAG-72QΔPRO

pPL019

(2µ)

GAL-FLAG-25QΔPRO-yemsfGFP

pPL020

GAL-FLAG-72QΔPRO-yemsfGFP

pPL021

2006)
+

Trp

This study
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Table 2.2 Primers used in this study

Template

Primers

GAL-FLAG-25/72QΔPRO

F: GATCGAGCTCCGGATTAGAG CCGC
R: GATCACTAGTGGATCCCCCGGGCTG

ymSFGFP

F: GATCACTAGTGTGAGCAAGGGCGAG
R: GATCGTCGACCTACTTGTACAGCTCGTCCATG

yemRFP

F: GATCACTAGTGTTTCAAAAGGTGAAG
R: GATCAAGCTTTTATTTATATAATTC

ymNeonGreen

F: GATCACTAGTGTATCCAAAGGTGAAG
R: GATCGTCGACCTACTTATACAATTCATCCATAC

yomTagBFP2

F: GATCACTAGTAGTGAGTTGATTAAGG
R: GATCGTCGACTTAGTTTAGTTTGTGTCCC

ymoxBFP

F: GATCACTAGTGTCTCAAAGGGTGAAGAATTG
R: GATCGTCGACCTTATACAATTCATCCATACCC

ymSFGFP V206K

F: TTGTCTACCCAATCAGTATTGTCCAAAGATCA
R: TTGTCTACCCAATCAAAATTGTCCAAAGATCA

yomTagBFP2 (with Kozak

F: GATCACTAGTCTAAAAATGAGTGAGTTGATTAAGG

and ATG)
ymoxBFP (with Kozak
and ATG)

F: GATCACTAGTCTAAAAATGAGTGAGTTGATTAAGG
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Fluorescence microscopy
Fluorescence microscopy was performed using a Zeiss 880 confocal microscope
equipped with a 405 nm diode laser for yomTagBFP2 and ymoxBFP and CFP, a 488
diode laser for ymsfGFP and ymNeonGreen and a 561 diode laser for yemRFP. Upon
polyQ expression, cells were transferred to LabTek imaging chambers (Thermo inc.) and
imaged at room temperature using a 63x PlanAprochromoat objective (1.4 NA). Images
were analyzed using the ImageJ software (https://imagej.nih.gov/ij/).

Dot blot and SDD-AGE
Biochemical analysis of polyQ oligomers were performed as previously described
(Duennwald, 2013). Briefly, cells were incubated in galactose-containing media to induce
the various polyQ constructs lysed in lysis buffer (100mM Tris pH 7.5; 200mM NaCl; 1
mM EDTA; 5% glycerol, 1mM Dithiothreitol (DTT). Protease inhibitors were added
directly before use: 4 mM phenylmethylsulfonyl fluoride (PSMF) and SigmaFast
protease inhibitor cocktail (Sigma-Aldrich, St.Louis MO). Cells were lysed using glass
beads. For dot blot, equally amount of proteins were spotted on nitrocellulose membranes
using a vacuum manifold and processed for immunoblot detection using an anti-FLAG
antibody (SIGMA-Aldrich, #F3040). For SDD-AGE or an anti-Pgk1 antibody, samples
were loaded on a 1.5% agarose gel containing 0.1% SDS and transferred onto
nitrocellulose membrane for immune detection as previously described (Halfmann and
Lindquist, 2008).

Statistical analysis
In order to quantify changes in yeast cells growth, growth curves were generated using
the BioscreenC and area under the curve was calculated using Graphpad Prism (La Jolla,
CA). Statistical significance was calculated using a two-tailed Student’s t-test where
indicated.
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2.4 Results and Discussion
The presence of a fluorescent protein tag unmasks expanded
Httex1 toxicity
In yeast, as in other model organisms, expression of Httex1 carrying disease-associated
length of polyQ repeats results in oligomerization, aggregation into IBs and cellular
toxicity that can be measured through reduced growth on agar plates (Duennwald, 2013).
The original constructs systematically tested by the Lindquist group contains Httex1
tagged at the N-terminus with a FLAG epitope tag and a fluorescent CFP at the Cterminus (Duennwald et al., 2006b). In absence of the FLAG tag, the expanded HDassociated fluorescent Httex1 protein displayed a significant change in IBs morphology,
resulting in soluble and non-toxic aggregates. These results highlight the fact that the
nature of the sequences flanking the polyQ region is indeed regulating its ability to
acquire the toxic conformation (Duennwald et al., 2006a). In our studies, we chose to use
an expanded Httex1 construct containing 72Q rather than the original 103Q (Duennwald et
al., 2006b). This length induces reduced toxicity therefore allowing us to test for
increased sensitivity to different conditions. Consistent with the finding that flanking
sequences modulate polyQ toxicity, we found that expression of FLAG-72Q protein
without the C-terminal CFP fragment (72Q-Stop) was not toxic (Figure 2.1A and B) even
when expressed at high levels from a multicopy plasmid (Figure S2.1). The CFP-tagged
version of 72Q showed typical toxic aggregates observed by fluorescence microscopy
(Figure 2.1C). Interestingly, both 72Q-CFP and 72Q-Stop constructs show similar ability
to

oligomerize

when

analyzed

on

Semi-Denaturing

Detergent

Agarose

Gel

Electrophoresis (SDD-AGE), a technique routinely employed to assess Httex1 aggregation
and detergent solubility (Halfmann and Lindquist, 2008) (Figure 2.1D). A dot blot was
performed using the same lysates to assess expression levels of the different constructs
(Figure 2.1D and S2.2).

Thus, our data argue that while both fusion proteins can

oligomerize and aggregate, only the CFP-tagged polyQ appears to be able to acquire a
toxic conformation. It is possible that addition of the fluorescent tag changes the
biophysical properties of Httex1 oligomers, leading to formation of the toxic species
similarly to what is observed with the addition of the FLAG tag at the amino terminus
end of the protein (Duennwald et al., 2006a). Indeed, recent in vitro data indicate that
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untagged Httex1 can behave differently than the tagged versions (Vieweg et al., 2016). In
addition, we found the CFP-tagged proteins produced a very weak fluorescent signal,
especially for the soluble 25Q construct. This signal is so low that it is on par or even
below that emanating from red vacuolar pigment due to the ade2-1 mutation in the W303
strain (Weisman et al., 1987) (Figure 2.1C). Given the variety of FPs available and their
frequent use of them as interchangeable building blocks, we sought to further determine
the impact of some of the most popular FPs on Httex1 aggregation and toxicity.
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Figure 2.1 C-terminal tagging of Httex1 regulates toxicity in yeast.
(A) The different Httex1 constructs contain either non-toxic 25Q or HD-associated
72Q followed by either a stop codon or a CFP fluorescent protein. Growth assays on
agar plate reveals increased toxicity of 72Q CFP –tagged Httex1 compared to the
untagged version. (B) Growth curves generated by liquid growth assays show
increased toxicity of the 72Q CFP –tagged Httex1. Area under the curve (AUC) is
shown. n=3 ±SEM, * p<0.001. (C) Representative fluorescent images of CFP-tagged
Httex1 constructs following overnight induction in galactose media displays formation
of IBs in 72Q expressing cells. (D) SDD-AGE and dot blots of cell lysates prepared
for the indicated Httex1 constructs. For dot blots, three five-fold serial dilutions of
protein lysates are shown. Httex1 proteins were detected using an anti-FLAG antibody.
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Differential impact of
aggregation and toxicity

fluorescent

proteins

on

Httex1

We assessed the impact of different fluorescent proteins on the ability of expanded polyQ
proteins to aggregate into toxic oligomers and IBs. We chose some of the brightest FPs
available for expression in yeast.

These include the yeast codon optimized and

monomeric versions of superfolder GFP (Pédelacq et al., 2006) (ymsfGFP), mNeonGreen
(Shaner et al., 2013) (ymNeonGreen), Cherry (Keppler-Ross et al., 2008) (yemRFP), and
TagBFP2 (yomTagBFP2) (Lee et al., 2013). All polyQ fusion proteins were cloned into a
low copy yeast vector under the control of the GAL1 promoter (Figure 2.2A). Expression
of these constructs in yeast cells led to two unexpected observations: first, we observed
that unlike its ymsfGFP, ymNeonGreen and yemRFP counterparts, 72Q-yomTagBFP2
showed no aggregation and displayed features similar to 25Q tagged with other FPs
(Figure 2.2A). Second, we found that that while both 72Q-ymsfGFP and ymNeonGreen
displayed strong growth inhibition compared to their 25Q counterparts, 72QyomTagBFP2 showed no toxicity and grew as well as 25Q yom-TagBFP (Figure 2.2B
and C). Interestingly, 72Q-yemRFP showed intermediate toxicity (Figure 2.2B and C).
Since aggregation and toxicity of Httex1 can be traced back to its ability to oligomerize,
we tested the ability of these proteins to oligomerize using SDD-AGE (Halfmann and
Lindquist, 2008). Surprisingly, 72Q-yemRFP displayed lower levels of SDS-resistant
oligomers compared to ymsfGFP or ymNeonGreen (Figure 2.2D). While 72Q-yemRFP
IBs appear similar to ymsfGFP IBs by fluorescence microscopy, these appear to have
different levels of solubility that could explain the milder growth defect. It is important to
note that different disease-causing aggregating proteins can form different types of IBs.
For example TDP43, a protein associated with amyotrophic lateral sclerosis (ALS), forms
SDS-soluble oligomers that are distinct from Httex1 oligomers (Johnson et al., 2008).
Moreover, TDP43 IBs formation is independent of the yeast prion protein Rnq1, which is
required for formation of Httex1 IBs (Meriin et al., 2002). We found that expanded Httex1yemRFP proteins still required Rnq1 since their expression in rnq1Δ cells did not result
in appearance of IBs (Figure S2.3). Therefore, yemRFP may only slightly mask polyQ
protein toxicity. This is consistent with a previous report that red fluorescent proteins can
impair protein behavior (Costantini et al., 2015; Shemiakina et al., 2012; Snaith et al.,

81

2010). One could envisage that robust folding of the FPs such as sfGFP and the bright
mNeonGreen (Pédelacq et al., 2006; Shaner et al., 2013) favors formation of toxic species
of polyQ oligomers by uncoupling the folding trajectory of the FP from the folding of
Httex1. By contrast, slower folding FPs are more prone to aberrant interactions that could
in turn favor the formation of non-toxic oligomers similarly to what is observed in the
construct that contain the proline rich region adjacent to the polyQ stretch in Httex1
(Duennwald et al., 2006a). However, we observed that robust β-barrel folders, such as
ymsfGFP displays similar toxicity compared to the original, non-optimized, CFP tagged
72Q construct (Figure S2.4). These data argue against a role for an FP's folding capacity
in Httex1 toxicity in yeast. Therefore, it appears that the phenotype observed for yemRFP
is probably caused by the previously reported inherent ability of red FPs to
oligomerize/aggregate (Costantini et al., 2012; Lam et al., 2012; Merzlyak et al., 2007;
Shemiakina et al., 2012). We should also note that the original CFP construct is not
monomerized but still induces toxicity, indicating that unlike what we observed for red
FPs, for Aequorea-derived FPs (GFP and its derivatives), the weaker tendency to
oligomerize does not appear to have a significant impact on Httex1-fusion toxicity.
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Figure 2.2 Differential impact of fluorescent proteins on Httex1 aggregation and
toxicity.
(A) 25Q and 72Q FLAG-Httex1 were fused to indicated yeast-optimized fluorescent
proteins. Representative fluorescent images of fluorescently tagged Httex1 constructs
following overnight induction in galactose media. (B) Spot assay on agar plates
reveals increased toxicity of 72Q-ymsfGFP/ymNeonGreen when compared to 72QyemRFP and yomTagBFP2. (C) Growth curves generated by liquid growth assays
show increased toxicity of the 72Q-ymsfGFP/ymNeonGreen. Area under the curve
(AUC) is shown. n=3, ±SEM * p<0.001. (D) SDD-AGE and dot blots of cell lysates
prepared for the indicated Httex1 constructs. For dot blots, three five-fold serial
dilutions of protein lysates are shown. Httex1 proteins were detected using an antiFLAG antibody.
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Optimized blue Httex1 protein fusion
Curiously, 72Q-yomTagBFP2 proteins migrated faster on the SDD-AGE gel compared to
the other 72Q constructs tagged with either ymsfGFP or ymNeonGreen (Figure 2.2D).
This indicates the presence of smaller oligomers that are not incorporated into IBs when
observed by fluorescence microscopy (Figure 2.2A). We originally chose yomTagBFP2
because it had been characterized as the optimal blue fluorescent protein for expression in
yeast (Lee et al., 2013). Recently, a new generation of fluorescent proteins, the moxFPs
have been described. These monomeric proteins lack internal cysteines and are therefore
optimized for the secretory pathway (Costantini et al., 2015). We codon optimized
moxBFP for expression in yeast and generated fusions with either 25 and 72Q Httex1
(Figure 2.3A). Interestingly, we found that unlike yomTagBFP2 tagged fusions, 72QymoxBFP displayed robust aggregation and toxicity (Figure 2.3 A-C). When we
compared the fluorescent signal of the diffuse 25Q constructs tagged with either of the
blue FPs we observed that ymoxBFP was significantly brighter than yomTagBFP2
(Figure 2.3D). Interestingly, we observed that 72Q-yomTagBFP2 displayed lower
fluorescent signal than the 25Q-yomTagBFP2 fusion (Figure 2.3E). We have previously
observed a similar phenomenon with the expanded mHttex1 proteins in mammalian cells
(Lajoie and Snapp, 2010). This may reflect increased degradation of the polyQ expansion
proteins. Thus, the yomTagBFP2 vectors could help studying the behavior of expanded
mHttex1 in absence of IBs that complicate both biochemical and fluorescent imaging
experiments. Finally, increased aggregation and toxicity of the moxBFP tagged
constructs correlated with slower migration of the ymoxBFP 72Q oligomers on SDDAGE (Figure 2.3F).
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Figure 2.3 New optimized ymoxBFP increases Httex1 toxicity.
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Figure 2.3
(A) Httex1 constructs generated contain either non-toxic 25Q or HD-associated 72Q
followed by either a yom-TagBFP2 or ymoxBFP fluorescent proteins. Growth assays
on agar plates reveal increased toxicity of 72Q ymoxBFP –tagged Httex1 compared to
the yomTagBFP2 tagged version. (B) Growth curves generated by liquid growth
assays show increased toxicity of the 72Q ymoxBFP tagged Httex1. Area under the
curve (AUC) is shown. n=3, ±SEM * p<0.001. (C) Representative fluorescent images
of yomTagBFP2/ymoxBFP-tagged Httex1 constructs following overnight induction in
galactose media displays formation of IBs in 72Q-ymoxBFP expressing cells. (D)
ymoxBFP significantly increases fluorescent intensity of 25Q-Httex1. Representative
fluorescent images of yomTagBFP2/ymoxBFP-tagged 25Q Httex1 constructs
following overnight induction in galactose. Images were collected using the same
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted
black and white images are shown for clarity. Plot of quantified individual cell mean
fluorescent intensities is shown for comparison. * p<0.001 (E) 72Q- yom-TagBFP2 is
significantly dimmer than its 25Q counterpart. Images were collected using the same
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted
black and white images are shown for clarity. Plot of quantified individual cell mean
fluorescent intensities is shown for comparison. * p<0.001 (F) SDD-AGE and dot
blots of cell lysates prepared for the indicated Httex1 constructs. For dot blots, 3
different serial dilutions of protein lysates are shown. Httex1 proteins were detected
using an anti-FLAG antibody.
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Our imaging result contrasts with the original report showing that TagBFP is significantly
brighter that than EBFP2, at least in solution (Subach et al., 2008). However, optimal
brightness will be possible only when FPs are expressed alone or when fused with well
folded proteins (Pédelacq et al., 2002; Waldo et al., 1999). Indeed, the superfolder variant
of GFP was created by screening for its ability to fluoresce when fused to poorly folded
proteins (Pédelacq et al., 2006). Thus, fusion of yomTagBPF2 with misfolded Httex1
could be problematic. It is important to note that the new moxBFP generated by
Costantini et al (Costantini et al., 2015) contains both superfolded mutations and
additional cycle-3 GFP mutations (F99S and V163A) (Crameri et al., 1996) that would
make it a robustly folded fusion partner. Indeed, we found that when expressed alone in
the yeast cytosol under a constitutive promoter, yomTagBFP2 was slightly brighter than
moxBFP (Figure 2.4). While the mean fluorescent intensity across the cell population
was similar, the standard deviation of the fluorescence signal was significantly higher for
yomTagBFP2. This result indicates that while yomTagBFP2 may be the brightest blue FP,
ymoxBFP performs better in the context of fusion protein reporters. These results should
be taken in consideration when designing new blue fluorescent protein fusions.
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Figure 2.4 Cytoplasmic, untagged yomTagBFP2 is brighter than ymoxBFP.
Cells constitutively expressing either yomTagBFP2 or ymoxBFP from the GPD
promoter were cultured to early log phase. Images were collected using the same
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted
black and white images are shown for clarity. Plot of quantified individual cell mean
fluorescent intensities is shown for comparison.
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TagBFP2 (Subach et al., 2011) is an optimized version of TagBFP (Subach et al., 2008),
which was originally derived from TagRFP (Merzlyak et al., 2007), which, like most red
FPs was derived from multimeric proteins isolated from Anthozoa corals and anemones.
While these proteins are reported to be monomeric, several studies have found that they
are actually strongly dimerizing (Costantini et al., 2012; Lam et al., 2012; Merzlyak et al.,
2007; Shemiakina et al., 2012). Unlike mCherry, which is only weekly dimerizing
(Costantini et al., 2015) and allows for the formation of IBs (Figure 2.2A), the TagRFP
family of FPs are very prone to dimerization/oligomerization (Costantini et al., 2012;
Costantini et al., 2015). Therefore, it is plausible that yomTagBFP2 strong tendency to
oligomerize prevents expanded Httex1 interaction either with other Httex1 molecules or
with other cellular components required for incorporation of polyQ proteins into IBs such
as the prion protein Rnq1 or chaperone proteins (Duennwald et al., 2006b; Meriin et al.,
2002).
It was previously shown that polyQ-expanded Httex1 proteins are recruited into
preexisting IBs formed by non-toxic Httex1 expansion reporters containing the prolinerich domain adjacent to the polyQ repeats, irrespective of the flanking sequences
(Duennwald et al., 2006b). Thus, we used the previously published construct encoding a
non-toxic 103Q containing the Httex1 proline-rich domain tagged with eGFP (103QP-GFP)
under the constitutively active GPD promoter (Duennwald et al., 2006b) to test whether
yomTagBFP2 tagged constructs could be recruited into preexisting IBs induced by other
Httex1 fusion constructs. We observed strong recruitment of both 25Q and 72QyomTagBFP2 into 103QP-GFP IBs upon induction in galactose (Figure 2.5A). Moreover,
recruitment of 72Q-yomTagBFP2 in IBs results in increased toxicity compared to 25Q
(Figure 2.5B). These observations were not solely the result of the increased total
amount of Httex1 proteins since expression of 72Q-yomTagBFP2 from a multicopy
plasmid failed to induce IBs or cause significant toxicity (Figure 2.6A and B). Another
possibility would be that 103Q Httex1 has a greater affinity for 72Q and can override the
yomTagBFP2 tendency to oligomerize. However, expression of a 103Q-yomTagBFP2
construct did not result in either IBs formation or toxicity (Figure 2.6C). Interestingly,
IBs induced in the presence of 103QP-GFP were equally bright for both and ymoxBFP
(Figure S2.5). This might be an indication that the combination of both a longer 103Q
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Httex1 and the presence of GFP are required to alleviate the phenotype caused by
yomTagBFP2.
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Figure 2.5 Httex1-yomTagBFP2 oligomers are recruited to preexisting 103QPRO-GFP IBs.
Cells constitutively expressing 103Q-PRO-GFP were grown in galactose containing
media overnight for induction of the various Httex1-yomTagBFP2/moxBFP
constructs. (A) Representative fluorescent images show incorporation of either Httex1yomTagBFP2 or ymoxBFP constructs into 103Q-PRO-GFP IBs. (B) Spot assays on
agar plates reveal increased toxicity of 72Q- yomTagBFP2 when incorporated in
103Q-PRO-GFP IBs.
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Figure 2.6 Effects of yomTagBFP2 on Httex1 toxicity and aggregation.
(A) High expression of 72Q Httex1-yomTagBFP2 is not toxic. Representative
fluorescent images of yomTagBFP2 and ymsfGFP tagged 25Q and 72Q Httex1
constructs expressed from high copy 2µ vectors following overnight induction in
galactose media. (B) Growth assays on agar plates show that unlike for ymsfGFP, no
significant toxicity of different 72Q-yomTagBFP2 Httex1 compared to the 25Q
version. (C) Growth assay on agar plate and fluorescent imaging shows that Httex1yomTagBFP2 is not toxic and remain diffused in the cytoplasm even in presence of
103Q.
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These results indicate that while Httex1-yomTagBFP2 constructs are unable to form IBs
when expressed alone, they can be recruited by Httex1 proteins tagged with other FPs
(Figure 2.4C). Based on these data, it appears that the affinity of yomTagBFP2 is stronger
than Httex1. yomTagBFP2 oligomerization may prevent assembly of Httex1 into toxic
oligomers and IBs by either preventing interaction between different Httex1 proteins or by
potential sterically challenge recruitment of factors required for IBs formation such as
Rnq1 (Figure 2.7). This strongly suggests that the inability of 72Q-yomTagBFP2 to form
higher oligomers and incorporate into IBs is at the root of the decreased toxicity observed
with this particular construct (Figure 2.2) Therefore, these results should be taken in
considerations when using yomTagBFP2 and other red FPs and their derivatives for
fusion proteins design.
Finally, it is important for scientists to appreciate the differences between the various
properties of FPs when designing fusion proteins in experiments. In Figure 2.8, we
compared side-by-side the complete panel of polyQ constructs used in our study. For
each fluorescent fusion, imaging conditions were kept the same to acquire images of 25
and the 72Q variants (Figure 2.8). A negative control was also included to compare the
fluorescent intensity of the different constructs over the autofluorescent background of
W303 yeast cells. These experiments revealed interesting phenotypes regarding the 25Q
Httex1 fusions. While ymsfGFP, ymNeonGreen and yemRFP displayed robust signal, the
CFP tagged version showed a much dimmer signal, closer to the background noise. Also,
CFP tagged 25Q was much dimmer than the 72Q-CFP. An opposite phenotype was
observed with the optimized FPs. These data highlight the advantages of using bright
codon optimized FPs which greatly improved detection of the soluble 25Q Httex1 fusions.
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Figure 2.7 Hypothetical model of regulation of polyQ toxicity by fluorescent
proteins.
While Httex1-yomTagBFP2 cannot form IBs on their own, the can be recruited to
preexisting IBs suggesting that the fluorescent proteins impairs Httex1 interaction with
cellular component that regulate IBs formation.
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Figure 2.8 Comparison of fluorescent intensities of the different Httex1 fusions.
Httex1 constructs generated contain either non-toxic 25Q or HD-associated 72Q
followed by either a CFP, ymsfGFP, yemRFP, ymNeonGreen, yom-TagBFP2 or
ymoxBFP fluorescent proteins. For each fusion reporter, the imaging parameters were
kept the same to acquire the images of W303 cells expressing either an empty vector,
the 25Q- Httex1 or 72Q Httex1 fluorescent constructs.
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Conclusion
Our study shows that Httex1 polyQ toxicity assays in yeast can be used to detect variations
among fluorescent protein fusions and could therefore be useful for development and
optimization of current and future FPs. Our results using blue fluorescent proteins clearly
show that there is no single FP that fits all the requirement for every experiments. Thus,
we encourage scientists to use technical resources available to guide them though
fluorescent proteins design (Costantini and Snapp, 2013; Costantini et al., 2012;
Costantini et al., 2015; Cranfill et al., 2016; Lee et al., 2013; Snapp, 2009). In addition,
our new palettes of optimized fluorescent Httex1 constructs could be used for optimal
imaging conditions to study Httex1 aggregation in living cells. Finally, our study supports
a role for sequences flanking the polyQ region in the toxicity observed in HD. Together
with previous reports (Atwal et al., 2011; Caron et al., 2013; Duennwald et al., 2006a;
Tam et al., 2009), our results suggest that targeting these regions may represent a
suitable approach in modulating Htt toxicity in HD.

96

Figure S 2.1 High expression of 72Q Httex1 is not toxic in absence of a fluorescent
protein tag.
Cells expressing either 25Q or 72Q Httex1-stop from a 2µ plasmid were cultured on
galactose overnight and spotted on agar plates.

Figure S 2.2 Specificity of the dot blot approach.
Whole lysates of yeast cells expressing either an empty vector W303 cells expressing
an empty vector or the 25/72Q- Httex1 either untagged or tagged with CFP constructs
were processed for dot blotting using an anti-FLAG and anti PGK1 antibodies.
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Figure S 2.3 RNQ1 is required for aggregation and toxicity of the various
fluorescent 72Q Httex1 constructs.
(A) Representative fluorescent images of fluorescently tagged 25Q and 72Q Httex1
constructs expressed in rnq1Δ cells following overnight induction in galactose media.
(B) Growth assay on agar plates shows no toxicity of different 72Q tagged Httex1
constructs compared to the 25Q version.
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Figure S 2.4 CFP and ymsfGFP tagged Httex1 are equally toxic.
Growth assays on agar plates show no significant difference in toxicity between the
CFP and ymsfGFP tagged 72Q Httex1. Both are significantly more toxic than their
25Q counterpart.

Figure S 2.5 Fluorescent intensities of IBs induced by blue fluorescent proteins
in cells expressing 103QP-GFP.
Plot of quantified individual cell mean fluorescent intensities is shown for
comparison for cells expressing either 25Q or 72Q-yomTagBFP2 or ymoxBFP in
presence of 103QP-GFP.
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Chapter 3

3

Polyglutamine toxicity assays highlight the advantages
of mScarlet for imaging in Saccharomyces cerevisiae

The yeast polyQ model has been shown to be a good tool for assessing new fluorescent
proteins. Although polyQ-yemRFP forms aggregates in yeast, it shows reduced toxicity.
In this chapter, we will tag polyQ with newest red fluorescent proteins FusionRed and
mScarlet to test their impact on fusion partners and on the other hand, generating an
optimized yeast model of HD featured RFP.

3.1 Abstract
Development of fluorescent proteins (FPs) enabled researchers to visualize protein
localization and trafficking in living cells and organisms. The extended palette of
available FPs allows simultaneous detection of multiple fluorescent fusion proteins.
Importantly, FPs are originally derived from different organisms from jelly fish to corals
and each FP displays its own biophysical properties. Among these properties, the
tendency of FPs to oligomerize inherently affects the behavior of its fusion partner. Here
we employed the budding yeast Saccharomyces cerevisiae to determine the impact of the
latest generation of red FPs on their binding partner. We used a yeast assay based on the
aggregation and toxicity of misfolded polyQ expansion proteins linked to Huntington’s
disease. Since polyQ aggregation and toxicity are highly dependent on the sequences
flanking the polyQ region, polyQ expansions provide an ideal tool to assess the impact of
FPs on their fusion partners. We found that unlike what is observed for green FP variants,
yemRFP and yFusionRed-tagged polyQ expansions show reduced toxicity. However,
polyQ expansions tagged with the bright synthetically engineered ymScarlet displayed
severe polyQ toxicity. Our data indicate that ymScarlet might have significant advantages
over the previous generation of red FPs for use in fluorescent fusions in yeast.

3.2 Introduction
Following the development of the green fluorescent protein (GFP) from the jellyfish
Aequorea Victoria (Chalfie et al., 1994), several other FPs with various spectral
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properties have been characterized (Thorn, 2017), allowing simultaneous detection of
multiple fluorescent reporters. Among the most popular alternatives to GFP are the red
fluorescent proteins (RFPs) isolated from Anthozoa coral and anemone species. One of
the drawbacks of RFPs is that Anthozoa derived FPs are obligate tetramers (Baird et al.,
2000; Verkhusha and Lukyanov, 2004). While development of RFPs into monomeric
versions has been successful, it is often associated with reduced brightness of the
fluorescent signal (Campbell et al., 2002) and therefore reduced overall performance of
the resulting monomeric FPs. Moreover, RFPs such as TagRFP and mRuby2 reported as
monomeric by passing purified proteins through sizing columns still display high
tendency to oligomerize in living mammalian cells (Costantini et al., 2012; Costantini et
al., 2015). Thus, under specific circumstances, FPs reported as monomeric can still be
prone to oligomerization. Unwanted formation of oligomers could potentially
significantly alter the function/localization of the protein of interest fused to the FP and
render reporters unreliable (Costantini et al., 2015; Snapp et al., 2003; Zacharias et al.,
2002). Indeed, various RFPs (mCherry, mKate2, mRuby, mKO2, mApple, TagRFP-T)
have been shown to have differential effects on localization of cdc12 in yeast (Lee et al.,
2013). Thus, being able to assess the behavior of fluorescent reporter in a given organism
and/or cellular compartment is critical to help optimize fluorescent reporter design
(Snapp, 2009).
We recently established a method to rapidly compare the behavior of FPs against a
monomeric variant of superfolder GFP (msfGFP) in yeast (Jiang et al., 2017). The assays
exploit the ability of polyglutamine expansions associated with Huntington’s disease (HD)
to form toxic aggregates in yeast cells. The cause of HD can be traced back to abnormal
expansion of a polyQ stretch within the first exon of the gene encoding the Huntingtin
protein (Httex1) resulting in chorea and cognitive defects in patients (Gusella and
MacDonald, 1995; Huntington, 2003; Penney et al., 1997). Expansion over 36 repeats is
known to cause the Htt protein to misfold and aberrantly accumulate into detergentinsoluble amyloid-like aggregates in the cytoplasm of striatal neurons (Penney et al.,
1997). Expression of expanded Httex1 in yeast results in severe polyQ aggregation and
growth defect (Duennwald, 2013; Krobitsch and Lindquist, 2000; Mason and Giorgini,
2011; Meriin et al., 2002). Interestingly, the nature of the sequences flanking the polyQ
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regions (in this case fluorescent or epitope tags) greatly affects the propensity of the
polyQ expansions to aggregate and to display significant growth defects in yeast
(Duennwald et al., 2006). Using polyQ toxicity assays in yeast, we previously showed
that a yeast-optimized version of mCherry termed yemRFP (Keppler-Ross et al., 2008)
displays only a mild growth defects compared to yeast-optimized msfGFP (ymsfGFP)
(Jiang et al., 2017). These results lead us to exploit the polyQ toxicity and aggregation
assays to explore the effects of two of the most recently available RFPs. Here, we focused
on FusionRed, a red monomeric fluorescent variant of mKate2 known for its low
cytotoxicity in cells (Shemiakina et al., 2012) that displays low propensity to oligomerize
in mammalian cells (Costantini et al., 2015). We also included mScarlet, a monomeric
synthetic RFP that was recently shown to outperform other RFPs in terms of brightness
of the fluorescent signal (Bindels et al., 2017). Both have yet to be characterized for
expression in yeast.

3.3 Materials and Methods
Yeast strains and culture conditions
All strains are derived from W303-1A (Thomas and Rothstein, 1989). All experiments
were conducted in synthetic complete media (SC) at 30 °C.

DNA constructs
yemRFP (Keppler-Ross et al., 2008) was previously described. yFusionRed and
ymScarlet were codon optimized for expression in yeast and synthesized by Genscript Inc.
based on previously published sequences (Bindels et al., 2017; Shemiakina et al., 2012).
RFPs were cloned into the SpeI/SalI site of p415 GPD. Alternatively, RFPs were cloned
into the SpeI/SalI sites of p415 GAL1 25Q/68Q Httex1 lacking the proline rich domain, as
previously described (Jiang et al., 2017). To generate 2µ vectors, the GAL1 25Q/68Q
Httex1-ymsfGFP or GAL1 25Q/68Q Httex1-yFusionRed fragments were cloned into the
SacI/SalI sites of pRS42N (Taxis and Knop, 2006). All Httex1 constructs lack the prolinerich domain since absence of this domain is required for Httex1 toxicity in yeast
(Duennwald et al., 2006). We also noted that since the publication of our previous study
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(Jiang et al., 2017), the original 72Q Httex1 plasmid has mutated into 68Q. We, therefore,
used the latter in this study. See Table 3.1 for a list of plasmids used in this study.

Table 3.1 Plasmids used in this study
Plasmids

Resistance

Source

marker
P415 GPD

Leu

P415 GPD-yemRFP

(Mumberg et al., 1995)
This study

P415 GPD-yFusionRed
P415 GPD-ymScarlet
P415 Gal1-FLAG-25Q-ymsfGFP

(Jiang et al., 2017)

P415 Gal1-FLAG-68Q-ymsfGFP

This study

P415 Gal1-FLAG-25Q-yemRFP

(Jiang et al., 2017)

P415 Gal1-FLAG-68Q-yemRFP

This study

P415 Gal1-FLAG-25Q-yFusionRed
P415 Gal1-FLAG-68Q-yFusionRed
P415 Gal1-FLAG-25Q-ymScarlet
P415 Gal1-FLAG-68Q-ymScarlet
PRS42N Gal1-FLAG-25Q-ymsfGFP

natNT2

This study

PRS42N Gal1-FLAG-68Q-ymsfGFP
PRS42N Gal1-FLAG-25Q-yFusionRed
PRS42N Gal1-FLAG-68Q-yFusionRed

Growth assays
Yeast growth was measured by spotting assay on agar plates. Briefly, cells were cultured
overnight to saturation in appropriate selection media. The next day, cells densities were
equalized to OD 600 0.2 and 5x serial dilutions were spotted on agar plates. Alternatively,
cell densities were equalized to OD

600

0.1 and 300 µl of cell suspensions were

transferred into a 96 well plate and incubated at 30oC for 24h with constant shaking in a
Biotek Epoch 2 microplate spectrophotometer and OD 600 was recorded every 15 minutes.
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Dot blot
After induction in galactose media overnight, cells were lysed using glass beads in lysis
buffer (100 mM Tris pH 7.5; 200 mM NaCl; 1 mM EDTA; 5% glycerol, 1 mM
Dithiothreitol (DTT) 4 mM phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor
cocktail). Equal amount of proteins were spotted on a nitrocellulose membrane.
Membranes were blocked for 30 min in PBS-0.05%Tween at room temperature and then
processed for immunoblot. Membranes were probed with anti-FLAG primary antibody
(Sigma F3040, 1:5000 dilution) overnight at 4 °C and subsequently with a secondary
anti-mouse fluorescent antibody (Thermo Alexa 555 #A21424, 1:5000 dilution) for 1h at
room temperature and imaged using a Bio-Rad ChemiDoc MP imaging system.
Membranes were then stripped using the Gene Bio-Application stripping buffer and
reprobed with an anti-Pgk1 primary antibody (Thermo 22C5D8) using the same
secondary antibody. In Figure 3, for each individual antibody, both membranes were
imaged simultaneously to allow direct comparison of fluorescent signal. Densitometric
analysis was performed using Image J.

Fluorescence microscopy
Under the different experimental conditions, cells were diluted 10x in growth media and
plated in Lab-tek (Thermo Inc.) imaging chambers and processed for fluorescence
microscopy. Images in Figure 3.1 were acquired using a Zeiss AxioVert A1 wide field
fluorescence microscope equipped with a 63X NA 1.4 Plan Apopchromat objective, a
560 to 600 nm excitation/630 to 705 nm emission bandpass filter and Zeiss Axiocam 506
mono camera. Images presented in Figure 3.2 and Figure 3.4 were collected using a Zeiss
800 confocal microscope equipped with 488 nm and 561 nm diode lasers and a 63x
PlanApochromat NA 1.4 objective.

Flow cytometry
Cell were cultured with appropriate media and processed for flow cytometry using a BD
Bioscience FACS Celesta flow cytometer equipped with a 561 Yellow laser for imaging
of RFPs. Data were analyzed using the BD FACS Diva software. All conditions were
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performed in triplicates, 20,000 cells were analyzed and median fluorescence intensities
were calculated. No gates were applied.

Statistical analysis
A one-way ANOVA followed by a multiple comparison test (Tukey’s or Dunnett’s
according to figure legends) was used to determine statistical significance between the
different experimental conditions in Figure 3.1D, 3.2B, 3.3 and 3.4A using GraphPad
Prism v6.0h.

3.4 Results and Discussion
mScarlet has higher fluorescent intensity in yeast
To analyze the performance of the three different RFPs in yeast, we first generated codon
optimized versions of both FusionRed and mScarlet (termed yFusionRed and ymScarlet,
respectively) (Table 3.2). Centromeric plasmids encoding yFusionRed, yemRFP and
ymScarlet under the control of the constitutive GPD promoter were transformed in yeast
(Figure 3.1A). Fluorescence intensities were compared using wide-field fluorescence
microscopy (Figure 3.1B). Median fluorescence intensity (MFI) was then quantified
using flow cytometry. Quantification revealed that yFusionRed was significantly dimmer
(~5x) than yemRFP (Figure 3.1C and D). This result was surprising given that previously
published data reported a slightly increased brightness for FusionRed when compared to
mCherry (Shemiakina et al., 2012). However, it is known that fluorescent brightness of
FPs expressed in yeast can be different from the ones registered for pure purified proteins
(Lee et al., 2013). As opposed to yFusionRed, ymScarlet displayed the strongest
fluorescent signal (~2x brighter than yemRFP) (Figure 3.1C and D). These results are in
agreement with previous studies reporting increased brightness of mScarlet compared to
other RFPs variants (Bindels et al., 2017). Based on the intensity of the fluorescent signal,
ymScarlet appears to be the optimal RFP for imaging in yeast.
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Table 3.2 Sequences of yeast optimized fluorescent proteins in this study
Name

Sequences

yFusionRed

ATGGTTTCTGAATTGATTAAAGAAAACATGCCAATGAAGTTGTACA
TGGAAGGTACTGTTAACAACCATCATTTTAAATGTACATCAGAAGG
TGAAGGTAAACCATACGAAGGTACTCAAACAATGAGAATTAAAGT
TGTTGAAGGTGGTCCATTGCCATTTGCTTTCGATATTTTGGCAACTT
CTTTTATGTACGGTTCAAGAACTTTTATTAAGCATCCACCAGGTATT
CCAGATTTCTTTAAGCAATCTTTCCCAGAAGGTTTTACTTGGGAAA
GAGTTACTACATATGAAGATGGTGGTGTTTTGACTGCAACACAAGA
TACATCATTGCAAGATGGTTGTTTGATCTATAACGTTAAAGTTAGA
GGTGTTAATTTTCCAGCTAATGGTCCAGTTATGCAAAAGAAAACTT
TGGGTTGGGAAGCTTCTACTGAAACAATGTACCCAGCAGATGGTG
GTTTAGAAGGTGCTTGTGATATGGCATTGAAATTGGTTGGTGGTGG
TCATTTGATCTGTAATTTGGAAACTACATACAGATCTAAGAAACCA
GCTACAAATTTGAAGATGCCAGGTGTTTACAACGTTGATCATAGAT
TGGAAAGAATTAAAGAAGCAGATGATGAAACTTACGTTGAACAAC
ATGAAGTTGCTGTTGCAAGATACTCTACAGGTGGTGCTGGTGACGG
TGGTAAATAA

ymScarlet

ATGGTTTCTAAAGGTGAAGCAGTTATTAAGGAATTCATGAGATTCA
AGGTACACATGGAAGGTTCTATGAATGGTCACGAATTTGAAATTG
AAGGTGAAGGTGAAGGTAGACCATATGAAGGTACTCAAACTGCTA
AGTTGAAGGTTACTAAAGGTGGTCCATTGCCATTTTCTTGGGATAT
TTTGTCTCCACAATTCATGTACGGTTCTAGAGCTTTTACAAAACATC
CAGCAGATATTCCAGATTACTACAAGCAATCATTCCCAGAAGGTTT
TAAATGGGAAAGAGTTATGAACTTCGAAGATGGTGGTGCAGTTAC
TGTTACACAAGATACTTCTTTGGAAGATGGTACATTGATCTATAAG
GTTAAGTTGAGAGGTACTAATTTTCCACCAGATGGTCCAGTTATGC
AAAAGAAAACTATGGGTTGGGAAGCTTCAACAGAAAGATTGTACC
CAGAAGATGGTGTTTTGAAGGGTGACATTAAGATGGCATTGAGAT
TGAAGGATGGTGGTAGATATTTGGCTGATTTCAAGACTACATACAA
GGCTAAGAAACCAGTTCAAATGCCAGGTGCTTACAACGTTGATAG
AAAGTTGGATATTACTTCTCATAATGAAGATTACACAGTTGTTGAA
CAATATGAAAGAAGTGAAGGTAGACACAGTACAGGTGGTATGGAT
GAATTATACAAATGA
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Figure 3.1 Comparison of red fluorescent proteins (RFPs) fluorescent intensities
in yeast.
(A) yemRFP, yFusionRed and ymScarlet were introduced into centromeric vectors
under the control of a constitutive GPD promoter. (B) Representative images from 3
fields of yeast cells expressing different RFPs. Imaging conditions were kept constant
between samples to allow direct comparison of fluorescent intensities. Inverted black
and white images are shown for clarity. Bar: 5µm (C) Yeast cells expressing the
different RFPs were analyzed by flow cytometry and compared to cells carrying an
empty vector. (D) Median fluorescent intensities of the various RFPs were calculated
from fluorescent data acquired using flow cytometry. *p<0.05.
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PolyQ-mScarlet displays a toxic phenotype
Next, we sought to determine how the three different FPs affect their fusion partners in
living yeast. To this end, we employed the polyQ toxicity assays. Each RFP was cloned
in frame with a galactose inducible version of Httex1 carrying either 25Q (nonpathological length) or 68Q (HD-associated) (Figure 3.2A). 25Q constructs show no
growth differences across the different FPs in both uninduced (glucose media) and
polyQ-induced (galactose media) conditions indicating that expression of the different
constructs results in similar growth phenotypes. When fused to 68Q Httex1, yFusionRed
displayed no significant toxicity when compared to the non-toxic 25Q fusion (Figure
3.2B). Interestingly, ymScarlet displayed severe toxicity, showing a slow growth
phenotype comparable to what was observed for ymsfGFP (Figure 3.2B). Based on these
observations, we then investigated the effects of the different RFPs on polyQ aggregation
using fluorescence microscopy. We found that yemRFP displayed robust 68Q
aggregation similar to ymsfGFP as we previously described (Jiang et al., 2017). It is
important to note that while prone to aggregation, yemRFP polyQ proteins were shown to
form aggregates with different biophysical properties (increased detergent solubility) that
can account for their moderately toxic nature (Jiang et al., 2017). In accordance with the
absence of toxicity noted in the growth assay, 68Q-FusionRed did not form visible
aggregates, while ymScarlet displayed strong aggregation propensity (Figure 3.2C).
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Figure 3.2 ymScarlet displays a toxic polyQ phenotype similar to ymsfGFP.
(A) FPs were cloned in frame with FLAG-Httex1 into a centromeric vector carrying a
GAL1 inducible promoter. (B) Yeast cells carrying a vector or 25/68Q Httex1 fused to
either ymsfGFP, yemRFP, yFusionRed or ymScarlet were grown to saturation
overnight in glucose (control) or galactose (polyQ induced) containing media. The
next days, cell concentrations were equalized to OD600 0.2 and 5 fold serial dilutions
of the cell suspension spotted on synthetic complete agar media plates containing
either glucose or galactose. (C) Yeast cells carrying an empty vector or 25/68Q Htt
ex1 fused to ymsfGFP, yemRFP, yFusionRed or ymScarlet or carrying an empty
vector were induced overnight in galactose containing media and protein levels
analyzed by dot blot using either an anti-FLAG (detection of fluorescent fusions) or
anti-Pgk1 antibody (loading control). (D) Representative fluorescent images from 3
fields of yeast cells expressing 25/68Q Htt ex1 fused to ymsfGFP, yemRFP,
yFusionRed or ymScarlet after overnight induction in galactose-containing media.

.
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In addition, assessment of protein abundance for each construct using dot blot revealed
that both 25 and 68Q yFusionRed fusions were present at lower levels compared to other
fluorescent counterparts (Figure 3.3A). The cause of this phenotype is unclear and could
result from increased turnover rate of the fusions. Interestingly, expression of 68QyFusionRed from a multicopy 2µ vector resulted in a growth defect, albeit toxicity was
reduced compared to ymsfGFP-tagged polyQ (Figure 3.4A). Moreover, under these
conditions, 68Q-yFusionRed displayed robust aggregation. This indicates that the lower
expression levels observed for yFusionRed constructs can potentially explain, at least
partially, the absence of polyQ toxicity when expressed at lower levels. Reduced toxicity
of the 68Q-yFusionRed is also consistent with our previous observation showing that
yomTagBFP2, a blue fluorescent proteins similarly does not form toxic aggregates (Jiang
et al., 2017). In fact, both FusionRed and mTagBFP2 (Subach et al., 2011) are evolved
versions of the wild-type RFP from sea anemone Entacmaea quadricolor (Merzlyak et al.,
2007). In the case of mScarlet, the protein was evolved from a synthetic template design
for generating a monomeric protein. Therefore, based on our data, mScarlet appears to be
an attractive alternative to mCherry, which minimizes the effect of the FP on its fusion
partner.
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Figure 3.3 yFusionRed-tagged Httex1 fusions are expressed at lower levels
compared to other fluorescent fusions.
Yeast cells carrying an empty vector or 25/68Q Htt ex1 fused to ymsfGFP, yemRFP,
yFusionRed or ymScarlet or carrying an empty vector were induced overnight in
galactose containing media and protein levels analyzed by dot blot using either an
anti-FLAG (detection of fluorescent fusions) or anti-Pgk1 antibody (loading control).
Quantification of the FLAG/Pgk1 ration is shown from 3 independent experiments.
***p<0.001 according to a one way ANOVA followed by a Tukey’s multiple
comparison test comparing samples to ymsfGFP-tagged fusion of the same polyQ
length.

.
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Figure 3.4 Expanded Httex1-yFusionRed is toxic when expressed at high levels.
(A) Images of yeast growth assays on agar plates. Yeast cells carrying 25/68Q Htt
ex1 fused to either ymsfGFP or yFusionRed in a 2µ multicopy vector were grown to
saturation overnight in glucose (control). The next days, cell concentrations were
equalized to OD 600 0.2, and 5-fold serial dilutions of the cell suspension spotted on
synthetic complete agar media plates containing either glucose (control) or galactose
(+polyQ). Alternatively, cells were cultured in liquid media and optical densities
were recorded over time to generate growth curves. The area under the curve (AUC)
was calculated from 3 experimental replicates. **p<0.01 and ****p<0.0001
according to a one way ANOVA followed by a Tuckey’s multiple comparison test
comparing the 68Q sample to its 25Q counterpart unless indicated otherwise. (B)
Representative fluorescent images from 3 fields of yeast cells expressing 25/68Q Htt
Httex1 fused to ymsfGFP or yFusionRed from a multicopy 2µ vector after overnight
induction in galactose-containing media. Under these conditions, 68Q-yFusionRed
displays robust aggregation.

.
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4

Sfp1 links TORC1 and cell growth regulation to the
yeast SAGA-complex component Tra1 in response to
polyQ proteotoxicity

In the past two chapters, we introduced the optimized yeast model of HD by tagging
mutant Httex1 with different modern FPs. With the help of the yeast polyQ model, we are
able to investigate the fundamental cellular mechanisms during HD. Proteotoxic stress
disrupts trafficking and triggers transcriptional responses to cope with the accumulation
of misfolded proteins. Transcriptional defects have been observed in different models of
HD. The mechanisms involve dysregulation of transcription factors, coactivators, RNA
polymerase II, and importantly, histones. In this chapter, we show that cells expressing
toxic polyQ expansions display impaired assembly of the SAGA acetyltransferase
complex that regulates chromatin remodeling and gene expression during stress. This
culminates in the Sfp1/TORC1-dependent increased expression of the SAGA component
Tra1. Our data identify a new nexus that links TORC1 to the regulation of SAGA activity
during loss of proteostasis.

4.1 Abstract
Chromatin remodeling regulates gene expression in response to the accumulation of
misfolded polyQ proteins associated with Huntington’s disease (HD). Tra1 is an essential
component of both the SAGA/SLIK and NuA4 transcription co-activator complexes and
is linked to multiple cellular processes, including protein trafficking and signaling
pathways associated with misfolded protein stress. Cells with compromised Tra1 activity
display phenotypes distinct from deletions encoding components of the SAGA and NuA4
complexes, indicating a potentially unique regulatory role of Tra1 in the cellular response
to protein misfolding. Here, we employed a yeast model to define how the expression of
toxic polyQ expansion proteins affects Tra1 expression and function. Expression of
expanded polyQ proteins mimics deletion of SAGA/NuA4 components and results in
growth defects under stress conditions. Moreover, deleting genes encoding SAGA and, to
a lesser extent, NuA4 components exacerbates polyQ toxicity. Also, cells carrying a
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mutant Tra1 allele displayed increased sensitivity to polyQ toxicity. Interestingly,
expression of polyQ proteins upregulated the expression of TRA1 and other genes
encoding SAGA components, revealing a feedback mechanism aimed at maintaining
Tra1 and SAGA functional integrity. Moreover, deleting the TORC1 effector SFP1
abolished upregulation of TRA1 upon expression of polyQ proteins. While Sfp1 is known
to adjust ribosome biogenesis and cell size in response to stress, we identified a new role
for Sfp1 in the control of TRA1 expression, linking TORC1 and cell growth regulation to
the SAGA acetyltransferase complex during misfolded protein stress.

4.2 Introduction
Eukaryotic cells need to correctly fold proteins to ensure their accurate function and
avoid the aggregation of toxic misfolded intermediates, which form the basis of several
human diseases (Balch et al., 2008; Henning and Brundel, 2017; Klaips et al., 2018;
Ruegsegger and Saxena, 2016). In Huntington’s disease (HD), expansion of a
polyglutamine region encoded by the first exon of the gene encoding the Huntingtin
protein (Httex1) leads to Htt misfolding and aggregation in detergent-insoluble, amyloidlike inclusion bodies (IBs) in the cytoplasm and nuclei of neuronal cells (Gusella et al.,
2014; Huang et al., 1998; Telenius et al., 1994). Accumulation of toxic polyQ oligomers
is linked to several cellular dysfunctions such as defects in protein trafficking, autophagy
and endoplasmic reticulum stress (Ashkenazi et al., 2017; Duennwald and Lindquist,
2008; Jiang et al., 2016; Koga et al., 2011; Lajoie and Snapp, 2011; Ravikumar et al.,
2004; Vidal et al., 2012). In response to the accumulation of misfolded proteins,
including polyQ huntingtin, cells modify their gene expression profile to favor adaptive
responses directed at restoring protein homeostasis (Becanovic et al., 2010; Neueder and
Bates, 2014; Tauber et al., 2011). Well-characterized responses to proteotoxic stress, such
as the unfolded protein response of the endoplasmic reticulum (Duennwald and Lindquist,
2008; Haynes et al., 2004; Lajoie and Snapp, 2011; Leitman et al., 2014; Vidal and Hetz,
2012; Vidal et al., 2012; Walter and Ron, 2011) and the heat shock response (Bersuker et
al., 2013; Chafekar and Duennwald, 2012; Fujikake et al., 2008; Verghese et al., 2012) in
the cytoplasm, increase the folding capacity of their respective compartments upon
accumulation of misfolded polyQ expansions. These responses prevent the protein quality

126

control machinery from being overwhelmed by sudden changes in the misfolded protein
burden.
It is now clear that multiple signaling pathways act in parallel to regulate gene expression
during misfolded protein stress. Acetyltransferase complexes regulate chromatin
remodeling, a process affected in HD (Dong et al., 2015; Guiretti et al., 2016; McFarland
et al., 2012; Sharma and Taliyan, 2015; Steffan et al., 2001; Valor et al., 2013). The
SAGA (Spt-Ada-Gcn5-Acetyltransferase) and NuA4 (Nucleosome acetyltransferase of
H4) complexes were first identified in yeast as containing the lysine acetyltransferases
Gcn5 and Esa1, respectively (Allard et al., 1999; Auger et al., 2008; Grant et al., 1997).
Both complexes have homologues in mammalian cells, hSAGA and Tip60, respectively.
The PIKK family member Tra1/TRRAP is an essential component of both SAGA and
NuA4 complexes in yeast and mammalian cells (Ikura et al., 2000; McMahon et al.,
1998). The group of PIKK proteins also includes mTOR, ATM and ATR, which are
characterized by a C-terminal PI3K domain (Baretić and Williams, 2014). In SAGA and
NuA4, Tra1 interacts with transcriptional activators thereby recruiting the complexes to
target promoters (Bhaumik et al., 2004; Brown et al., 2001; Fishburn et al., 2005; Reeves
and Hahn, 2005). Because of its presence in both SAGA and NuA4, reducing Tra1
function affects cells distinctly from deletions of components specific to either individual
complex. For example, impaired Tra1 function causes generation-dependent telomere
shortening, a phenotype that is not detected in cells carrying deletions of either SAGA or
NuA4 components (Mutiu et al., 2007b).
Misfolded polyQ expansions specifically alter the composition of the SAGA complex and
SAGA-regulated gene transcription in both yeast and mammalian models (Burke et al.,
2013; Chen et al., 2012; Helmlinger et al., 2004; Lan et al., 2015; McMahon et al., 2005;
Yang et al., 2015). These studies employed polyQ-expanded ataxin-7/Sca7, which causes
the neurodegenerative disease spinocerebellar ataxia 7 (Holmberg et al., 1998).
Sca7/ataxin-7 is a component of SAGA and SLIK (SAGA-like) acetyltransferase
complexes, explaining the effect of polyQ expanded-Sca7 on SAGA function (McMahon
et al., 2005; Yang et al., 2015). Targeting Httex1 to the yeast nucleus also alters
transcription similarly to cells carrying deletions in genes encoding SAGA components
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(Hughes et al., 2001); however, the specific molecular mechanism by which Httex1 polyQ
expansions affect SAGA function remains unclear. Our previous genetic screen for
synthetic interactions linked Tra1 to the regulation of several stress responses, including
protein misfolding stress (Hoke et al., 2008). Tra1 is therefore a strong candidate target to
regulate the transcriptional response to protein misfolding stress caused by polyQ
proteins.
To study the effect of Httex1 polyQ expansion on yeast, we employed a well-characterized
model that involves expressing fluorescently-tagged Httex1 (Albakri et al., 2018;
Duennwald, 2013; Duennwald et al., 2006a; Duennwald et al., 2006b; Jiang et al., 2017;
Meriin et al., 2002). We define the interplay between Tra1 and polyQ-induced stress and
identify the TORC1 effector Sfp1 as a regulator of polyQ toxicity that regulates Tra1
expression during proteotoxic stress. Our study thus expands the understanding of its role
beyond the regulation of cell growth and ribosome biogenesis (Fingerman et al., 2003;
Jorgensen et al., 2004; Marion et al., 2004) and defines how TORC1, Sfp1 and Tra1
respond to toxic polyQ proteins.

4.3 Materials and Methods
Yeast genetic manipulation and growth assays
All strains are derivatives of either BY4741/4742 or W303a (see Table 4.1). Gene
deletions were performed using standard yeast genetics procedures (Janke et al., 2004)
and validated by sequencing. Plasmids were transformed using the lithium acetate
method (Gietz and Woods, 2002). Cell growth was assessed by both spot assay on agar
plates and growth in liquid culture as previously described (Jiang et al., 2018). Yeast cells
were cultured overnight in selective synthetic complete media with 2% glucose as a sole
carbon source. For spot assays, cultures were diluted to equal concentrations and then
spotted in 4 five-fold dilutions using a pinning tool with the most concentrated spot
equalized at OD600 0.2. Cells were grown on selective plates at 30 °C for 2 days and
imaged using a GelDoc system (Bio-Rad). For liquid culture, cells were diluted to OD600
0.1 and incubated at 30oC. OD600 was measured every 15 min using a BioscreenC plate
reader (Growth curves USA) for 24 hours. Growth curves were generated and the area
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under the curve calculated for each biological replicates and a two-tailed Student’s t-test
was used to determine statistical significance between the different experimental
conditions using Graphpad (Prism). To generate the sfp1Δ tra1Q3 double mutant,
the sfp1Δ and tra1Q3 (CY6586) were mated and diploids were selected on media
containing G418 and lacking leucine. The diploid strain (CY8479) was sporulated in 3
mL 1% potassium acetate and tetrads were dissected. The haploid double sfp1
tra1Q3 strain (CY8482) was selected based on its ability to grow on media containing
G418 and media lacking leucine and histidine.

Drugs
Stock solutions of tunicamycin (5 µg/ml in DMSO; Amresco), Trichostatin A (10 mM in
H2O; Biovision), calcofluor white (30 mg/ml in H2O; Sigma-Aldrich), rapamycin (1
mg/ml in DMSO, Fisher Scientific), H2O2 (9.79 M) cycloheximide (10 mg/ml in
H2O;Fisher Scientific), and MMS (99%; Acros Organics) were prepared and used at the
indicated concentrations.

DNA constructs
Plasmids encoding fluorescently tagged Httex1 and LacZ reporter constructs carrying
TRA1, PHO5, and NCW2 (Berg et al., 2018; Mutiu et al., 2007a) promoters in YCp87
(Brandl et al., 1993) were previously described (see Table 4.2). SPT7 promoter sequences
relative to the translational start, -633 to +68, NGG1 promoter sequences -430 to +5 and
EAF1 promoter sequences -890 to +31 were engineered by PCR as BamHI/HindIII
fragments using oligonucleotides listed in Table 3 and cloned into YCp87 (Brandl et al.,
1993) to generate transcriptional reporters. Vectors encoding fluorescently tagged Tra1
with yemRFP (Keppler-Ross et al., 2008) were generated by replacing the eGFP coding
sequence by the new codon-optimized fluorescent proteins using the BamHI/NotI sites in
the previously described eGFP-Tra1 vector (Genereaux et al., 2012) using primers listed
in Table 4.3.
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Table 4.1 Strains used in this study
Strains
W303
BY4741
BY4742
W303 GALFLAG-25Q
ΔPRO-CFP
W303 GALFLAG-46Q
ΔPRO-CFP
W303 GALFLAG-72Q
ΔPRO-CFP

Genotype
MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0

Reference
(Thomas and
Rothstein, 1989)
(Brachmann et al.,
1998)

Isogenic to W303 + GAL-FLAG-25Q ΔPROCFP
Isogenic to W303 + GAL-FLAG-46Q ΔPROCFP
Isogenic to W303 + GAL-FLAG-72Q ΔPROCFP

(Duennwald et al.,
2006)

TS161
TS184
BY4742 sch9Δ
BY4742 sfp1Δ
W303 sfp1Δ
BY4741 eaf1Δ

MATα ura3-52
MATα ura3-52 TOR L2134M
Isogenic to BY4742 sch9Δ:: KAN
Isogenic to BY4742 sfp1Δ:: KAN
Isogenic to W303 sfp1Δ:: NAT
Isogenic to BY4741, eaf1Δ:: KAN

(Takahara and
Maeda, 2012)

BY4741 ada2Δ
yMS928

Isogenic to BY4741, ada2Δ:: KAN
Isogenic to BY4742, SFP1-GFP:: KAN
MATa ura3Δ0 his3Δ0 leu2Δ0 tra1-F3744AHIS3
MATa ura3Δ0 his3Δ0 leu2Δ0 TRA1-HIS3
MATa/α SFP1/sfp1::KanMX TRA1/tra1Q3-HIS3
YCplac111-DED1pr-YHR100C
Matα spf1::KanMX tra1Q3-HIS3 YCplac111Ded1pr-YHR100C
Isogenic to BY4742 except URA3-Flag5-TRA1

CY4350
CY4353
CY8479
CY8482
CY6808
YSC1178202230655
YSC1178202230938

Thermo/deletion
collection
This study
Thermo/deletion
collection
(Lopez et al., 2011)

(Hoke et al., 2010)
This study
This study
(Berg et al., 2018)

Isogenic to BY4741 except TAP-ADA2
Isogenic to BY4741 except TAP-EPL1

(Ghaemmaghami et
al., 2003)
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Table 4.2 Plasmids used in this study
Plasmids
MET-25Q ΔPRO-CFP
MET-103Q ΔPRO-CFP
GAL-FLAG-25Q ΔPROymsfGFP
GAL-FLAG-72Q ΔPROymsfGFP
GAL-FLAG-25Q ΔPROCFP
GAL-FLAG-103Q
ΔPRO-CFP
TRA1-ymsfGFP
TRA1-yemRFP
TRA1-LacZ
SPT7-LacZ
NGG1-LacZ
EAF1-LacZ
PHO5-LacZ
NCW2-LacZ

Number

Vector backbone

Resistance

Reference

pRS426

URA

(Duennwald et al., 2006)

pRS415

LEU

(Jiang et al., 2017)

pRS416

URA

pTZ19

URA

(Duennwald et al., 2006)
This study
This study
(Berg et al., 2018)
This study
This study
This study
(Mutiu et al., 2007)
(Berg et al., 2018)

pPL005
pPL006

pPL022
pPL023

YCp87

LEU

Table 4.3 Primers used in this study
Gene

Forward Primer

Reverse Primer

U3

CCCAGAGTGAGAAACCGAAA

AGGATGGGTCAAGATCATCG

RPL6

GCGTGCCTCTCTAGTTCCAG

CGTTGACACCTTCGACAGAA

RPL30

ATCATTGCCGCTAACACTCC

CCGACAGCAGTACCCAATTC

RPL38

GACGTTAAGACCGCCACTGT

AAGTTGGTGGCAAAGATGG

TRA1

CTACTGCCACCACAAGCTGA

CCTTTGCTTCAGGTCTTTGC

SPT7
promoter

GGATCCGCGAGCTACTATTTG
TTGAAGG

AAGCTTCAGTCAATTTAAGTA
AAGCTTTG

NGG1
promoter
EAF1
promoter

GGGGATCCTTCTCTCACAGTT
TTAGC
CCCAAGCTTTGAGTGACATCG
GCAAAATGC

GGGAAGCTTCAGACATTATTC
CTGTCCAATACTTCTCGT
AAAGGATCCACCGGAAGTCG
TTCCACCTT

ymsfGFP

CGGGATCCATGGTATCCAAAG
GTGAAGAAT

ATAAGAATGCGGCCGCCTTAT
ACAATTCATCCATACCG

YemRFP

CGGGATCCATGGTTTCAAAAG
GTGAAGAAG

ATAAGAATGCGGCCGCTTTAT
ATAATTCATCCATACCACC
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Fluorescence microscopy
Cells were diluted 10X and transferred to LabTek imaging chambers (Thermo Inc.) and
imaged at room temperature. Fluorescence microscopy was performed using a Zeiss 800
confocal microscope equipped with a 63× Plan Aprochromoat objective (1.4 NA).
Images were analyzed using the ImageJ software (Schindelin et al., 2015).

qRT-PCR
RNA extraction was performed using MasterPure Yeast RNA Purification Kit (Lucigen).
cDNA synthesis was done by qScript Flex cDNA Synthesis Kit (Quanta Bioscience). The
cDNA preparations were used as the template for amplification using PerfeCTa SYBRGreen Supermix (Quanta Bioscience). The primers used are listed in supplemental Table
3. The relative expression level was calculated using the comparative Ct method and U3
was used as a reference gene.

Western blot
Yeast cells were lysed using 0.1 M NaOH for 5 min at room temperature, resuspended in
SDS sample buffer and boiled for 5 min (Kushnirov, 2000). Proteins were separated
using SDS-PAGE and transferred to PVDF membrane. The membrane was blocked with
5% milk. Then the membrane was incubated with anti-Flag (M2, Sigma-Aldrich), antiPGK1 (Invitrogen), anti-histone H3 and anti-acetyl-histone H3K14 (Abcam) overnight,
followed by 1 h incubation with the appropriate fluorescent secondary antibody and
imaged with an Odyssey infrared imager (Licor) to detect the signal.

β-galactosidase assay
Cells were harvested and resuspended in LacZ buffer. β -galactosidase activity from 50 µl
of cell lysate was calculated using o-nitrophenol-β-D-galactosidase as substrate and
values were normalized to cell densities as previously described (Berg et al., 2018; Mutiu
et al., 2007b).
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Pull-down assay
Pull down was performed as previously described (Berg et al., 2018). 4L of cells were
harvested and washed in IPP150 buffer, expelled into liquid nitrogen and grinded to
powder. Lysates were resuspended in 1ml IPP150 buffer and spun at 40k rpm for 1h at
4 °C. The middle layer was extracted and then transferred to a column and mixed with
400 µl IgG agarose resin. The column was then rotated at 4 °C for 2 h before transfer to a
new column with 250 µl TEV cleavage buffer and 3 µl TEV. The column was inverted
manually every 15 min for 3 h. Proteins were then collected in a new column with
calmodulin resin and rotated 1 h at 4 °C. Samples were eluted with calmodulin elution
buffer. Finally, protein was mixed with SDS sample buffer and processed for gel
electrophoresis followed by staining with coomassie blue and imaging with a GelDoc
system (Bio-RAD).

Statistical analysis
Unless indicated otherwise, a Student’s t-test was used to determine statistical
significance between the different experimental conditions using GraphPad Prism v6.0h.

4.4 Results
PolyQ expansions compromise
acetyltransferase complex

the

SAGA

histone

In our experiments, Httex1 is placed under the control of the GAL1 promoter and induced
by growth in galactose as sole carbon source. Under these conditions, expressing HDassociated polyQ lengths 46Q and 72Q result in a polyQ length-dependent growth defect
compared to the non-HD associated 25Q (Duennwald and Lindquist, 2008; Duennwald et
al., 2006b; Duennwald et al., 2006a) (Figure 4.1A). 25Q does not cause a growth defect
when compared to the corresponding empty vector (Supplemental Figure 4.1). As
opposed to other disease-causing misfolded proteins, such as α-synuclein, polyQ
expression inhibits cell growth but does not cause significant cell death as measured by
either regrowth assays or labeling of dead cells with propidium iodide (Supplemental
Figure 4.2). The effect of a 103Q Httex1 polyQ expansion is also apparent when expressed
at lower levels under the transcriptional control of the relatively weak MET25 promoter
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(Duennwald and Lindquist, 2008) (Figure 4.1B). This model allows testing low polyQ
toxicity without altering the carbon source. High expression of polyQ expanded Httex1
results in polyQ length-dependent formation of cytoplasmic aggregates that can be
observed using fluorescence microscopy (Figure 4.1C).
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Figure 4.1 PolyQ expansions are toxic and aggregate in yeast.
(A) The yeast model of HD as previously developed (Duennwald, 2013; Duennwald
and Lindquist, 2008; Duennwald et al., 2006a). Cell expressing high levels of CFPtagged Httex1 driven by the GAL1 promoter display polyQ length-dependent toxicity.
25Q serves as a control for non-pathological Httex1. Cell growth was assessed by
serial dilutions on SC plates containing either glucose (control) or galactose (polyQ
induced). (B) Cells expressing low levels of CFP-tagged Httex1 driven by the MET25
promoter display only modest growth defect even in presence of 103Q. Cell growth
was assessed by serial dilutions on SC plates containing presence (control) or
absence (polyQ induced) of methionine. (C) Fluorescent images show accumulation
of inclusion bodies in 46Q and 72Q-expressing cells as opposed to diffused cytosolic
distribution of 25Q after induction in galactose.
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Misfolded polyQ proteins associated with the polyglutamine disease spinocerebellar
ataxia disrupt assembly of the SAGA complex and SAGA-dependent transcription
(McMahon et al., 2005). The ensuing phenotype resembles those associated with
deletions of SAGA complex components. Sca7, the protein responsible, is a subunit of
the hSAGA complex. Thus, its impact on SAGA function is expected. To investigate the
relationship between Httex1, a protein that is not part of the acetyltransferase complexes,
we examined genetic interactions of Httex1 with deletions of NuA4 (eaf1Δ, eaf6Δ, yaf9Δ)
and SAGA (ada2Δ, spt8Δ, ubp8Δ) components (Figure 4.2A). Expanded polyQ
expression displayed increased growth defects with deletion of the SAGA components
Ada2 and Ubp8, but not Spt8. This could indicate that specific Spt8 activities such as
interaction of SAGA with the TATA-box binding protein (TBP) are not targeted by
polyQ expansions (Mohibullah and Hahn, 2008; Warfield et al., 2004). 72Q expression
affected growth in one of the NuA4 related deletions, eaf6Δ. To look at the effect of
polyQ on a Tra1 mutant, we employed a previously characterized loss-of–function
mutant of TRA1 (tra1-F3744A) that carries a mutation in the C-terminal FATC domain
(Hoke et al., 2010). tra1-F3744A displayed growth defects in presence of expanded 46 Q
in both plate and liquid growth assays (Figure 4.2B). Supporting these data, polyQ
expression sensitized cells to stresses that result in slow growth of strains carrying TRA1
mutations, i.e. calcofluor white, growth at 39 °C, 5% ethanol, MMS and caffeine (Berg et
al., 2018) (Figure 4.2C). Expression of expanded polyQ proteins was also associated
with decreased activity from SAGA regulated promoters (HIS4 and PHO5) but not from
the SAGA-independent NCW2 promoter (Figure 4.3A).

Similar to the results of

expanded PolyQ on SAGA function described by Hughes et al., 72Q reduced global
acetylation of the SAGA modified histone H3 approximately to 60% of wild-type (Figure
4.3B). Global acetylation of the NuA4-modified histone H4 was reduced to a lesser
extent, approximately 80% of wild-type (Figure 4.3B).
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Figure 4.2 PolyQ enhanced toxicity in strains deleted for the SAGA components
UBP8 and ADA2 as well as a tra1-F3744A mutant strain.
(A) Wild-type, ada2Δ, spt8Δ, ubp8Δ (SAGA) and eaf1Δ, eadf6Δ, yaf9Δ (NuA4) cells
expressing either GAL1-inducible 25Q or 46Q Httex1 assessed by growth assays on
SC media plates in presence of glucose (control) or galactose (polyQ induced). (B)
Wild-type and tra1-F3744A cells expressing either GAL1-inducible 25Q or 46Q
Httex1 were assessed by growth assay on SC media plates and in liquid growth assay
in presence of glucose (control) or galactose (polyQ induced). The area under the
curve was quantified for each replicates (n=3) **p<0.005. (C) Cells expressing either
MET25-inducible 25Q or 103Q Httex1 were spotted on plates containing various
stressors (0.1% caffeine, 6µg/ml calcofluor white (CFW), 5% ethanol (ETOH), 0.1%
caffeine, 0.03% methyl methanesulfonate (MMS) or incubated at 39oC) in presence
or absence of methionine.
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Figure 4.3 PolyQ expansions reduce Tra1-regulated gene expression.
(A) Expression of GAL1-inducible 72Q induced a significant decrease in the
expression from the SAGA-regulated genes HIS4 and PHO5. NCW2 is shown as a
control. Gene expression was analyzed using LacZ transcriptional reporters and was
assessed after overnight induction of polyQ in galactose under conditions that
induced each promoter (absence of histidine or low phosphate respectively).
**p<0.005, n=3±SEM. (B) Reduced histone acetylation in cells expressing expanded
polyQ. Immunoblot of total (H3 and H4) and acetylated histone H3 (H3-AcK14) and
H4 (H4-AcK16) with or without expression of GAL1-inducible 25 and 72Q. *p<0.05,
**p<0.005, n=3±SEM.
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Accumulation of misfolded polyQ proteins increase TRA1
expression
We previously observed that Tra1 bearing mutations in its PI3K domain (tra1Q3) decrease
nuclear localization of the protein (Berg et al., 2018). We therefore assessed whether
expressing polyQ expansion affects Tra1 localization using confocal microscopy. We
found that expanded polyQ expression (72Q-ymsfGFP) did not change the nuclear
localization of fluorescently tagged Tra1 (yemRFP-Tra1) (Figure 4.4A). Consequently,
polyQ possibly alters SAGA function independently of Tra1 sequestration into
cytoplasmic polyQ inclusions, possibly by altering composition of the SAGA complex.
We tested this possibility by pulling down SAGA using a TAP-tagged Ada2 in cells
expressing either 25 or 72Q and analyzing the associated proteins by SDS-PAGE. As
shown in Figure 4.4B Tra1 was still assembled into SAGA in strains expressing 72Q.
However other components such as Ngg1 and Spt7 displayed reduced incorporation.
Cells also respond to the defective tra1Q3 allele by increasing the transcription of the
TRA1 gene (Berg et al., 2018). We assayed expression from the TRA1 promoter to
evaluate whether expanded polyQ results in increased TRA1 expression. As shown in
Figure 4.4A, we found a ~2.5 fold increase in TRA1 expression of a TRA1-promoter LacZ
fusion upon expression of 72Q compared to the non-toxic 25Q. Increased transcription
was also observed from promoters of other components of SAGA and NuA4, i.e. NGG1,
SPT7 and EAF1, as was the case for tra1Q3 (Berg et al., 2018) (Figure 4.5A). We also
observed that the polyQ-induced increase in TRA1 expression was abolished when cells
expressing 72Q were treated with the HDAC inhibitor trichostatin A (TSA) (Figure 4.5B),
suggesting that changes in chromatin remodeling regulate TRA1 expression in the
presence of polyQ expansion. As a consequence of increased mRNA levels (as measured
by qRT-PCR (Figure 4.5C), Tra1 protein abundance increased upon expression of 72Q
(Figure 4.5D). These results suggest that expanded polyQ impairs Tra1 function inducing
a feedback mechanism to cope with disrupted SAGA/NuA4 function. As shown in Figure
4.5E, the increased TRA1 expression was specific to polyQ and was not observed with
other stressors that result in protein misfolding, such as induction of endoplasmic
reticulum stress by tunicamycin, heat shock, oxidative stress caused by H2O2, or
perturbation of cell wall integrity by calcofluor white (Figure 4.5E).

Moreover,
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expression of α-synuclein, another disease causing misfolded protein, reduced TRA1
promoter activity, indicating that various misfolded proteins differentially affect TRA1
transcriptional regulation (Figure 4.5F). This is in agreement with previous data showing
that α-synuclein and Httex1 expression in yeast display a different subset of genetic
interactions and differential induction of stress responses (Cooper et al., 2006;
Willingham et al., 2003).
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Figure 4.4 Tra1 is not sequestered into polyQ inclusion bodies.
(A) Tra1 remains localized to the nucleus in the presence of polyQ aggregates.
Fluorescent images showing localization of GAL1-inducible polyQ-ymsfGFP (25 and
72Q) and yemRFP-Tra1 after overnight culture in glucose (control) or galactose
(polyQ induced). (B) Pull-down assay using Ada2TAP shows that Tra1 still
incorporates into SAGA in presence of GAL1-inducible 72Q-ymsfGFP. However,
levels of Ngg1 and Spt7 are reduced upon expression of 72Q-ymsfGFP.
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Figure 4.5 TRA1 expression is increased in presence of toxic polyQ expansions.
(A) Increased expression of TRA1 and other SAGA (NGG1, SPT7) and NuA4
(EAF1) components as well as the control NCW2 after overnight induction of GAL1inducible 72Q-CFP compared to 25Q-CFP. Expression was analyzed using
promoter-LacZ reporters. **p<0.005, ***p<0.001 n=3±SEM (B) Treatment with the
HDAC inhibitor trichostatin A (TSA) abolished TRA1 upregulation caused by polyQ
expansions. GAL1-inducible 25 and 72Q-CFP were induced overnight in galactose
media in presence or absence of 80 µM TSA. (C) Overnight expression of GAL1inducible 72Q-CFP leads to increased expression of TRA1 as measured by qRT-PCR.
(D) Expanded polyQ increases Tra1 protein abundance. Cells expressing
eitherGAL1-inducible 25 or 72Q-CFP and a chromosomally integrated Tra15x-Flag
were cultured in glucose or induced overnight in galactose and processed for
immunoblot. (E) Effects of other stressors on TRA1 expression. Cells expressing the
TRA1-LacZ reporter were treated with tunicamycin (Tm; 5 µg/ml), heat shocked at
42 °C, treated with calcofluor white (CFW; 300 µg/ml) or H2O2 (300 µM) for 2 hr.
n=3 ±SEM. (F) Expression of α-synuclein decreased TRA1 expression. Cells
expressing a galactose inducible version of α-synuclein-GFP were cultured in either
glucose or galactose overnight and TRA1 expression was measured using a LacZ
reporter. n=3.
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Both inhibition and hyperactivation of TORC1 exacerbate
polyQ toxicity
Our previous genetic screen highlighted a potential role for Tra1 in stress responses
(Hoke et al., 2008), including the control of cellular homeostasis by the TORC1 (Target
of Rapamycin Complex 1) regulated signaling cascades that link nutrient availability to
cell growth and division. In this screen, a tra1 mutant displayed a synthetic slow growth
phenotype with a deletion of tor1 (Hoke et al., 2008). Studies in mammalian cells report
both a protective and adverse role for TORC1 in HD (Ferrarelli, 2015; Lee et al., 2015;
Pryor et al., 2014; Ravikumar et al., 2002; Ravikumar et al., 2004; Renna et al., 2010).
We therefore tested the effect of modulating TORC1 activity on polyQ toxicity in yeast.
First, we determined the effects of TORC1 inhibition using rapamycin (Figure 4.6A and
B). We found that rapamycin treatment significantly reduced growth of cells expressing
expanded 103Q protein in both solid and liquid media assays when compared to the
untreated condition. Interestingly, rapamycin treatment did not significantly alter polyQ
aggregation (Figure 4.6C). This result argues against a protective role for TORC1
inhibition by rapamycin through stimulating polyQ aggregates removal through
autophagy (Ravikumar et al., 2002). Similar to rapamycin, a hyperactive allele of TOR1
(TOR1L2134M) (Takahara and Maeda, 2012) also exacerbated polyQ toxicity (Figure 4.6D
and E). The TOR1 mutant had only a modest effect on the toxicity of TDP-43
(Supplemental Figure 4.4), a protein linked to amyotrophic lateral sclerosis (ALS)
(Johnson et al., 2008), indicating that the role of TORC1 may diverge in different
diseases. TORC1 hyperactivation did not prevent the formation of polyQ aggregates
(Figure 4.6F). These data indicate that precise regulation of TORC1 signaling is crucial
for cells to cope with polyQ expansion. Interestingly, the same hyperactive TOR1 mutant
decreases levels of glutathione (Oku et al., 2013), which is important to counteract ROS
accumulation in HD models (Mason et al., 2013). TORC1 regulates translation and
ribosome biogenesis in both yeast and mammals and decreased translation has been
proposed as a contributor to polyQ toxicity in mammals (Leitman et al., 2014).
Incidentally, cells expressing 72Q displayed increased sensitivity to the translational
inhibitor cycloheximide (Figure 4.7A and B) and decreased expression of ribosomal
protein genes (Figure 4.7C) when compared to 25Q, further supporting a role for TORC1
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signaling in polyQ toxicity. Therefore, we next investigated the role of downstream
TORC1 effectors in polyQ toxicity.
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Figure 4.6 Both inhibition and hyperactivation of TORC1 exacerbate polyQ
toxicity.
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Figure 4.6
(A) TORC1 inhibition by rapamycin exacerbates polyQ toxicity. Wild-type cells
expressing either MET25-inducible 25Q or 103Q Httex1 assessed by growth assay on
SC containing media plates untreated or supplemented with 2 ng/ml rapamycin in
presence (control) or absence (polyQ induced) of methionine. (B) Wild-type cells
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid
growth assay in presence (control) or absence (polyQ induced) of methionine ± 2
ng/ml rapamycin. The area under the curve was quantified for each replicates (n=3)
***p<0.001. (C) Representative fluorescent images of wild-type cells expressing
GAL1-inducible 25Q or 72Q Httex1-ymsfGFP after overnight induction in galactose
containing media untreated or supplemented with 100 ng/ml rapamycin. (D) Wildtype and TOR1L2134M cells expressing either MET25-inducible 25Q or 103Q Httex1
assessed by growth assay on SC containing media plates in presence (control) or
absence (polyQ induced) of methionine. (E) Wild-type and TOR1L2134M cells
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid
growth assay in presence (control) or absence (polyQ induced) of methionine ± 100
ng/ml rapamycin. The area under the curve was quantified for each replicates (n=3)
***p<0.001. (F) Representative fluorescent images of wild-type and TOR1L2134M
cells expressing GAL1-inducible 25Q or 72Q Httex1-ymsfGFP after overnight
induction in galactose containing media.
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Figure 4.7 PolyQ expansions sensitize cells to translational inhibition.
(A) PolyQ increased cell sensitivity to cycloheximide. Wild-type cells expressing
either MET25-inducible 25Q or 103Q Httex1 assessed by growth assay on SC
containing media plates untreated or supplemented with 0.1 µg/ml cycloheximide in
presence (control) or absence (polyQ induced) of methionine. (B) Wild-type cells
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid
growth assay in presence (control) or absence (polyQ induced) of methionine ± 0.1
µg/ml cycloheximide. The area under the curve was quantified for each replicate (n=3)
***p<0.001. (C) PolyQ expression decreased expression of ribosomal protein genes.
RNA was isolated from wild-type cells expressing GAL1-inducible 25Q or 72Q Httex1CFP after overnight induction in galactose containing media and processed for RTqPCR to assess transcript levels of RPL6, RPL30 and RPL38. *p<0.05, **p<0.01.
(n=3)
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Sfp1/TORC1 regulates TRA1 expression
In yeast, TORC1 controls gene expression via two main downstream effectors, the
mammalian S6 kinase homologue Sch9 and the transcription factor Sfp1 (Loewith and
Hall, 2011). Sch9 localizes to the vacuolar membrane and mediates TORC1 signaling
that regulates ribosomal protein gene expression and cell cycle progression (Urban et al.,
2007). Tor1 also interacts with the transcription factor Sfp1, which regulates expression
of ribosomal proteins (Jorgensen et al., 2004; Lempiäinen et al., 2009; Marion et al., 2004;
Singh and Tyers, 2009). During exponential growth, Sfp1 localizes to the nucleus, where
it drives transcription of ribosomal protein genes. During various types of stress,
including protein misfolding, oxidative stress, and nutrient deprivation, Sfp1 translocates
to the cytoplasm (Jorgensen et al., 2004; Lempiäinen et al., 2009; Marion et al., 2004;
Singh and Tyers, 2009) where it is degraded by the proteasome (Lopez et al., 2011). Here,
we found that deleting SFP1, but not SCH9 exacerbated polyQ toxicity (Figure 4.8A).
This agrees with Sfp1 and Sch9 having non-overlapping functions(Jorgensen et al., 2004).
Indeed, the two deletion strains display specific phenotypes. Relevant to our study, sfp1Δ
increases rapamycin sensitivity as compared to sch9Δ (Lempiäinen et al., 2009).
Increased polyQ toxicity in sfp1Δ cells was not associated with significant changes in
formation of inclusion bodies (Figure 4.8B). Expression of ribosomal protein genes
decreased in the presence of misfolded polyQ (Figure 4.7C) consistent with a loss of
Sfp1-mediated TORC1 signaling. This may include the global effects on translation due
to targeting the ribosomal protein genes, since loss of protein translation due to
cycloheximide treatment exacerbates polyQ toxicity. In the same way, reduced
translation is linked to polyQ toxicity in mammalian cells (Leitman et al., 2014).
Surprisingly, sfp1Δ cells crossed with the tra1Q3 mutant allele are viable with the
mutations displaying epistasis, suggesting that both genes function in the same pathway
(Figure 4.8C). Indeed, tra1Q3 displayed reduced ribosomal protein gene expression
(Figure 4.8D). In the same way, nuclear depletion of Tra1 using the anchor-away
approach decreases recruitment of Esa1 and Gcn5 to ribosomal protein gene promoters
(Bruzzone et al., 2018).
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Figure 4.8 Deletion of SFP1 exacerbates polyQ toxicity.
(A) Deletion of SFP1 but not SCH9 exacerbates polyQ toxicity. Wild-type, sfp1Δ and
sch9Δ cells expressing either MET25-inducible 25Q or 103Q Httex1 assessed by
growth assay on SC media plates in presence (control) or absence (polyQ induced) of
methionine. (B) Deletion of SFP1 does not affect formation of polyQ IBs.
Representative fluorescent images of wild-type and sfp1Δ cells expressing GAL1inducible 25Q or 72Q Httex1-ymsfGFP after overnight induction in galactose
containing media. (C) The tra1Q3 allele displays an epistatic phenotype with sfp1Δ.
Cells carrying the SFP1 deletion were crossed with cells carrying the tra1Q3 allele.
Growth of the double mutant and the parental strains were assessed by spotting
assays on agar plates. (D) The tra1Q3 allele displays reduced levels of ribosomal
protein gene expression. Wild-type cells and cells carrying the tra1Q3 allele were
processed for RT-qPCR to assess transcript levels of RPL6, RPL30 and RPL38.
***p<0.005. (n=3)
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In agreement with reduction of ribosome protein gene levels, Sfp1-GFP relocalized to the
cytoplasm upon 103Q expression, in contrast to its nuclear localization in cells expressing
non-toxic 25Q (Figure 4.9A). Interestingly, cytoplasmic Sfp1 is recruited to polyQ
aggregates (Figure 4.9A). To quantify recruitment or exclusion of Sfp1 in polyQ
aggregates we adapted a size-normalized, averaging based analysis method developed by
Li et al. for studying Httex1 aggregates in mammalian cells (Li et al., 2016). Briefly, we
analyzed several 1.75 x 1.75 µm polyQ-aggregates containing regions of interest (Figure
4.9B). Then, we generated an intensity map by averaging multiple regions for 20
different cells (Figure 4.9C). We next calculated the fluorescent intensity of 103Q-RFP
and Sfp1-GFP along a line across the region to generate an intensity curve for both
channels. Similar shaped curves revealed incorporation of Sfp1-GFP into polyQ
aggregates (Figure 4.9D).
Interestingly, Lempiäinen et al. demonstrated that Sfp1 physically interacts with Tra1,
suggesting that Tra1 may be regulated by Sfp1 in the presence of polyQ proteins
(Lempiäinen et al., 2009). Tra1 protein levels (Figure 4.10A) but not mRNA (Figure
4.10B) were modestly decreased in sfp1Δ cells, potentially reflecting reduced global
translation due to decreased ribosome production (Fingerman et al., 2003; Jorgensen et al.,
2004; Lempiäinen et al., 2009; Marion et al., 2004). Thus, it appears that Tra1 function
rather than protein level is affected by Sfp1. Indeed, sfp1Δ cells are sensitive to high
temperature, ethanol, MMS and calcofluor white treatment, hallmarks of impaired Tra1
function (Figure 4.10C). Reduced Tra1 activity in sfp1Δ cells was further supported by
the reduced expression of PHO5, a Tra1/SAGA regulated gene (Barbaric et al., 2003;
Gregory et al., 1998). This phenotype was reversed by the HDAC inhibitor TSA (Figure
4.11A), indicating that deleting SFP1 may affect SAGA and possibly NuA4-mediated
chromatin modifications that regulate PHO5 transcription (Barbaric et al., 2003; Gregory
et al., 1998). We next tested the effect of deleting SFP1 on the polyQ-induced
upregulation of SAGA and NUA4 components observed in Figure 4.5A. Whereas the
transcription from the SPT7, NGG1 and EAF1 promoters were still increased upon
expression of misfolded 72Q, SFP1 deletion abolished TRA1 upregulation (Figure 4.11B).
These results suggest that Sfp1 is required for proper control of TRA1 expression upon
polyQ expression. Sfp1 is a known TORC1 effector and TORC1 inhibition with
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rapamycin downregulates TRA1 expression (Marion et al., 2004) (Figure 4.11C)
highlighting a role for TORC1 in the control of TRA1 transcriptional regulation. Since
deleting SFP1 causes hyperactivation of TORC1 as a compensatory mechanism
(Lempiäinen et al., 2009; Rousseau and Bertolotti, 2016), we hypothesized that
hyperactivation of TORC1 may prevent upregulation of TRA1 upon accumulation of
misfolded polyQ expansion. Indeed, TRA1 was not significantly upregulated after
expression of expanded 103Q in the hyperactive TOR1L2134M strain (Figure 4.11D).
Coupled to the observed decrease in TRA1 expression upon TORC1 inhibition by
rapamycin (Figure 4.11C), our results establish that TORC1 signaling regulates TRA1
expression.
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Figure 4.9 SFP1 accumulates in cytoplasmic aggregates in response to expanded
polyQ expression.
(A) Representative fluorescent images of wild-type cells expressing GAL1-inducible
25Q or 103Q Httex1-RFP and Sfp1-GFP after 2hr induction in galactose containing
media. Red arrows highlight localization of Sfp1 into polyQ aggregates. Bar = 5µm.
(B) Intensity maps for 20 polyQ aggregates containing regions. Panels displaying
fluorescent signal for both 103Q-RP and Sfp1-GFP are shown. (C) Average of each
panel presented in (B). An intensity trend line is calculated across the region. (D)
Intensity plots as a function of the distance across the region are presented for both
channels. N= 20 regions.
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Figure 4.10 Loss of SFP1 does not significantly affect Tra1 expression but
sensitizes cells to stress.
(A) Deletion of SFP1 has minimal effect on Tra1 protein abundance. Immunoblot
performed with cell lysates of from wild-type and sfp1Δ cells expressing a
chromosomally integrated Tra15x-Flag. Blot was probed with anti-Flag. Anti-Pgk1 was
used as loading control. Densitometric analysis from 3 independent samples is
shown. (B) Deletion of SFP1 has minimal effect on TRA1 mRNA levels. RNA was
isolated from wild-type and sfp1Δ cells and processed for RT-qPCR to assess
transcript levels of TRA1. (C) Wild-type and sfp1Δ cells were spotted on YPD agar
plates untreated, supplemented with 6µg/ml calcofluor white (CFW), 5% ethanol
(ETOH), 0.03% methyl methanesulfonate (MMS) or incubated at 39oC.
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Figure 4.11 Sfp1 and TORC1 regulate TRA1 expression in response to misfolded
polyQ.
(A) Sfp1 regulates PHO5 expression. Cells expressing the PHO5-LacZ reporter were
incubated in absence of phosphate overnight and treated with trichostatin A (TSA) at
the indicated concentration. Expression from the NCW2 promoter is shown as
control. β-galactosidase activity is shown as the average of 3 replicates with the
SEM indicated by the error bars. ***p<0.001 using a one-way anova followed by a
Tukey’s multi comparison test. (B) Deletion of SFP1 specifically abolishes TRA1
upregulation by polyQ. Gene expression from TRA1 and other SAGA (NGG1, SPT7)
and NuA4 (EAF1) promoters after overnight induction of GAL1-inducible 72Q-CFP
compared to 25Q-CFP in wild-type and sfp1Δ cells. Gene expression was analyzed
using LacZ transcriptional reporters. **p<0.005, ***p<0.001 n=3±SEM. (C)
Rapamycin treatment decreases transcription from the TRA1 promoter in both wildtype and sfp1Δ cells. Gene expression was analyzed using the TRA1-LacZ
transcriptional reporter. **p<0.005, ***p<0.001 n=3±SEM. (D) Hyperactive TORC1
signaling prevents upregulation of TRA1 by polyQ. RNA was isolated from wild-type
and TOR1L2134M cells after overnight induction of GAL1-inducible 25 and 103Q
Httex1-CFP in galactose media and processed for RT-qPCR to assess transcript levels
of TRA1.
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4.5 Discussion
Tra1/SAGA and polyQ toxicity
The ability of cytoplasmic polyQ expanded Httex1 to disrupt Tra1 functions echoes
previous reports showing that expressing nuclear-targeted Httex1 results in transcriptional
changes similar to deleting components of the SAGA complex (Hughes et al., 2001).
Other reports show a similar phenotype using a different disease-associated polyQ protein,
the SAGA-associated spinocerebellar ataxia 7 (SCA7) (Hughes et al., 2001; McMahon et
al., 2005). We do not detect significant nuclear localization of Httex1 in our model (Figure
4.1). Since Tra1 remains localized to the nucleus upon expression of expanded polyQ, it
is unlikely that the two directly interact, thus favoring indirect regulation of Tra1 function
by polyQ. Our previous genetic screen using a tra1 mutant allele revealed that Tra1 is
linked to cellular responses of proteotoxic stress, such as the heat shock response,
mitochondria homeostasis and TORC1 signaling (Hoke et al., 2008). Interestingly, all
these processes are linked to polyQ toxicity (Chafekar et al., 2012; Costa et al., 2010;
Ferrarelli, 2015; King et al., 2008; Lee et al., 2015; Oliveira et al., 2007; Pryor et al.,
2014; Ravikumar et al., 2004; Sakahira et al., 2002; Shirendeb et al., 2011; Squitieri et al.,
2006; Wyttenbach et al., 2002). It is reasonable to deduce that impaired Tra1-regulated
transcription has an important role in the toxic phenotype observed in HD models. Indeed,
reduced histone acetylation is closely associated with HD and histone deacetylase
inhibitors improve the HD phenotype in animal models (Guiretti et al., 2016; Jia et al.,
2016; McFarland et al., 2012; Sharma and Taliyan, 2015; Steffan et al., 2001; Yeh et al.,
2013). Thus, further analysis of the role of the major regulators of chromatin remodeling,
gene expression and their specific targets may provide avenues for modulating the
toxicity of polyQ expansion in HD.

Sfp1/TORC1 regulates TRA1 expression in presence of toxic
polyQ proteins
Sfp1 is well characterized for its role in adjusting cell size and ribosome production
during stress (Fingerman et al., 2003; Jorgensen et al., 2004; Lempiäinen et al., 2009;
Marion et al., 2004; Singh and Tyers, 2009), yet its functions outside the control of
ribosome biogenesis are understudied. Recently, Matthew et al. found that sequestration
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of the splicing factor Hsh155 during genotoxic stress was regulated via TORC1 signaling
through Sfp1 (Mathew et al., 2017). Together with our data showing that Sfp1 regulates
TRA1 expression, this study supports an expanded role for Sfp1 in stress response,
beyond regulating ribosome biogenesis. The mechanism by which Sfp1 contributes to
TRA1 expression during proteotoxic stress is unclear, but the results mimic our previous
findings showing that compromising Tra1 function by mutating its PI3-kinase domain
increases transcription of TRA1 (Berg et al., 2018). It appears that the cells use a
transcriptional feedback mechanism to increase the expression of TRA1 and other
components of the SAGA and NuA4 complexes to compensate for the loss of Tra1
function. Whether a common transcription factor is involved remains unknown.
PolyQ expansions and expression of the tra1Q3 mutant allele (Berg et al., 2018) are the
only experimental conditions identified to date that increase TRA1 expression. Deletion
of other SAGA/NuA4 components does not upregulate TRA1, indicating that disruption
of HAT complexes cannot solely explain the phenotype (Berg et al., 2018). Moreover,
polyQ expansions also upregulated TRA1 in the absence of ADA2 (Supplemental Figure
4.5). Thus, an intact SAGA complex does not appear to be required for TRA1
upregulation by polyQ. Interestingly, polyQ-induced TRA1 expression requires Sfp1
(Figure 4.8). Microarray analyses revealed that overexpressing SFP1 does not upregulate
TRA1, indicating that Sfp1 might regulate Tra1 indirectly (Jorgensen et al., 2004). Similar
to what we observe with TRA1, deleting SFP1 abolishes upregulation of the proteasome
regulator ADC17 during tunicamycin-induced endoplasmic reticulum stress (Rousseau
and Bertolotti, 2016). Since in both cases, stress leads to Sfp1 relocalization to the
cytoplasm, it appears that Sfp1 regulates these targets indirectly, potentially via its
regulation of TORC1. In our case, relocalization of Sfp1 to the cytoplasm may disrupt the
previously reported Sfp1 interaction (Lempiäinen et al., 2009) with Tra1 (which remains
in the nucleus). Moreover, recruitment of Sfp1 to polyQ aggregates could contribute to
reduced Sfp1 function and signaling in these cells, resulting in impaired Tra1/SAGA
function. Sfp1 is known for its ability to acquire a prion form termed [ISP+] (Matveenko
et al., 2016; Rogoza et al., 2010; Volkov et al., 2002). At the same time, polyQ toxicity
relies on certain prions such as [RNQ+] (Manogaran et al., 2011; Meriin et al., 2002) and
polyQ expansions both stimulate formation (Derkatch et al., 2004) and interact with
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prions (Douglas et al., 2009). Thus, one could postulate that recruitment of Sfp1 and/or
its prion form [ISP+] could play a role in restricting Tra1 function. That could explain
why TRA1 upregulation observed with polyQ is not seen with α-synuclein, which toxicity
is largely independent of the prion status (Derkatch et al., 2004). It is also possible that
Sfp1/[ISP+] interacts with polyQ oligomers outside of the visible aggregates. Several
studies in mammalian cells have implicated intermediate oligomers as the cause of
toxicity in HD (Arrasate et al., 2004; Lajoie and Snapp, 2010; Moily et al., 2017;
Takahashi et al., 2007).
The physiological relevance of the Tra1-Sfp1 interaction will require further investigation.
A possible explanation for TRA1 transcriptional regulation by Sfp1/TORC1 is that TRA1
is regulated at multiple levels, one that involves TORC1 but also other pathways
modulated by toxic polyQ expansions. Interestingly, recent data show that Sfp1 can
negatively regulate a subset of genes, in particular the Swi4 regulon, which are
upregulated when Sfp1 is depleted from the nucleus (Albert et al., 2018). This offers an
attractive model where Sfp1 could act as a negative regulator of TRA1 expression. Finally,
though there is no homologue of SFP1 in mammals, Sfp1 shares key functions with the
mammalian proto-oncogene MYC. These functions include regulating ribosomal protein
gene expression and cell growth (Dang et al., 2006). Importantly, mammalian TRRAP
interacts with and is required for the activity of Myc (Bhattacharya and Ghosh, 2015;
Kenneth et al., 2007; Liu et al., 2003; Zhang et al., 2014). These results delineate a link
between Myc and TRRAP that is reminiscent of the Sfp1/Tra1 connection observed in
yeast.

TORC1, SAGA and polyQ toxicity
Our data show that TORC1 has to be finely tuned for yeast cells to compensate for polyQ
toxicity. This is not surprising considering the multitude of cellular processes regulated
by TORC1 (Betz and Hall, 2013; González and Hall, 2017; Liko and Hall, 2015).
Interestingly, both activation and inhibition of TORC1 are protective in rodent models of
HD (Ferrarelli, 2015; Lee et al., 2015; Pryor et al., 2014; Ravikumar et al., 2004). Our
results suggest that downstream targets of TORC1 function in mammalian cells, similar
to Sfp1 in yeast, to regulate polyQ toxicity. The inter-relationship of these targets is
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important for understanding the therapeutic potential of TORC1 for HD. A TRA1 mutant
allele is hypersensitive to rapamycin and results in a synthetic slow growth phenotype
with tor1 deletion (Hoke et al., 2008). In fission yeast, SAGA control of cell proliferation
and differentiation in response to starvation requires the differential TORC1/TORC2dependent phosphorylation of the SAGA component Taf12 (Laboucarié et al., 2017).
TORC1 also regulates yeast histone acetylation by regulating the sirtuin deacetylases
Hst3 and Hst4 (Workman et al., 2016) and integrates signals through the INO80
chromatin remodeling complex (Beckwith et al., 2018). Because of the breadth of cellular
functions affected by TORC1 and transcriptional regulators like SAGA, a comprehensive
understanding of how these pathways converge to regulate homeostasis is crucial.
Inhibiting histone deacetylase is protective in various disease models, including HD (Jia
et al., 2016; Valor, 2015; Valor and Guiretti, 2014; Yeh et al., 2013). Defining how
disease-associated proteins affect the global acetylome and identifying specific targets for
acetylation, including non-histone targets, could lay the basis for the development of new
small molecule/compounds for combinational therapy.

158

Figure S 4.1 The non-HD associated 25Q Httex1 does not induce a growth defect.
Cell expressing high levels of GAL1-inducible CFP-tagged 25Q-Httex1 display no
growth defect when compared to the corresponding empty vector. Cell growth was
assessed by serial dilutions on SC plates containing either glucose (control) or
galactose (polyQ induced).
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Figure S 4.2 PolyQ expansions do not cause cell death.
(A) Representative fluorescent images of wild-type cells expressing GAL1-inducible
25Q or 72Q Httex1-CFP after overnight induction in galactose containing media and
stained with propidium iodide (PI). Boiled cells are shown as a positive control. (B)
α-synuclein expression results in yeast cell death. Growth of cells expressing an
empty vector or α-synuclein-GFP was assessed by serial dilutions on SC plates
containing either glucose (control) or galactose (induced). Staining with PI assessed
cell viability.
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Figure S 4.3 Hyperactive TOR1L2134M strain is resistant to rapamycin.
(A) Growth of wild-type and TOR1L2134M cells on agar plate containing 10 ng/ml
rapamycin.
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Figure S 4.4 Hyperactive TORC1 signaling has minimal effect on TDP-43
toxicity.
(A) Growth of wild-type and TOR1L2134M cells expressing a control empty vector
(+Vector) or TDP-43 (+TDP-43) was assessed by serial dilutions on SC plates
containing either glucose (control) or galactose (TDP-43 induced). Cells were
incubated either in glucose (top) or galactose (bottom) prior to spotting on agar plate.
(B) Growth of wild-type and TOR1L2134M cells expressing an empty vector or TDP-43
was assessed by growth in either glucose (control) or galactose (TDP-43 induced)
liquid media. Cells were incubated either in glucose (top) or galactose (bottom) prior
to spotting on agar plate. (C) Quantification of the liquid growth assays. The area
under the curve was quantified for each replicates (n=3) ***p<0.001 when compared
to the control empty vector under the same conditions unless noted otherwise.

162

Figure S 4.5 ADA2 deletion does not abolish Tra1 upregulation by polyQ
expansions.
Increased expression of TRA1 after overnight induction of GAL1-inducible 103QCFP compared to 25Q-CFP in wild-type and ada2Δ cells. Expression was analyzed
using promoter-LacZ reporters. ***p<0.001 n=3±SEM.
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Chapter 5

5

Impaired Tra1-dependent transcription during heat
shock in the presence of polyQ expansions

In the last chapter, we demonstrated that HD-associated polyQ expansions lead to
abnormal upregulation of TRA1 and dysregulate the SAGA HAT complex assembly. As
reviewed in chapter one, impaired activation of the HSR is one of the hallmarks of HD.
How expanded polyQ expression dysregulates the HSR remains unclear. Given that
Tra1/SAGA is involved in the activation of the HSR, we next focused on how polyQ–
dependent impairment of Tra1/SAGA affects the HSR. Studying Tra1-dependent
transcription during heat shock in polyQ cells will provide new insights into the
mechanisms underlying the loss of proteostasis in HD.

5.1 Abstract
Dysregulation of proteostasis is a significant contributor of polyglutamine (polyQ)
toxicity in Huntington’s Disease (HD). The heat shock response (HSR) is a vital pathway
activated under multiple stress conditions to maintain protein homeostasis. The activation
of HSR allows transcription of genes encoding the heat shock proteins (HSPs) to improve
the cellular folding environment. Impaired HSR activation has been observed in HD and
correlates with the reduced cellular capacity to fix damaged protein under stresses such as
exposure to high temperature and oxidative stress. To understand how polyQ expansions
impair the HSR, we used a yeast model of HD to study the transcriptional regulation
under heat shock in the presence of polyQ expansions. The yeast cell wall protects cell
survival during stresses associated with protein misfolding, including heat shock. We
found that polyQ impairs the cell wall integrity and exacerbates cell sensitivity to heat
shock. The transcription co-activator Tra1 has been found to be involved in cellular stress
response that regulate polyQ toxicity. Our data showed that cells with a mutant Tra1
allele fail to activate the HSR. These cells were also more sensitive to cell wall stress.
Our findings suggest that polyQ impairs cell growth under heat shock stress through a
non-canonical HSR that allows the yeast cells to remodel their cell wall. Thus, our data
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reveals a new mechanism by which polyQ impairs cellular stress responses and
proteostasis in the yeast model of HD.

5.2 Introduction
Protein homeostasis is crucial for cell viability. Accumulation of misfolded proteins is at
the root of many neurodegenerative disorders (Parakh and Atkin, 2016; Tan et al., 2009;
Tayubi et al., 2015). One example is Huntington’s disease (HD), which is linked to
expanded polyglutamine (polyQ) repeats within the exon 1 of Huntingtin (Htt) protein
(Gusella and MacDonald, 2009). Misfolded Htt oligomerizes into insoluble aggregates in
the cytosol and nucleus of the neuronal cells, causing a series of cellular dysfunctions
such as transcriptional dysregulation, increased endoplasmic reticulum stress,
mitochondria defects, and impaired HSR (Chafekar and Duennwald, 2012; Duennwald
and Lindquist, 2008; Kumar et al., 2014; Quintanilla and Johnson, 2009). PolyQ
expansion leads to neurodegeneration resulting in chorea, cognitive decline, and muscle
contracture (Roos, 2010).
Cellular stress responses are signaling pathways induced under stress conditions, which
are crucial to increase cellular capacity to handle misfolded protein accumulation and
maintain proteostasis. The HSR is an evolutionarily conserved signaling pathway to
regulate protein folding and degradation during cell stress (Morimoto and Westerheide,
2010). Reduced activation of heat shock factor 1 (HSF1), the major transcription
regulator of the HSR, as well as decreased expression of heat shock proteins (HSPs)
during heat shock has been observed in cells expressing mutant Htt and in HD knock-in
mice (Chafekar and Duennwald, 2012). However, the mechanism of how polyQ impairs
HSR is not clear. A chromatin immunoprecipitation sequencing study reported that most
genes lost HSF1 binding during polyQ expansion were not directly related to proteostasis,
but involved in cytoskeletal binding, focal adhesion, and GTPase activity (Riva et al.,
2012). Furthermore, overexpressing Hsp26, Hsp42, and Hsp104 have been shown to
attenuate polyQ toxicity in a yeast HD model (Cashikar et al., 2005). Interestingly,
knocking out HSP26 or HSP42 causes cell dehydration, cytoskeleton and cell wall
damage (Haslbeck et al., 2004). These results suggest that the impaired HSR in cells
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expressing expanded polyQ is linked to multiple cellular processes not necessarily linked
to protein folding.
Yeast cells have a cell wall structure which is vital in protecting cell integrity and
survival under stress conditions (Lesage and Bussey, 2006). The cell wall integrity (CWI)
pathway is activated in response to cellular stresses which regulates cell wall biosynthesis
and actin cytoskeleton polarization (Levin, 2005). Previous studies demonstrated a clear
link between the CWI pathway and the HSR in yeast (Dunayevich et al., 2018; Lamoth et
al., 2012; Levin, 2011). For example, Truman et al. suggested the crosstalk between the
two stress response pathways by showing that the osmotic stabilizer sorbitol rescued the
temperature sensitivity of cells carrying a mutant HSF1 lacking the C terminal domain,
and that cells with an impaired CWI displayed a growth defect during heat shock
(Truman et al., 2007).
Transcriptional regulation of stress-induced genes is critical for the activation of cellular
stress responses (Boy-Marcotte et al., 1999; Godon et al., 1998; Rep et al., 2000). Many
stress-related gene transcriptions require the recruitment of the SAGA histone
acetyltransferase (HAT) complex (Bonnet et al., 2014; Huisinga and Pugh, 2004;
Koutelou et al., 2010; Sanz et al., 2016). Tra1, an essential component of the SAGA
complex, has been shown to be involved in cellular stress responses (Berg et al., 2018;
Hoke et al., 2008; Hoke et al., 2010). Our previous study found that polyQ dysregulated
Tra1 expression and SAGA assembly (Jiang et al., 2019). Thus, the impaired cellular
stress responses during polyQ expansion may be traced back to Tra1-dependent
transcriptional defects.
We found that cells expressing expanded polyQ displayed impaired cell wall homeostasis,
which contributes to the previously reported high-temperature sensitivity. Furthermore,
cells carrying a Tra1 PI3K mutant (tra1Q3) allele failed to activate the HSR during heat
shock. These cells also showed a cell wall defect. Our results raise the possibility that
polyQ impairs cellular stress responses through the dysregulation of Tra1-dependent
transcription.
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5.3 Materials and Methods
Yeast strains
All yeast strains used in this study were derived from BY4741/4742. The Tra1 mutant
strain was described in Berg’s study (Berg et al., 2018). The polyQ strains were described
in our previous paper (Jiang et al., 2019).

Monitoring yeast growth
Yeast growth assays were performed in both agar plate spot and liquid growth curve
following previous protocols (Jiang et al., 2017). Briefly, cells were cultured in selective
synthetic complete media to stationary phase. For cells expressing 25/103Q, cells were
washed twice and re-incubated in media without methionine overnight. For spot assay,
each yeast culture was diluted to OD600 0.2, 0.04, 0.008, 0.0016 and spotted on selective
plates. After incubating for two days, images were taken with a GelDoc system (Bio-Rad).
Yeast cultures were also diluted to OD600 0.1 into a 96 well plate and incubated in a plate
reader (Biotek). Concentration was measured every 15 min for 24 h. Growth curves were
generated and quantified by Student's t-test using GraphPad (Prism).

Chemicals
Caffeine (1% in H2O; ScholAR Chemistry), Trichostatin A (10 mM in H2O; Biovision)
and calcofluor white (30 mg/mL in H2O; Sigma-Aldrich) were diluted to indicated
concentration for each experiment.

Western blot
Cells were lysed using standard protocol. The concentrations of each sample were
measured using BCA assays and diluted equally. Samples were separated using SDSPAGE and transferred to PVDF membranes by semi-dry blotting. Membrane was
blocked with 5% milk, washed with PBST and then incubated with indicated antibodies
overnight. The anti-Hsp104 antibody was from the Linquist lab (Whitehead Institute,
MIT, USA). The anti-Hsp26 antibody was from the Buchner’s lab (TU Munich,
Germany). Next, the membrane was washed and incubated with secondary antibody for
1h. Membrane was washed before images taken using a Odyssey infrared imager (Licor).
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Real-time qPCR
Cells expressing 2X MET25-polyQ were heat shock at 42 °C for 1 hour. RNA was
extracted using the MasterPure Yeast RNA Purification Kit. The reverse transcription
was performed using Quanta Bioscience qScript Flex cDNA Synthesis Kit. Then, 1 μl
cDNA was used as the template for qPCR reaction and detected by PerfeCTa SYBRGreen Supermix (Quanta Bioscience). U3 was used as a reference control. Primers used
are listed below.

Table 5.1 Primers used in this study
Gene

Forward Primer

Reverse Primer

U3

CCCAGAGTGAGAAACCGAAA

AGGATGGGTCAAGATCATCG

HSP26

AAGGCGGCTTAAGAGGCTAC

GACACCAGGAACCACGACTT

HSP42

TGAACGCATTACCAACCAA

TGTCTTGTAGTGCCGCTGTC

HSP104

AGCAGGCTCGTCAAGGTAAA

TTACCGATACCTGGCTCACC

Fluorescence microscopy
20 μl of overnight culture was loaded to LabTek imaging chambers (Thermo Inc.) and
mixed with 180 μl of growth media. Images were acquired using a Zeiss 800 confocal
(63X) and then analyzed using the free ImageJ software.

Statistical analysis
Student’s t-test was performed using the GraphPad Prism 7 to analyze the statistical
significance between the different experimental groups in Figure 5.1B, 5.3A, and 5.3B.
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5.4 Results and Discussion
PolyQ impairs the heat shock response in yeast
Impaired HSR has been observed in a striatal cell line expressing full-length Htt with
polyQ expansion and HD knock-in mouse model (Chafekar and Duennwald, 2012).
However, the underlying mechanisms remain elusive. Studying the highly conserved and
well-characterized HSR in yeast will help us better determine how polyQ affects stress
response thus further understand the basic pathology of HD. In our model, Httex1
expressing expanded polyQ was designed under a MET25 promoter. The expression was
induced by culturing cells in growth media without methionine. To investigate the effects
of polyQ on the HSR, we incubated cells expressing Htt carrying non-pathological (25Q)
and HD-associated polyQ (103Q) at 39 °C. Cells expressing toxic 103Q showed a growth
defect at high temperature compared to cells growth at 30 °C (Figure 5.1A). Consistent
with the previous findings in mammals, there was a substantial decrease in the expression
of Hsp26, Hsp42, and Hsp104 in 103Q cells upon heat shock at both mRNA and protein
level (Figure 5.1B), indicating reduced activation of the HSR.
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Figure 5.1 PolyQ impairs the heat shock response in yeast.
(A) Cells expressing polyQ showed a growth defect at high temperature. Cells were
induced in growth media without methionine overnight and spotted on selective
plates incubated at 30 or 39 °C. (B) Expression of Hsp104, Hsp26 were reduced in
polyQ cells during heat shock. Cells were heat shock at 42 °C or incubated at room
tempreture for 1 hour before lysed. Protein expression was measured by western
blotting. Pgk1 was used as a control. The mRNA level of HSP104, HSP42, and
HSP26 was also quantified in cells expressing 2X polyQ after heat shock for 1 hour.
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Dysregulation of the cell wall integrity pathway during polyQ
expansion
Previous studies found that the osmotic stabilizer sorbitol can rescue the growth of cells
expressing truncated HSF1 at high temperature (Truman et al., 2007). Thus, we tested
whether sorbitol attenuates growth defect caused by polyQ at 39 °C. Indeed, the growth
defect of polyQ cells incubated at high temperature was improved by the addition of 1M
sorbitol (Figure 5.2A). Thus, the growth defect of cells expressing 103Q at high
temperature can be traced back to cell wall defects. To test whether polyQ expansion
leads to cell wall stress, cells carrying wild-type or expanded polyQ were treated with cell
wall stressor caffeine. 103Q cells showed increased sensitivity to caffeine, suggesting
these cells had cell wall defects (Figure 5.2B). The CWI pathway activation has been
shown to have a protective effect under conditions that affect cell wall integrity (Levin,
2005). Thus, we examined the impact of polyQ expansion in cells carrying a deletion of
SLT2, a gene encoding the MAP kinase essential for the proper execution of the CWI
transcription program. The slt2Δ cells displayed exacerbated polyQ toxicity (Figure 5.2C).
This result further supports that polyQ impairs the CWI pathway, rendering to multiple
stresses such as heat shock.
Interestingly, Truman et al. showed that overexpressing Hsp90 rescues Slt2 activity
during heat shock in cells expressing a defective HSF1 (Truman et al., 2007). However,
we did not observe the same effect in polyQ cells (Figure S5.1). It therefore appears that
the phenotype associated with polyQ expansion is somewhat different from the HSF1
mutant. The CWI pathway is functionally conserved with the MAP kinase pathways in
mammalian cells, which plays an important role in regulating cell proliferation and
differentiation (Wang et al., 2006). Especially, ERK5, the human homolog of Slt2, is vital
in cardiovascular development and neural differentiation (Truman et al., 2006; Wang et
al., 2006). Interaction between ERK5 and HSPs such as Hsp70 and Hsp90 have also been
studied (Sohn et al., 2002; Zheng and Studzinski, 2017). Furthermore, polyQ expansions
have been found to dysregulates ERK signaling and activating the ERK pathways showed
protective effects against HD (Apostol et al., 2006; Maher et al., 2011; Varma et al.,
2007). Even though human cells do not have a cell wall, investigating the crosstalk
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between the CWI pathway and the HSR in the yeast model will help to understand the
role of ERK in polyQ toxicity and identify potential therapeutic targets for HD.
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Figure 5.2 PolyQ impairs the cell wall integrity pathway.
(A) Sorbitol rescues sensitivity to high temperature of polyQ cells. Cells were
induced in growth media without methionine overnight and spotted on selective plates
incubated at 39 °C ± 1M sorbitol. (B) Cells expressing toxic polyQ were sensitive to
cell wall stressor. Cells were induced in growth media without methionine overnight
and spotted on selective plates in the presence or absence of 0.05% caffeine and
incubated at 30 °C for 2 days ± 1M sorbitol. (C) Deletion of SLT2 exacerbates polyQ
toxicity. Wild type and Slt2 deletion cells expressing polyQ were induced in growth
media without methionine overnight and spotted on selective plates and incubated at
30 °C for 2 days.
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Tra1 is involved in cellular stress response
Previous studies have shown that Tra1, and its mammalian homolog TRRAP, play a
crucial role in the activation of HSR (Breitkreutz et al., 2010; Herceg et al., 2003).
However, the mechanism needs further investigation. The PI3K domain is vital for Tra1
function (Berg et al., 2018). Thus, I tested the HSR activation in cells carrying a tra1Q3
allele in which the three arginine residues within the PI3K domain are mutated to
glutamine. When incubating the tra1Q3 cells at 39 °C, they displayed a strong growth
defect at high temperature (Figure 5.3A).
Moreover, treating the cells with a histone deacetylase inhibitor trichostatin A (TSA)
attenuated the phenotype (Figure 5.3A). The data indicated that Tra1 regulates the HSR
through its role in histone acetylation. To further study how Tra1 regulates the HSR, a
GFP reporter fused to the heat shock element (HSE) was expressed in wild-type and
tra1Q3 cells. As shown by fluorescence microscopy, GFP intensity was significantly
lower in tra1Q3 cells compared to wild-type after heat shock for 2 hours, suggesting a
failure to activate HSPs transcription in the tra1Q3 strain (Figure 5.3B). The tra1Q3 cells
were also shown to be more sensitive to cell wall stress (Berg et al., 2018). I was able to
reproduce the experiment by treating these cells with a cell wall stressor calcofluor white.
Cells carrying the tra1Q3 mutation displayed a growth defect under cell wall stress.
Furthermore, the defect can be rescued by adding sorbitol, indicating that Tra1 is vital for
cell wall stress responses. Moreover, the growth defect of tra1Q3 strain at 37 oC was also
alleviated by sorbitol treatment (Figure 5.4). Overall, these data suggested that Tra1
regulation is crucial in cellular stress responses.
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Figure 5.3 Tra1 plays an important role in the heat shock response.
(A) Tra1 mutant cells displayed growth defect at high temperature. Cells were
induced in growth media without methionine overnight and spotted on selective plates
incubated at 30 or 39 °C for 2 days. WT and tra1Q3 cells treated with TSA were
assessed by liquid growth assay at 37 °C. The area under the curve was quantified for
each replicate (n = 3), ***P < 0.001. (B) Reduced HSE transcription during heat
shock in Tra1 mutant cells. Representative fluorescent image of WT and tra1Q3 cells
incubated at 42 °C for 2 hours. Fluorescent intensity was quantified by imageJ. ***P
< 0.001.
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Figure 5.4 Tra1 is crucial in regulating cell wall stress.
Cells expressing tra1Q3 mutation are more sensitive to heat shock and cell wall
stress. The defect was rescued by sorbitol. Cells were spotted on selective plates with
calcofluor white and incubated at 30 or 37 °C for 2 days ±1M sorbitol.
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The connection between impaired cellular stress response during polyQ expansion and
the regulation of Tra1 needs further investigation. The Triple T complex which contains
Tel2, Tti1, and Tti2 is required for the stabilization of PIKK family proteins (Hurov et al.,
2010). Tti2 has been shown to be involved in stress responses via its role in maintaining
Tra1 folding and nuclear localization (Genereaux et al., 2012; Hoffman et al., 2016).
Therefore, polyQ may affect Tra1 dependent cellular stress responses through the
dysregulation of Tti2. Our data showed that Tti2 was sequestered into polyQ aggregates,
indicating that polyQ impairs Tti2 function (Figure 5.5). However, overexpressing Tti2
was not able to rescue the sensitivity to heat shock and cell wall stress in cells expressing
toxic polyQ (Figure S5.2). Thus, increased sensitivity to high temperature could be, at
least in part, linked to loss of function of Tti2.
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Figure 5.5 Tti2 is sequestered into polyQ aggregates.
Cells expressing GAL1-25/68Q-mScarlet were induced in galactose overnight and
then monitored by confocal microscope. Representative fluorescent images showed
co-localization between Tti2-GFP and 68Q aggregates.
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Perspective
I have shown that cell wall stress and defect in the CWI signaling pathway is involved in
cell sensitivity to heat shock during polyQ expansions. Tra1-dependent transcriptional
regulation plays a critical role in the HSR activation and cell wall stress response. Thus,
Tra1 dysregulation caused by expanded polyQ expression may explain the impaired
cellular stress responses in HD (Figure 5.6). Future studies need to determine the
recruitment of Tra1 to the promoters of HSPs and CWI targets using Chromatin
immunoprecipitation during polyQ toxicity to better understand the mechanism. Defining
how polyQ impairs cellular stress responses and the transcriptional regulation will guide
future studies in developing target specific compounds for HD therapy.
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Figure 5.6 Hypothetical model of heat shock sensitivity in a yeast model of HD.
The sensitivity to high temperature in cells expressing expanded polyQ is due to
dysregulation of HSR and a cell wall defect. The impaired HSR and CWI during
polyQ expansions may be caused by dysregulation of Tra1-dependent stress-induced
gene transcriptions.
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Figure S 5.1 Overexpressing Hsp90 did not rescue growth defect at high
temperature in polyQ cells.
MET25 induced 25/103Q cells were induced in -methionine media overnight before
spotted on selective plates and incubated at 30 or 37 °C for 2 days. 103Q cells
overexpressing Hsc82 still displayed a growth defect at 37 °C.
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Figure S 5.2 Overexpressing Tti2 did not rescue sensitivity to cell stress in polyQ
cells.
Cells carrying MET25 induced 25/103Q and GAL1 induced Tti2 were induced in methionine media overnight before spotted on selective plates containing 10 μg/ml
Calcofluor white. 103Q cells overexpressing Tti2 were still more sensitive to high
temperature and cell wall stress compared to 25Q.
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Chapter 6

6

Tra1 is a novel potential target for antifungal therapy

The emergence of drug-resistant strains among fungal pathogens represents a major
public health challenge. Thus, it is essential to identify new therapeutic targets to fight
pathological yeast infections. The previous chapters demonstrated that Tra1 plays a vital
role in promoting yeast survival during stress conditions (including cell wall perturbation;
a major mode of action of antifungal compounds), suggesting that it could represent a
rational target for antifungal treatment. In this chapter, I will investigate the role of Tra1
in antifungal drug resistance, especially through the regulation of the calcineurin pathway.

6.1 Abstract
Fungal infections have become a growing threat to human health. Current treatment is
very limited and often insufficient. Furthermore, several pathological yeast strains have
acquired significant multidrug resistance. Thus, it is urgent to understand the mechanisms
of fungal stress resistance to identify new therapeutic targets for antifungal drug
development. The conserved Tra1 protein is involved in the yeast cellular stress
responses critical for cell viability and survival under stress conditions. Our new data
showed that Tra1 is involved in the calcineurin signaling pathway that regulates calcium
homeostasis, which has been shown to be crucial for fungi virulence and drug resistance.
Cells expressing a mutant Tra1 allele displayed impaired activation of the calcineurin
pathway and were more sensitive to antifungal drugs. Furthermore, Tra1 plays a critical
role in the cell wall stress response. Synthesis of the cell wall is the target of a major class
of antifungal drugs such as echinocandins. Our study provides new insights into the
mechanisms of cellular stress responses in yeast and identifies Tra1 as a novel target for
antifungal drug development.

6.2 Introduction
Fungal infections are affecting 25% of the population worldwide (Havlickova et al.,
2008). Most common fungal pathogens include Cryptococcus, Candida, and Aspergillus,
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which can cause serious chronic diseases and are potentially fatal if not diagnosed and
treated in time (Brown et al., 2012). There are only a limited number of antifungal agents
available. Azoles, such as fluconazole and miconazole, target ergosterol synthesis by
inhibiting lanosterol 14α-demethylase that converts lanosterol to ergosterol, a major
component of fungal plasma membranes. Membrane sterol is also targeted by polyenes
through direct binding which causes changes in membrane permeability and leakage of
cytoplasmic material. Another class of antifungal drugs is the echinocandins (caspofungin
and anidulafungin), which inhibit fungal β(1,3)-d-glucan biosynthesis and lead to severe
cell wall defect (Ghannoum and Rice, 1999; Groll et al., 1998; Kathiravan et al., 2012).
These drugs usually have strong side effects and they speed the fungal evolution to gain
antifungal resistance. Multidrug resistance of fungal pathogens has been observed in
many cases, specifically among Candida species (Cowen, 2008; Cowen et al.,
2014). Therefore, developing new antifungal drugs which are more specific and efficient
is challenging but urgent.
Cellular stress responses including the heat shock response (HSR), the cell wall integrity
(CWI) pathway and the calcium-calcineurin pathway are activated under stress conditions
to regulate cell viability and survival by assisting with protein folding, cell wall synthesis,
and maintaining calcium homeostasis (Cyert, 2003; Levin, 2005; Morimoto and
Westerheide, 2010). Therefore, key proteins in the cellular stress response pathways can
be targets for antifungal drug development. For example, a major heat shock protein
Hsp90 has been found to be involved in antifungal resistance (Lamoth et al., 2016).
Hsp90 inhibitors significantly enhance the efficacy of antifungal drugs (Cowen et al.,
2009). The combination of Candida albicans Hsp90 antibody and an antifungal agent
amphotericin B has shown beneficial effects in a clinical trial (Pachl et al., 2006). The
regulation of cell stress responses requires the transcription of stress-induced genes. The
transcriptional regulation involves the recruitment of specific activators and co-activators
such as histone acetyltransferase (HAT) complexes (Bonnet et al., 2014). An essential
component of SAGA and NuA4 complexes, Tra1, has been shown to be involved in
cellular stress responses (Hoke et al., 2008; Hoke et al., 2010). Literature showed that
yeast cells expressing mutant Tra1 were more sensitive to cell stressors MMS, ethanol,
and caffeine (Berg et al., 2018; Mutiu et al., 2007). Therefore, Tra1 is critical for cell
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survival and growth during stress and could be a target for antifungal therapy. To test the
role of Tra1 in antifungal resistance, we assessed the effects of common antifungal agents
on yeast growth in cells carrying a mutant Tra1 (tra1Q3) allele in the well-characterized
Saccharomyces cerevisiae.
Calcineurin signaling is conserved among fungal species, critical for cell growth and
stress responses (Cyert, 2003). The calcineurin pathway has been shown to be involved
in pathogen virulence and drug resistance in different fungal pathogens through its role in
the cell membrane and cell wall synthesis (Juvvadi et al., 2014; Liu et al., 2015; Yu et al.,
2014). Furthermore, calcineurin inhibitors FK506 and cyclosporine A and their analogs
have been studied for antifungal treatment (Lee et al., 2018; Pandit, 2003). However, due
to the immunosuppressive effects, they cannot be directly used in the clinic. Tra1 mutant
strain showed significant growth defect in presence of high calcium, suggesting that Tra1
is vital for calcium homeostasis (Berg et al., 2018). However, the mechanism of how
Tra1 regulates the calcineurin pathway remains unclear. Understanding the vital role of
Tra1 in the calcineurin pathway activation is crucial for developing target-specific drugs
for antifungal treatment.
Using the well-studied yeast model, we found that Tra1 is essential for the calcineurin
pathway activation. Cells expressing tra1Q3 failed to activate the calcineurin signaling,
leading to increased sensitivity to antifungal drugs. Our results expand the understanding
on the role of Tra1 in cellular stress responses and identify its potential for the
development of novel antifungal therapy.

6.3 Materials and Methods
Yeast strains and culturing
The TRA1/tra1Q3 strains used in this study was described in Berg et al., 2018. Preparation
of growth media was instructed by standard protocol from Amberg and Strathern, 2005.
Cell growth was assessed by spot and liquid culture. After OD600 of the overnight culture
was measured, cells were diluted to OD600 0.2 and then spotted in three fivefold dilutions
for spot assay. For liquid culture assay, yeast cells were diluted to OD600 0.1 from the
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beginning. Three replicates for each group were cultured in a 96 well plate and
concentration was measured per 15 minutes by a plate reader (Biotek) for 24 hours.

Chemicals and drugs
Trichostatin A (10 mM in H2O; Biovision), calcofluor white (30 mg/mL in H2O; SigmaAldrich), tunicamycin (5 μg/mL in DMSO; Amresco), fluconazole (50 mg/ml in DMSO;
Alfa Aesar), miconazole (30 mg/ml in DMSO; Alfa Aesar), and caspofungin (1mg/ml in
H2O; Sigma-Aldrich) were diluted to concentrations listed for each experiment.

qRT-PCR
Cells were treated with 200mM CaCl2 for four hours before RNA extracted using
MasterPure Yeast RNA Purification Kit. Reverse transcription was done by qScript Flex
cDNA Synthesis Kit (Quanta). The cDNA samples were diluted five times as the qPCR
reaction templates. PerfeCTa SYBR-Green Supermix (Quanta) was employed for
amplified DNA measurement. The primers used were listed in Table 6.1. The relative
expression level was calculated by the ΔΔCT method using U3 as a housekeeping control.

Table 6.1 Primers used in this study
Gene

Forward Primer

Reverse Primer

U3

CCCAGAGTGAGAAACCGAAA

AGGATGGGTCAAGATCATCG

PMR1

TGCCGTTTTTGAAATGATGA

ATAGCAGCAACCGCTAAGGA

PMC1

GATGGCAGGTTCCATGATCT

CCCATCGTTTCACAGCTTCT

Beta-galactosidase assay
Overnight culture was washed and resuspended by lacZ buffer. To measure betagalactosidase activity, 50 μl of cells were diluted in 950 μl lacZ buffer with 2.7μl βmercaptoethanol, one drop 0.1% SDS, two drops chloroform and incubated 15 minutes at
30 °C. 100 μl ONPG (4mg/ml) was added to each sample to start the reaction. Then the
cells were put back to 30 °C until the color changed to yellow. Time was recorded. To
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stop the reaction, 300 μl 1M Na2CO3 was added. The beta-galactosidase activity was
determined by measuring 420 nm absorbance using a plate reader (Biotek), standardizing
to cell density.

Statistical analysis
Growth curves were generated to quantify the differences in yeast growth under different
conditions. The area under the curve was measured using the Graphpad Prism 7 software.
Statistical significance was calculated using the Student’s t-test.

6.4 Results and Discussion
Tra1 is a regulator of the calcium-calcineurin pathway
The calcineurin pathway is crucial for fungal survival and resistance to antifungal drugs
(Juvvadi et al., 2014). Literature showed that the activation of the signaling pathway
requires an intact SAGA complex. Deletion of the gene encoding the histone
acetyltransferase Gcn5 leads to a significant downregulation of the calcineurin A subunit
in

fungal

pathogen

Cryptococcus

neoformans

(O’Meara

et

al.,

2010).

To

comprehensively determine the effects of SAGA and NuA4 components on the regulation
of calcium homeostasis in S. cerevisiae, we assessed the sensitivity to high calcium stress
in strains carrying deletions of the major components of the SAGA or NuA4 HAT
complexes (Han et al., 2014; Searle et al., 2017). We found that knocking out the SAGA
components GCN5, ADA2, and SPT20 or NuA4 component EAF1 resulted in a severe
growth defect in presence of 200 mM CaCl2 (Figure 6.1). The data suggest that both
SAGA and NuA4 are required for calcium homeostasis.
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Ctrl
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eaf1Δ

gcn5Δ

eaf3Δ

ada2Δ

eaf6Δ

spt20Δ

eaf7Δ

ubp8Δ

yaf9Δ

200mM CaCl2

NuA4

spt3Δ

arp6Δ

spt8Δ

SWR1 complex H2

sgf11Δ

SAGA

Figure 6.1 SAGA and NuA4 complexes are essential for calcium homeostasis.
Deletion of SAGA/NuA4 components increases cell sensitivity to high Ca2+. Cells
were incubated in YPD media containing 0.05M succinic acid overnight before
spotted on YPD plus 0.05M succinic acid plates in the presence or absence (Control)
of 200mM CaCl2 and incubated for 2 days.
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Tra1 is the only essential subunit within both SAGA and NuA4 complexes and has been
found to be involved in stress responses (Hoke et al., 2008). Therefore, we further
investigated whether Tra1 played a role in regulating cell growth towards high calcium.
The Tra1 PI3K domain is essential for maintaining protein stability and nuclear
localization (Berg et al., 2018). My study involved a tra1Q3 allele, where three arginine
residues within the PI3K domain were mutated to glutamine (Berg et al., 2018). As
shown in Figure 6.2, the mutant tra1Q3 stain had a significant growth defect when
cultured in media containing 200mM CaCl2.
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Figure 6.2 A functional Tra1 is required for growth in presence of high calcium
levels.
Tra1 mutation strain displayed a growth defect at high calcium concentration. WT and
tra1Q3 cells were incubated in YPD media containing 0.05M succinic acid overnight
before spotted on YPD plus 0.05M succinic acid plates in the presence or absence
(Control) of 200mM CaCl2 and incubated for 2 days. Growth of WT and tra1Q3 cells
were also assessed by liquid growth assay. The area under the curve was quantified for
each replicate (n = 3), ***P < 0.001.
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Previous synthetic genetic array analysis showed a negative genetic interaction between
Tra1 and the calcineurin regulatory subunit, Cnb1 (Hoke et al., 2008). Indeed, the tra1Q3
mutant displays a synthetic slow growth phenotype when crossed with the CNB1Δ strain
(Figure 6.3A). The activation of the calcineurin pathway targets requires Crz1 binding to
the calcineurin-dependent response element (CDRE) (Stathopoulos and Cyert, 1997). To
further explore the mechanisms underlying the sensitivity to high calcium of the tra1Q3
strain, we measured the activation of the calcineurin pathway using a lacZ reporter under
the control of a promoter carrying the CDRE motif (Stathopoulos and Cyert, 1997).
Results in Figure 6.3B indicated that cells expressing tra1Q3 fails to activate the calciumcalcineurin pathway when treated with a high concentration of Ca2+. Moreover, unlike in
wild-type cells, the expression of downstream calcineurin target genes PMR1 and PMC1
in tra1Q3 cells remained unchanged upon treatment with high calcium (Figure 6.3C). The
data suggested that Tra1 is vital for activation of the calcineurin pathway to regulate
calcium homeostasis. Furthermore, addition of TSA, a histone deacetylase inhibitor
significantly alleviated the growth defect in Tra1 mutant cells at high CaCl2 concentration,
indicating the critical role of histone acetylation in regulating the calcineurin pathway
(Figure 6.3D). How Tra1 is involved in the calcineurin pathway activation remains
unclear. Expression of a truncated CNA1 without the autoinhibitory domain that leads to
constitutive activation of calcineurin (Chaudhuri et al., 1995), or overexpressing the
transcriptional regulator CRZ1 did not rescue the sensitivity to high Ca2+ treatment of
cells expressing the tra1Q3 allele (Figure S6.1). The data suggested that Tra1 is required
for the activation of Crz1 downstream target gene transcriptions, potentially by targeting
the transcription factor to its targeted promoters.
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Figure 6.3 Tra1 regulation is required for the calcineurin pathway.
(A) Genetic interaction between Tra1 and Cnb1. CNB1 deletion strain carrying Tra1
mutation cause slow cell growth. (B) Cells carrying tra1Q3 allele cannot activate the
calcineurin pathway. Cells expressing the CDRE-LacZ reporter were incubated in SC
media containing 0.05M succinic acid in the presence or absence of 200mM CaCl2.
Gene expression was analyzed using LacZ transcriptional reporters. ***P < 0.001, n =
3 ± SEM. (C) Reduced PMR1 and PMC1 expression during high calcium stress in
cells expressing mutant Tra1. WT and cells carrying the Tra1Q3 allele were processed
for RT-qPCR to assess transcript levels of PMR1 AND PMC1. **P < 0.005, ***P <
0.001 (n = 3). (D) Inhibiting histone deacetylation partially attenuates sensitivity to
high Ca2+ in Tra1 mutant cells. The growth of WT and tra1Q3 cells were assessed by
liquid growth assay. Experimental groups were treated with 40 μM trichostatin A
(TSA). The area under the curve was quantified for each replicate (n = 3), ***P <
0.001.
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Tra1 is involved in yeast tolerance of antifungal agents
Since Tra1 is vital for the activation of the calcineurin pathway, we next investigated the
role of Tra1 in cell sensitivity to antifungal reagents. As shown in Figure 6.4A, the tra1Q3
strain was significantly more sensitive to the antifungal agents fluconazole, miconazole,
and caspofungin. To test the activation of calcineurin signaling, the expression of CDRE
was determined by a lacZ reporter. We found that cells carrying mutant Tra1 were unable
to activate the calcineurin pathway when treated with azoles (Figure 6.4B).
Previous studies and our results show that Tra1 plays an essential role in cellular stress
responses such as the HSR and cell wall stress response. As shown in Figure 6.5A, tra1Q3
cells displayed a growth defect when treated with a cell wall stressor calcofluor white as
well as incubated at a higher temperature. In addition, the tra1Q3 mutant shows no growth
defect when treated with tunicamycin, suggesting that the requirement for Tra1 function
(or at least its PI3K domain) is specific to several stresses. Furthermore, our data show
that osmotic stabilizer sorbitol attenuated the growth defect of the tra1Q3 mutant cells
when treated with antifungal drugs (Figure 6.5B), reinforcing the crucial role of Tra1 in
cell wall homeostasis. The stress responses are vital in regulating cell survival when
exposed to antifungals. Thus, Tra1 emerges as a new potential therapeutic target for
fungal infections. The Tra1 PI3K domain is highly conserved from S. cerevisiae to fungal
pathogen C. albicans (Figure 6.6). Therefore, the results found in S. cerevisiae can direct
future investigations on the role of Tra1 in C. albicans and antifungal drug development.

214

(A)

YPD

20μg/ml FLC

0.5μg/ml MIC

200μg/ml Casp

WT
tra1 Q3
1.5

1.5

WT
tra1Q3
WT FLC

WT
tra1Q3
WT MIC

1.0

0.5

tra1Q3 FLC
0

500

tra1Q3 MIC

1000

0

500

tra1Q3 Casp
0

500

1000

Time(min)

CDRE-lacZ

CDRE-lacZ

**

ns
1.0

0.5

WT
tra1Q3
WT FLC
tra1Q3 FLC

Relative lacZ activity

1.5

1.5

**
ns

1.0

WT
tra1Q3
WT MIC
tra1Q3 MIC

0.5

tr
a

1
Q

3

M

IC

M
IC

a1
Q

W
T

3

a1
Q
tr

W

T

FL

FL

C

C

3

a1
Q
tr

W
T

3

0.0

0.0

tr

Relative lacZ activity

0.0

1000

Time(min)

Time(min)

(B)

0.0

W
T

0.0

1.0

0.5

0.5

WT
tra1Q3
WT CASP

OD600

OD600

OD600

1.0

1.5

Figure 6.4 Tra1-dependent activation of calcineurin pathway is critical for
antifungal resistance.
(A) Cells expressing tra1Q3 mutation are more sensitive to antifungals. WT and tra1Q3
cells were spotted on selective plates containing fluconazole, miconazole, and
caspofungin at indicated concentrations and incubated for 2 days. Cell growth was
assessed by liquid growth assay. (B) Tra1 mutant cells fail to upregulate the calciumcalcineurin pathway treated with antifungals. Cells expressing the CDRE-LacZ
reporter were incubated in SC media in the presence or absence of fluconazole for 6
hours or miconazole for 4 hours. Gene expression was analyzed using LacZ
transcriptional reporters. **P < 0.005, n = 3 ± SEM.
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Figure 6.5 Tra1 plays an important role in cellular stress responses.
(A) Cells expressing mutant Tra1 are more sensitive to heat shock and cell wall stress.
Cells were spotted on selective plates with calcofluor white (CFW) or tunicamycin
(TM) and incubated at 30 or 39 °C for 2 days. (B) The sensitivity to antifungals of
tra1Q3 cells is linked to cell wall stress. WT and Tra1 mutant cells were spotted on
selective plates containing fluconazole, miconazole, or caspofungin and incubated at
30 °C for 2 days ±1M sorbitol.
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Figure 6.6 Sequence alignment of homologous Tra1 PI3K domain.
The PI3K domain of Tra1 in S. cerevisiae, C. albicans, and TRRAP in human was
aligned using the online MUSCLE tool (http://www.ebi.ac.uk/Tools/msa/muscle/).
The three arginine (R3389, R3390, R3456) to make the tra1Q3 strain was marked with
the red box.
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Perspective
My study investigated the role of Tra1 in the activation of the calcineurin pathway and
antifungal resistance. Future studies including growth assays, protein expression
quantification, ChIP, and genome-wide sequencing assays comparing tra1Q3 to wild-type
strain will be performed in the fungal pathogen C. albicans in collaboration with Dr.
Rebecca Shapiro at the University of Guelph to investigate whether the phenotypes
observed in S. cerevisiae are recapitulated in pathogenic fungi. These experiments will
help gain a better understanding on the mechanisms of Tra1 regulated stress responses
during antifungal drug treatment.
The PI3K domain is vital for Tra1 stability and function. Although lacking kinase motifs,
structural studies suggested that the PI3K domain of Tra1/TRRAP is still able to catalyze
the transfer of a modifying unit other than phosphate moieties (Mutiu et al., 2007). Many
PI3K inhibitors and small molecules have been designed targeting the PI3K domain of
the PIKK family proteins for treatment of cancer and several other diseases (Fruman et al.,
2017), this domain could be an excellent binding target for target-specific antifungal drug
development. Sequence alignment has identified the differences between fungal Tra1 and
human TRRAP within the PI3K domain (Berg et al., 2018), further studies should
investigate the structure and function of these specific targets in regulating Tra1 and cell
survival.
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Figure S 6.1 Hyperactivation of the calcineurin pathway did not rescue sensitivity
to high Ca2+ concentration in cells expressing mutant tra1Q3.
(A) Constitutively activated calcineurin did not rescue the growth defect of tra1Q3
cells at high Ca2+ treatment. Truncated Cna1 was transformed into wild-type and Tra1
mutant cells. Cells were incubated in YPD media containing 0.05M succinic acid
overnight before spotted on YPD plus 0.05M succinic acid plates in the presence or
absence (Untreated) of 200mM CaCl2 and incubated for 2 days. (B) Overexpressing
Crz1 showed little effects on cells carrying the tra1Q3 allele. GAL1 induced Crz1 was
expressed in WT and tra1Q3 mutant cells. Cells were incubated with 0.05M succinic
acid overnight before spotting on selective plates containing 200mM CaCl2.
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Chapter 7

7

Discussion

In this last chapter, I will summarize the main findings and discuss the overall
implications and significance of my thesis project. First, I will introduce the methods
available to assess new fluorescent proteins including the advantage of using the yeast
assay I have developed. Then, I will address the link between protein aggregation and
toxicity in neurodegenerative disorders. Furthermore, I will discuss the controversial role
of the TORC1 signaling in HD and the importance of combining different experimental
models in HD research. Finally, I will evaluate the therapeutic potential of Tra1/TRRAP
for human disease therapy.

7.1 Summary of major results
The main goal of my thesis is to investigate the function of Tra1 in regulating cellular
stress responses and the implications for stress-related diseases. To accomplish that, I
employed the well-characterized yeast model of HD to investigate Tra1-dependent
regulation on polyQ toxicity. First, I developed an optimized yeast model to study polyQ
toxicity and aggregation in yeast by tagging mutant Htt exon1 with newest yeast codon
optimized FPs. I found that different FPs can alter polyQ toxicity and aggregation
formation. Following this, I assessed the effects of two latest generation of RFP,
FusionRed and mScarlet, using the yeast polyQ model. I found that tagging polyQ with
FusionRed attenuated its toxicity in yeast. With the help of the optimized HD model in
yeast, I revealed how Tra1 and SAGA complex regulates polyQ toxicity. My data
suggested that polyQ expansion impairs SAGA assembly and leads to upregulation of
Tra1 expression dependent on Sfp1, a downstream target of the TORC1 signaling
pathway regulating ribosome biogenesis. Impaired HSR has been found in HD before;
however, the precise mechanism remains unclear. Functional Tra1 has been linked to
cellular stress responses. Therefore, I studied how Tra1 regulates heat shock tolerance in
the presence of expanded polyQ. I showed that the heat shock sensitivity of cells
expressing polyQ is linked to a defect in cell wall integrity, which requires Tra1
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regulation. Since Tra1 is crucial for cellular stress responses and yeast survival, I then
investigated its role in antifungal resistance. My results indicated that a functional Tra1 is
vital for yeast resistance to antifungal agents, through the activation of the calcineurin
pathway. My studies therefore identify Tra1 as a novel potential therapeutic target for
fungal infections.

7.2 Assessing fluorescent proteins and the impact on their
fusion partners
The development of GFP (2008 Nobel Prize in Chemistry jointly to Osamu Shimomura,
Martin Chalfie, and Roger Y. Tsien) and other FPs make a powerful tool in nowadays’
scientific field. In modern biological researches, a great number of findings were
achieved with the help of FPs to visualize protein localization and trafficking, proteinprotein interactions, and organelle metabolic functions (Kremers et al., 2011;
Wiedenmann et al., 2009). There are now numerous FP options available. However,
because of the different nature of FPs, whether a given FP is appropriate can vary from
experiment to experiment. My study is a good example and showed that tagging
expanded polyQ with different fluorescent proteins can alter its toxicity and aggregation
(Jiang et al., 2017). Many factors can affect the expression of FPs and one needs to take
them all into consideration when designing a protein fusion. These include N versus Cterminal fusion, FP maturation and photostability, environmental conditions, codon
optimization, and oligomerization (Costantini et al., 2015; Huang et al., 2014; Palmer and
Freeman, 2004; Snapp, 2009). Due to the lack of rapid and quantitative methods to
evaluate FPs, especially their impact on fusion partners, testing newly synthesized FPs
and choosing the correct FPs for specific experiments has always been challenging.
Most quantitative comparisons between different FPs have been made in vitro, which do
not necessarily reflect their behavior in living cells. Cranfill et al. characterized more than
40 FPs based on their visible spectrum, photostability, and monomeric nature to look for
the best performing FPs. The light absorbance and fluorescence quantum yield of purified
FPs were measured to determine the brightness. Photobleaching rates were measured by
embedding FPs in polyacrylamide or microdroplets using laser scanning microscopy
(Patterson and Piston, 2000; Piston et al., 1999). The monomeric quality was quantified

225

using the OSER assay (Costantini et al., 2012). Using the monomeric FP is critical for
correct folding and maintaining the structure of fusion targets. The OSER assay is based
on the ability of oligomerized membrane protein fluorescent fusions to transform the
branching tubules network ER into a whorls-like organized smooth ER (OSER) structure
(Snapp et al., 2003). Tagging FPs to ER-targeted transmembrane domain of cytochrome
p450 to form the CytERM-FP and quantify the OSER structures can represent the FP
oligomeric status in vivo. Compared to the traditional in vitro assays to assess the
oligomeric tendency of FPs through ultracentrifugation or gel filtration methods, the
OSER assay allows scientists to study FP behavior in living cells. Furthermore, another
study expressed FPs in transgenic C.elegans embryos to assess their performance in a
multicellular animal model (Heppert et al., 2016). However, both of the in vivo methods
are not high throughput.
In Chapter 2 and 3 of my thesis, I demonstrated an ideal tool to study FP brightness,
photostability and specifically the impact on their fusion partners using the yeast polyQ
model. Different FPs alter the toxicity and aggregation of mutant Htt. Thus, this model
can be used to characterize new FPs and evaluate the effects on their targeted proteins.
With the advantage of using yeast as a model, this method provides researchers with a
rapid and high throughput tool to screen for newly synthesized FPs or potential mutations
of classic FPs that may improve their performance. Therefore, the polyQ assay is a good
complement to existing methods to test the next generation FPs. Furthermore, the method
can also be used to test other genetically encoded tags.

7.3 Correlation between aggregation and
neurodegeneration
Aggregation is a hallmark of a series of neurodegenerative disorders including AD, PD,
and HD; however, its role in toxicity is debatable. It is proposed that the non-soluble
large aggregates directly contribute to disease pathology of neurodegeneration
(Donaldson et al., 2003; McCampbell et al., 2000). However, more evidence is showing
that these amyloid-like aggregates may actually be cytoprotective (Todd and Lim, 2013).
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In HD, inclusion bodies (IBs) accumulate in the striatum, cerebral cortex, cerebellum,
and the spinal cord. The formation of IBs is found before neuron cell death and correlates
with severe behavioral symptoms in HD transgenic mice model (Davies et al., 1997).
Although the function of normal Htt is not fully understood, it has been found to be
critical for clathrin-mediated endocytosis, apoptosis, and vesicle transport (Harjes and
Wanker, 2003). Therefore, misfolded Htt may disrupt essential cellular functions by
impairing the functions of the wild-type allele. Due to the nature of the polyQ
oligomers/IBs, expanded polyQ may sequester other proteins. A transcriptional regulator
CBP was found to be incorporated into the IBs in an HD cell line (McCampbell et al.,
2000). Furthermore, sequestration of essential ubiquitin binding proteins into the
aggregates was also found in other polyQ diseases, e.g. Spinocerebellar Ataxia
(Donaldson et al., 2003). Thus, the recruitment of other proteins may cause cellular
dysfunctions and lead to neurotoxicity. However, this sequestration is not observed in all
different HD models (Yu et al., 2002). Moreover, the impairment of the proteasome can
occur before IBs formation (Mitra et al., 2009). Several studies showed that there is no
correlation between aggregations and toxicity. An HD mouse model expressing human
Htt 120Q displayed no significant neuronal degeneration, although IBs were observed in
the striatum and cortex (Slow et al., 2005). Interestingly, a longitudinal survival analysis
by following long-time survival of the same living neurons in HD demonstrated that
neuronal cell death highly correlates with diffuse Htt (Arrasate and Finkbeiner, 2012;
Miller et al., 2010). The accumulation of IBs reduced diffuse Htt expression and the risk
of striatal neuronal death. The results suggested that the aggregation may be actually
protective against neuron cell death. In addition, Takahashi et al. also reported that the
cytotoxicity is caused by soluble oligomers but not IBs (Takahashi et al., 2008).
The toxicity also seems dependent on the localization of mutant Htt. Tissue culture cells
have been found to take up chemically synthesized polyQ peptides. IBs were observed
mainly in the cytoplasm and do not affect cell viability. Adding a nucleolus localization
signal on the other hand, significantly induce cell death in the PC-12 cell line (Yang et al.,
2002). Indeed, nuclear aggregation is quite rare in HD patient striatal neurons (Gutekunst
et al., 1999; Kuemmerle et al., 1999), further suggesting that polyQ aggregates may not
be a predictor of neuronal cell death. The kinetics of aggregation formation may also
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affect its toxicity. A time-lapse microscopy analysis showed that cells that formed
delayed IBs formation survived longer than those forming IBs quickly (Gong et al., 2008).
Several studies also supported the idea that aggregations are epiphenomena or protective
in PD and AD, representing a compensating mechanism to cellular stress to promote cell
survival (Espay et al., 2019; Wan and Chung, 2012). Accepting the hypothesis that
aggregation is protective, new therapeutic targets other than preventing aggregation and
activating misfolded protein degradation pathways are investigated for HD and other
misfolded protein diseases. A chemical compound library screen identified a compound
B2 to be protective against HD and PD in mammalian cell line by promoting IBs
formation however reduce cytotoxicity (Baldo et al., 2012).
The yeast model of HD provides researchers with a practical tool to study the connection
between aggregation and toxicity. Even though polyQ affects Tra1/SAGA functions, it
did not sequester Tra1 into the aggregates, indicating that sequestration into aggregates is
not the only mechanism that contributes to the cellular toxicity. Furthermore, we
observed that compared to other FPs, cells expressing 72Q-moxBFP displayed the
strongest growth defect (Figure 2.5). Interestingly, these cells seem to form fewer
aggregates although further quantitation is required. Therefore, further studies focusing
on the relationship between aggregation and toxicity as well as other specific factors that
may coordinate polyQ toxicity and aggregation morphology, for example flanking
sequences outside of the polyQ region (Dehay and Bertolotti, 2006; Duennwald et al.,
2006), is crucial for identifying new targets for HD therapy.

7.4 TORC1 signaling in Huntington’s disease
The highly conserved TORC1 signaling controls many cellular processes that regulate
cell growth and proliferation, including transcription, stress responses, cell cycle, and
importantly, autophagy (Kamada et al., 2010). TORC1 is a negative regulator of
autophagy, which is critical for degrading protein aggregates (Ravikumar et al., 2002).
Thus, one could quickly think that TORC1 should be inhibited in HD therapy. By
contrast, conflicting views argue that TORC1 activation can be beneficial in HD because
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it promotes cellular functions that have been found to be impaired by polyQ expansion
(Ferrarelli, 2015).
The clearance of misfolded protein aggregates is crucial for HD therapy. Multiple studies
showed that autophagy plays a vital role in degrading aggregate-prone proteins
(Ravikumar et al., 2002; Roscic et al., 2011; Webb et al., 2003). Ravikumar et al. (2004)
reported that inhibiting autophagy leads to increased aggregation and cell death in the
COS-7 cell line expressing mutant Htt. Treatment of mTOR inhibitor rapamycin, which
activates autophagy, had opposite effects. Furthermore, another study demonstrated that
mTORC1 is sequestered into mutant Htt aggregates in an HD cell model, transgenic mice,
and patient brain samples (Ravikumar et al., 2004). The recruitment impairs mTOR
kinase activity and induces autophagy. They observed increased aggregation formation
and cell death in COS-7 cell line carrying polyQ expansion when mTOR signaling is
enhanced by overexpressing the upstream regulator Rheb (Manning and Cantley, 2003).
The authors hypothesized that inhibiting mTOR has protective effects in HD. Using a fly
model of HD, they showed slower neurodegeneration when treated with rapamycin.
Furthermore, when treated with a rapamycin analog CCI-799, Ross/Borchelt mice
expressing Htt N-terminal fragment with 82Q showed fewer aggregates in the striatum
and performed better in behavioral tests (Ravikumar et al., 2004). However, rapamycin
treatment leads to significant weight loss and reduced brain mass. It also does not
improve the lifespan of HD mice, which makes the potential of rapamycin analog in HD
treatment questionable.
Lee and colleagues hold the opposite opinion (Lee et al., 2015). When they activated
mTORC1 through overexpression of Rheb (Ras homolog enriched in the brain) or Rhes
(Ras homolog enriched in the striatum) in HD mice striatal neurons, they observed
protective effects. mTORC1 activation promoted mitochondrial function, increased
cholesterol synthesis, attenuated striatal atrophy, and improved HD mice disease
phenotypes. Notably, they observed increased levels of autophagy markers LC3-II and
Beclin-1 when mTORC1 is activated. Several studies have shown that autophagy can
happen through mTORC1-independent pathways (Gordon et al., 1993; Petiot et al., 2000;
Sarkar, 2013). Furthermore, mTOR reactivation can regulate lysosome formation under
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starvation (Yu et al., 2010). Therefore, mTOR-independent or mTOR-promoted
autophagy may be contributing to proteostasis during polyQ expansion. Targeting
mTOR-independent autophagy pathways have shown benefits to HD in cell lines, fly, and
zebrafish models (Sarkar et al., 2009; Williams et al., 2008).
The role of mTOR in HD can also be tissue specific. mTOR activation is higher in
skeletal muscles than in the brain in the transgenic R6/2 mice model of HD (She et al.,
2011) and is believed to contribute to muscle atrophy. These results may explain the
behavior improvement see in the animal following treatment of rapamycin. Furthermore,
inhibiting mTORC1 has shown protective effects against other neurodegenerative
diseases such as Fragile X syndrome and ALS (Bhattacharya et al., 2012; Saxena et al.,
2013).
The regulation of TORC1 in mammals is complicated. Suppressing or hyperactivating
TORC1 can cause strong side effects (Li et al., 2014). The well-studied S. cerevisiae
allows researchers to investigate the role of TORC1 in polyQ toxicity and identify
downstream proteins that can be therapeutic targets for HD. Our data suggested that
functional TORC1 is critical in HD. TORC1 inhibition and activation both lead to
increased sensitivity to polyQ toxicity (Figure 4.6). TORC1 hyperactivation suppressed
the upregulation of TRA1 during polyQ expansion, which may partly explain the growth
defect. It is vital to investigate downstream mechanisms of the TORC1 signaling pathway
that is crucial for HD and identify specific therapeutic targets.

7.5 HD model organisms
Other than the yeast model of HD used in my thesis, there are different model organisms
developed to study HD pathology including worms, fruit flies, rodents, and larger
mammals such as monkeys and pigs (Pouladi et al., 2013). Each model has its advantages
and limitations. Thus, the combination of diverse HD models is meaningful for the
research field to investigate fundamental cellular mechanisms together with neuronal
functions and behavioral phenotypes resulting from polyQ expansions. The following
section is extracted from Jiang, Chadwick, and Lajoie (2016).
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Researchers have studied HD in worms; they are a useful invertebrate model of neuronal
dysfunction and death because of their conserved basic neuronal functions compared to
vertebrates and their simple neuroanatomy. The Hart’s group developed a C. elegans HD
model specifically expressing Q150 in sensory neurons induced by an osm-10 promoter
(Faber et al., 1999). There are other worm models mimicking HD, as well. One uses a
mec-3 promoter expressing 57-residue fragment of Htt followed by GFP (Parker et al.,
2001) and another study expressed expanded polyQ in the C. elegans body wall muscle
cells (Satyal et al., 2000). Despite lacking a homolog to the human Htt, worms provide
researchers a good tool to study cellular events in HD, especially in neuronal cells. Fruit
flies are also an excellent system to study HD because the Htt gene is conserved with
mammals (Sipione and Cattaneo, 2001). Expressing Htt exon1 in photoreceptor neurons
in the compound eye in Drosophila was achieved via the UAS-GAL4 system (Jackson et
al., 1998; Kim et al., 2004). This small model organism allows rapid genetic
manipulation and, as it is the case with the Huntingtin protein, it expresses a large number
of genes with a homologue to the human proteome (Wangler et al., 2015). As with many
other human diseases, rodents are commonly-used models in investigating the basis of
HD. The R6/1 and R6/2 transgenic mouse model expressing Htt exon1 designed by
Mangiarini and colleagues shows many HD symptoms, including chorea, involuntary
stereotypic movements, tremor, and loss of muscle strength (Mangiarini et al., 1996).
Another model expresses a cDNA encoding the N-terminal fragment of the Htt protein
with 82Q, which also show severe Huntington’s disease phenotypes (Schilling et al.,
1999). The Hayden laboratory also created a yeast artificial chromosome (YAC)
transgenic mice expressing the full-length HTT gene with 18Q, 46Q or 72Q. YAC mice
expressing the 72Q HTT gene (YAC72) show a selective degeneration of medium spiny
neurons associated with N-terminal Htt translation to the nucleus (Hodgson et al., 1999).
Another way to express mHtt in mice is through knocking in a human HTT exon1 into the
endogenous mouse Huntington’s disease gene homolog (Hdh) (Trettel et al., 2000;
Wheeler et al., 2000). These mice always show a milder phenotype compared to
transgenic models. For example, in the mutant HdhQ50 and HdhQ111, where mutant Htt is
expressed under the endogenous mouse HTT gene promoter, an age-dependent Htt
nuclear relocalization and inclusion bodies were observed after six months. However,
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these mice did not show a severe movement disorder (White et al., 1997). Although over
20 different rodent HD models have been created over the years, each has its own
advantages and disadvantages. The transgenic models may just mimic the disease
symptoms rather than the age-dependent onset of HD, but the knock-in models do not
mimic the human symptoms because the Hdh gene in mice differs from HTT in humans.
Thus, the choice of a specific model should be made with caution (Jiang et al., 2016;
Pouladi et al., 2013).
The major advantage of the yeast model is the ease of genome editing and large-scale
screening which allows researchers to focus on specific signaling pathways in cells
expressing mutant Htt expansion and identify potential modifiers and suppressors of
polyQ toxicity. The findings in yeast can be verified in higher eukaryotic models and
guide the future therapeutic studies in clinic. The majority of HD yeast studies focus on
rescuing growth defect during fermentative metabolism. A genome-wide overexpression
screen identified that suppressors for polyQ toxicity are mainly glutamine- and
asparagine-rich prion-like proteins (Kayatekin et al., 2014). However, there are a lot of
questions left to be answered. Future studies can investigate the mechanisms by which
polyQ affects mitochondria respiration in yeast, how cells cope with polyQ toxicity at
early time points, and the role of chromatin remodeling and transcriptional regulation
during polyQ expansions.

7.6 Tra1/ TRRAP as a novel target for human diseases
In my thesis, I demonstrated that Tra1 is a major regulator of the cellular stress responses
to protein misfolding, which indicates the possibility to target Tra1 or its mammalian
ortholog TRRAP in the treatment of HD and fungal infections. Dysregulation of
Tra1/TRRAP and dysfunctions in histone acetylation has been found in other stressrelated human diseases, especially in cancer.
The protein TRRAP was initially identified through its interaction with the oncoprotein cMyc by affinity purification (McMahon et al., 1998). In addition, the group also
identified the binding of TRRAP to E2F transcription factors in controlling the cell cycle.
The constitutive activation of E2F is considered an important event in oncogenesis
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(Johnson and Schneider-Broussard, 1998). More studies have implicated the role of
TRRAP in cancer development in recent years. TRRAP is a coactivator of an important
tumor suppressor p53 (Barlev et al., 2001). However, it has also been found to promote
mutant p53 accumulation in cancer cells by regulating p53 degradation machinery
(Jethwa et al., 2018). Furthermore, TRRAP is the target of viral oncoprotein E1A. The
adenovirus E1A directly binds to TRRAP/GCN5 and dysregulates transcription
activation (Lang and Hearing, 2003). Additionally, TRRAP Ser722Phe mutation is
frequently observed in melanoma (Wei et al., 2011). Patients with high expression of
TRRAP exhibit lower survival rates in ovarian cancer according to cBio Cancer
Genomics Portal (Cerami et al., 2012). Importantly, TRRAP is essential for cell survival
and TRRAP knockout causes embryonic lethality (Herceg et al., 2003). Conditional
knock out or knock down techniques allow researchers to study the role of TRRAP
during cancer development. TRRAP knockdown was found to attenuate brain tumor
formation in a mouse model (Wurdak et al., 2010). Another study using a high
throughput shRNA library screen also reported that TRRAP was required for
glioblastoma stem-like cells and TRRAP expression was increased in the gliomas
(Wurdak et al., 2010). However, a microarray analysis of breast cancer tissue showed a
negative correlation between TRRAP and patient survival (Wang et al., 2016). The
evidence suggests that its role may vary in different types of cancer. Moreover, histone
deacetylase inhibitors (HDACi) have been studied as potential cancer therapeutics due to
their potential to compensate for the attenuation of histone acetylation observed in cancer
development (Li and Seto, 2016). While some HDACi have been approved for clinical
trials, these therapies still have serious limitations including side effects and low efficacy
(Dell’Aversana et al., 2012). Therefore, targeting specific regulators of histone
acetylation could be a better solution for cancer treatment.
All the evidence suggests that TRRAP is an essential modifier of various diseases and
could be a therapeutic target. The yeast models allow scientists to investigate the basic
functions of the highly conserved homolog Tra1 and reveal the mechanisms of Tra1
regulation during diseases. Previous studies and ours have implicated Tra1 in cellular
stress responses. Future studies should focus on understanding the mechanisms by which
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Tra1 regulates stress response pathways and how to control Tra1 activity in stress-related
disease therapy.

7.7 The potential of Tra1/TRRAP in drug development
Tra1 and its mammalian homolog TRRAP is essential for cell survival during stresses.
We have explored the critical role of Tra1 in HD and antifungal resistance. Thus, drugs
and small molecules that regulate Tra1 function can be investigated in disease therapies.
Although missing the catalytic residues, this PIKK family member has the similar
substrate binding cleft between the N- and C-lobes comparing to TOR, ATM, and ATR
(Díaz-Santín et al., 2017; Sharov et al., 2017), which makes it an ideal druggable target.
Currently, there is no drug targeting Tra1/TRRAP available.
Many PI3K inhibitors and small molecules have been designed to target the PI3K domain
of PIKK proteins, which benefits various disease in model organisms and even clinical
trials. As introduced previously, mTOR inhibitors showed protective effects against HD
(Ravikumar et al., 2004). A PI3K inhibitor LY294002 inhibits PI3K activity by
competitive inhibition of ATP binding, attenuated molecular hallmarks of AD (Aoyagi et
al., 2010). PI3K inhibitors have also been used in cancer therapy. Through suppression of
PI3K p110α catalytic subunit, BYL719 inhibited cancer cell proliferation both in vitro
and in vivo (Keam et al., 2015). It has shown beneficial effects in breast cancer patients
(Mayer et al., 2017). Furthermore, our data suggested that yeast cells carrying tra1Q3
mutation were more sensitive to antifungal drugs, indicating that yeast Tra1 can be a
potential therapeutic target for fungal infections. Sequence alignment data showed that
the PI3K domain of Tra1 homologs in different species is not 100% identical (Berg et al.,
2018). Thus, it is possible to target specific amino acids in fungal Tra1 without
interfering the host cells and thus significantly reduce side effects.
The specific function of Tra1 PI3K has not been fully described. Studies showed that the
PI3K domain is crucial for Tra1 stability and nuclear localization (Berg et al., 2018). The
authors also observed reduced incorporation with the HAT complexes and increased
sensitivity to cell stress when three arginine residues proximal to the PI3K binding cleft
are mutated (tra1Q3). These results suggested an important role of the PI3K domain in
regulating Tra1 function. Even though lacking ATP binding motifs, structural studies
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suggested that the substrate-binding pocket of Tra1 PI3K is still able to interact with
small molecules (Mutiu et al., 2007). The function of Tra1/TRRAP, primarily its PI3K
domain needs further investigations. No small molecule ligands or RNAs have been
identified to interact with the Tra1 PI3K domain. Our data showed that tra1Q3 cells fail to
activate the HSR and the calcineurin pathway, indicating that the PI3K domain may be
implicated in its binding to other transcription factors and target gene promoters.
Understanding the critical role of the Tra1 PI3K domain will provide insights into the
transcriptional regulation of cellular stress responses and guide the development of drugs
and small molecules that target Tra1 for the treatment of human diseases.

7.8 Limitations of the research
There are some limitations to this study. The yeast model of HD we use expresses only
the Httex1 fragment instead of the full length Htt, which may not fully represent the
cellular functions and mechanisms of the disease-causing protein. Previous studies in
mice models of HD have shown that, although disease progressions happen earlier, mice
expressing mutant Httex1 develop similar phenotypes compared to full length Htt knock in
mice (Woodman et al., 2007). The evidence supports the continued employment of the
more efficient Httex1 to investigate the basic cellular mechanisms of HD in different
model organisms. Moreover, the proline-rich region and protein tags can affect polyQ
toxicity and aggregation morphology in yeast, which limits the use of the model to
understand the aggregation formation in nuerons (Dehay and Bertolotti, 2006;
Duennwald et al., 2006; Jiang et al., 2017). However, this result develops ideas that
flanking sequences outside of the polyQ region can affect polyQ toxicity thus could be
potential therapeutic targets for HD. In addition, the polyQ toxicity in yeast depends on
cellular prion status that may result from yeast specific mechanisms (Jiang et al., 2017;
Meriin et al., 2002; Ripaud et al., 2014). Overall, the findings in this thesis can be tested
in mammalian cell models.
In chapter 6, we demonstrate the role of Tra1 in antifungal resistance. The preliminary
experiments were performed in the non-pathological yeast S. cerevisiae. Therefore, the
results need to be verified in infectious fungi for further studies. We will evaluate the

235

functions of Tra1 and its potential as a target for antifungal treatment in the pathogenic
yeast C. albicans in collaboration with Dr. Rebecca Shapiro (University of Guelph).

7.9 Significance of the research
Dysregulation of cellular stress responses is a hallmark of several human diseases, such
as neurodegenerative disorders and fungal infections and antifungal resistance. An ideal
model to study misfolded protein caused cellular stress is HD. By optimizing the yeast
model of HD with modern FPs, my research supports the view that flanking sequences
can alter polyQ toxicity and aggregation formation. We also provided a high throughput
platform to rapidly assess the impact of FPs on their fusion partners. Moreover, the active
stress responses in fungi promote cell survival and contribute to antifungal resistance. A
key process of cellular stress responses is the transcriptional activation of stress-induced
genes, which is regulated by transcription factors as well as co-activators. The highly
conserved transcription co-activator Tra1 within the SAGA and NuA4 HAT complexes is
linked to cellular stress responses. However, the roles of Tra1 and mechanisms on how it
regulates cellular stress response pathways remains obscure. Therefore, it is crucial to
investigate the specific regulatory roles of Tra1 and connections to disease pathology.
Using S. cerevisiae, my studies target the regulation of Tra1 on the HSR, the CWI
pathway, and the calcineurin signaling during polyQ expansions and antifungal treatment.
First, we identified a novel connection between TORC1/Sfp1 pathway regulated cell
growth and histone acetylation controlled by Tra1/SAGA during misfolded protein stress.
Next, we showed that impaired HSR in HD can be traced back to a cell wall defect,
which may all regulated by Tra1. By showing the critical role in the calcineurin pathway,
we reported that Tra1 is vital for yeast survival against antifungal drugs.
My thesis will provide new insights into the novel transcriptional mechanisms of cellular
stress responses that promote cell survival as well as the underlying cellular mechanisms
of HD and antifungal resistance. Understanding the specific functions of Tra1 within the
HAT complexes will help uncover the secrets of transcriptional defects and dysregulation
of cellular stress responses observed in HD and other human diseases. Furthermore, my
study reveals a novel potential therapeutic target for the research of stress-related
disorders generally.
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Appendices
Appendix A: Effect of Fluorescent Proteins on Fusion
Partners Using Polyglutamine Toxicity Assays in Yeast
The appendix describes protocols to assess the effects of FPs on the aggregation and
toxicity of misfolded polyQ expansions for the rapid evaluation of a newly
uncharacterized FP in the context of fluorescent reporters. The protocol was published in
the Journal of Visualized Experiments. Reference: Jiang, Y., Di Gregorio, S., Albakri, M.
B., Duennwald, M. L., Lajoie, P. Effect of Fluorescent Proteins on Fusion Partners Using
Polyglutamine Toxicity Assays in Yeast. J. Vis. Exp. (141), e58748, doi:10.3791/58748
(2018).

Abstract
For the investigation of protein localization and trafficking using live cell imaging,
researchers often rely on fusing their protein of interest to a fluorescent reporter. The
constantly evolving list of genetically encoded fluorescent proteins (FPs) presents users
with several alternatives when it comes to fluorescent fusion design. Each FP has specific
optical and biophysical properties that can affect the biochemical, cellular, and functional
properties of the resulting fluorescent fusions. For instance, several FPs tend to form
nonspecific oligomers that are susceptible to impede on the function of the fusion partner.
Unfortunately, only a few methods exist to test the impact of FPs on the behavior of the
fluorescent reporter. Here, we describe a simple method that enables the rapid assessment
of the impact of FPs using polyglutamine (polyQ) toxicity assays in the budding yeast
Saccharomyces cerevisiae. PolyQ-expanded huntingtin proteins are associated with the
onset of Huntington’s disease (HD), where the expanded huntingtin aggregates into toxic
oligomers and inclusion bodies. The aggregation and toxicity of polyQ expansions in
yeast are highly dependent on the sequences flanking the polyQ region, including the
presence of fluorescent tags, thus providing an ideal experimental platform to study the
impact of FPs on the behavior of their fusion partner.
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Introduction
Since the initial characterization of the green fluorescent protein (GFP) from Aequorea
Victoria (Chalfie et al., 1994), a wide palette of genetically encoded FPs have been
developed, allowing cell biologists to simultaneously localize and track multiple cellular
events/proteins in living cells (Shcherbakova et al., 2012; Thorn, 2017). FPs are derived
from multiple organisms, from jellyfish to coral, and therefore, display specific
biophysical properties that divert extensively beyond their respective fluorescent
spectrum. These properties include brightness, photostability, and a tendency to
oligomerize among others (Snapp, 2009; Thorn, 2017). Selecting monomeric FPs is an
important aspect in the selection of a suitable tag when designing a fluorescent reporter,
in order to minimize inappropriate interactions and alterations of the fusion partner’s
function and maximize the reporter efficiency for a given cellular compartment
(Costantini and Snapp, 2013; Costantini et al., 2015; Snapp, 2009). While GFP has, over
time, been evolved to minimize the effect of adding the fluorescent tag to the fusion
partner (Costantini et al., 2015; Yang et al., 1996; Zacharias et al., 2002), how new FP
variants perform compared to GFP remains difficult to assess.
Few methods exist to characterize the behavior of FPs. Most of them involve testing
biophysical properties of FPs using biochemical approaches, such as ultracentrifugation
and gel filtration protocols (Baird et al., 2000; Laue and Stafford, 1999; Pédelacq et al.,
2002; Pédelacq et al., 2006). Such methods have the caveat of using purified FPs in
solution, offering little insight into their behavior in intact cells. The development of the
organized smooth endoplasmic reticulum (OSER) assay offers a quantifiable assessment
of FPs’ tendency to oligomerize in living cells (Costantini et al., 2012) by testing the
ability of overexpressed FPs to reorganize endoplasmic reticulum tubules into OSER
whorls (Snapp et al., 2003). This technique can successfully detect changes between
monomeric and oligomeric variants of GFP and other FPs. However, it relies mostly on
overexpression in transiently transfected cells, and the quantitation and image analysis
can be time-consuming unless the technique is adopted as an automated data collection
and analysis workflow.
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In order to complement these approaches, we established an assay that takes advantage of
the effect of fluorescent tags on the toxicity and aggregation of polyQ expansions in yeast
(Duennwald et al., 2006a; Jiang et al., 2017). The expansion of the polyQ stretch with
more than 36 repeats within the first exon of the gene encoding the huntingtin protein
(Htt) is associated with Huntington’s disease (Gusella and MacDonald, 2006; Penney et
al., 1997). The expression of expanded Httex1 in yeast results in a strong aggregation of
the misfolded Htt protein coupled to a severe growth defect. Interestingly, these
phenotypes are strongly influenced by the sequences flanking the polyQ stretch,
including FPs (Duennwald et al., 2006a; Jiang et al., 2017). It was rationalized that the
different properties of FPs can differentially affect polyQ toxicity in yeast. Indeed,
compared to GFP-like FPs, red fluorescent proteins and their evolved forms have shown
a reduced toxicity and aggregation (Jiang et al., 2017). This manuscript provides a
detailed protocol to assess the effect of the next generation of FPs on polyQ toxicity and
aggregation in yeast. This assay allows for a rapid and potentially high-content analysis
of FP variants that can be used in parallel with previously characterized techniques for
the optimal characterization of new FPs and can assess how they perform compared to
GFP.

Protocol
1. Generation of New Fluorescently Tagged Httex1 Reporters for an Expression in
Yeast
Note: This section has been modified from the protocol by Jiang et al. and Albakri et al.
(Albakri et al., 2018; Jiang et al., 2017).
1.1. Design primers to amplify the sequence encoding the fluorescent protein or
interest by PCR. The forward primer should include a leader sequence to assist
the restriction enzyme during digestion (GATC), followed by a SpeI restriction
site (ACTAGT) and 20 bases downstream of the ATG (excluding ATG) of the
fluorescent protein gene of interest. The reverse primer should include the leader
sequence (GATC), followed by a SalI restriction site (GTCGAC) and the reverse
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complement of 20 bases upstream of the stop codon of the FP sequence
(including stop).
1.2. Using the primers designed in step 1.1, perform the PCR reaction using a
thermocycler with the following settings: heat to 95 °C for 1 min and cycle at
95 °C for 30 s, 60 °C for 30 s, and 72 °C for 2 min per kB of PCR product.
Performing 18 cycles is ample.
1.3. Run the PCR reaction on an agarose gel (0.5% in Tris-acetate-EDTA). There
should a single band corresponding to the expected product size. Isolate the
fragment using a gel purification kit.
1.4. The protocol employs an Httex1 vector carrying 25 (nontoxic) and 72 (HDassociated, displaying a strong aggregation) polyQ repeats. Digest both the PCR
fragments and the vector with SpeI and SalI restriction enzymes for 3 h at 37 °C.
1.5. Purify the digested vector by running it on an agarose gel as in step 1.3.
1.6. Purify the digested PCR fragment using a PCR purification kit.
1.7. Ligate the resulting digested PCR fragment and p415-GAL1-FLAG-25/72QpolyQ
plasmids1 using T4 ligase (1 h at room temperature). Use a 10 µL reaction (1 µL
of T4 enzyme, 1 µL of 10X buffer, 6 µL of PCR fragment, and 2 µL of vector).
1.8. Transform 2 µL of the ligation reaction into 50 µL of Escherichia coli-competent
cells and incubate them on ice for 30 min. Then, heat-shock the cells at 42 °C for
30 s. Add 1 mL of SOC outgrowth media and incubate at 37 °C for 1 h in a
shaker. Plate 200 µL of the reaction on an LB-agar plate containing 100 µg/mL
ampicillin. Incubate the plate at 37 °C overnight.
1.9. Select three individual bacterial colonies, grow them overnight in 3 mL of LBbroth containing 100 µg/mL ampicillin at 37 °C in a shaker and extract the
plasmid DNA using a plasmid purification kit.
1.10. Check the plasmid by digesting 500 ng of DNA using SpeI and SalI restriction
enzymes for 1 h at 37 °C and run the reaction on an agarose gel (0.5% in Trisacetate-EDTA). There should be two bands at the right sizes of the vector (~7 kb)
and the insert (size varies according to the gene of interest). Then, verify the
plasmid by sequencing.
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1.11. Transform the p415-GAL1-FLAG-polyQ-FP plasmids into the yeast strain
W303 following a standard yeast transformation protocol.
2. Spotting Assay
2.1. Streak the yeast clones carrying 25Q/72Q tagged with the FP of interest on an
agar plate containing yeast selection media (synthetic complete-SC without
leucine) with glucose as the carbon source. At the same time, also streak
25Q/72Q-ymsfGFP to serve as a positive control.
Note: 25Q/72Q constructs that do not contain a fluorescent tag are not toxic and can
serve as negative control.
2.2. Incubate the plates at 30 °C for 2 - 3 d.
2.3. Select up to three single colonies from the plate.
2.4. Inoculate 5 mL of SC supplemented with 2% glucose as the carbon source.
2.5. Pellet 200 µL of each overnight culture and wash it 3x with sterile distilled water.
2.6. Resuspend the cells in SC media containing 2% galactose as the carbon source to
induce the expression of polyQ fusions. Incubate the galactose media overnight
at 30 °C in a tube rotator. As a control, repeat this step by using glucosecontaining media.
2.7. The next morning, equalize the cell densities to optical density at 600 nm (OD600)
of 0.2 in 100 µL of SC media in a sterile 96-well plate.
2.8. Prepare four fivefold dilutions of each sample with sterile water by pipetting 20
µL of the sample from the previous well into 80 µL of media in the next well.
2.9. Use a yeast pinning tool to spot the cells onto selective plates (containing glucose
or galactose) and incubate at 30 °C for 2 d.
2.10. Image the plates with an image documentation device.

252

3. Quantification of Cell Growth in Liquid Culture
3.1. Prepare the cell cultures, following steps 2.1 - 2.5 of this protocol.
3.2. Measure the OD600 using a spectrophotometer.
3.3. Dilute the cells to an OD600 of 0.1 in 300 µL of media in a 96-well plate.
3.4. Run each sample in triplicate.
3.5. Incubate the plate in a plate reader/incubator with shaking capabilities. Set the
number of samples, the temperature at 30 °C, the absorbance at 600 nm, the
length of the experiments to 24 h, and the measurement intervals to 15 min, and
select the continuous shaking mode.
3.6. Create the growth curve and quantify the area under the curve using scientific
graphing software. The GraphPad Prism 7 is recommended. Paste the data into an
XY table with three replicate values. The growth curve will be shown under the
Graphs folder at the left side. To quantify the area under the curve, select
Analyze at the top left and click Area under curve in XY analyses.
4. Fluorescence Microscopy
4.1. Prepare the cell cultures, following steps 2.1 - 2.5 of this protocol.
4.2. Dilute the cells 10x in growth media and transfer 200 µL of each sample to 8well imaging chambers.
4.3. Image the cells using a confocal microscope equipped with a 63X Plan
Aprochromoat objective (1.4 NA) at room temperature.
Note: The usage of a confocal microscope is optional. A standard wide-field fluorescent
microscope can also be employed.
4.4. Adjust the pinhole and laser power for optimal image acquisition. Since the 72Q
aggregates are much brighter than the diffuse 25Q signal, it is often required to
use a different acquisition setting between the different plasmids in order to avoid
saturation of the fluorescent signal.
4.5. Process the images using ImageJ(Schindelin et al., 2015) or another imageprocessing software. At this step, the percentage of cells that display aggregate
can be calculated manually is desired.
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5. Dot Blot
Note: In this protocol, dot blot is used to examine the protein expression levels. Prepare
the cell cultures, following steps 2.1 - 2.5 of this protocol.
5.1. Generate protein lysates using glass beads in lysis buffer (100 mM Tris, pH 7.5;
200 mM NaCl; 1 mM EDTA; 5% glycerol, 1 mM dithiothreitol [DTT]). Add
protease inhibitors, 4 mM phenylmethylsulfonyl fluoride (PSMF) and protease
inhibitor cocktail, directly before use. Pellet 5 mL of the overnight culture and
resuspend it in 200 µL of glass beads and 200 µL of lysis buffer. Vortex 30 s for
12 rounds. Centrifuge at 12,000 x g at 4 °C for 10 min and collect the supernatant.
5.2. Spot an equal amount of total proteins on a nitrocellulose membrane using a
microfiltration apparatus. Prewet the membrane with PBS and assemble the
apparatus. Connect to a vacuum source and make sure the screws are tightened.
Turn on the vacuum and let the sample filter through the membrane by gravity.
5.3. Block the membrane in PBS- 0.05% Tween/5% fat-free milk.
5.4. Incubate the membrane with primary anti-FLAG antibody overnight at 4 °C. The
monoclonal anti-FLAG M1 is recommended.
5.5. Wash the membrane 3x for 10 min each with PSB- 0.05% Tween.
5.6. Incubate the membrane with a fluorescently labeled secondary antibody (antimouse IgG) for 1 h at room temperature in PBS- 0.05% Tween/5% fat-free milk.
5.7. Wash membrane 3x 10 min with PSB- 0.05% Tween.
5.8. Image-blot using an immunoblot documentation system.

Representative results
FPs have different biophysical properties, including their tendency to oligomerize, that
can affect the behavior of their fusion partners in the context of fluorescent reporters.
This protocol describes a simple method where multiple FPs can be fused to toxic polyQ
expansions. Since polyQ toxicity is highly dependent on the sequences flanking the
polyQ stretch (Duennwald et al., 2006a), this assay allows a rapid and direct comparison
of fluorescent polyQ fusion reporters (Figure 1). A non-HD-associated polyQ length
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(25Q) is used as a negative control and does not display significant toxicity or
aggregation (Duennwald, 2013; Duennwald et al., 2006a; Duennwald et al., 2006b; Jiang
et al., 2017). 72Q is employed to obtain the HD-like phenotypes, including strong growth
inhibition and polyQ aggregation. Importantly, the Httex1 coding sequence employed lack
the proline-rich domain that follows the polyQ stretch. In the presence of the proline-rich
domain, Httex1 is not toxic in yeast (Duennwald et al., 2006a). In this assay, an Httex1
fused to a yeast-optimized monomeric variant of superfolder GFP (Pédelacq et al., 2006)
(ymsfGFP) (Jiang et al., 2017) is used as a positive control as previously described (Jiang
et al., 2017). The constructs also contain a FLAG epitope tag at the N-terminus of Httex1.
This allows detection of the different fusions with the same antibody (anti-FLAG) for
biochemical analysis. As a proof-of-principle, 72Q Httex1 fused to yeast-optimized
TagBFP (yomTagBFP) (Lee et al., 2013) does not result in slow growth measured by
either spot assays on agar plates or growth in liquid media (Figure 2), indicating that the
nature of the fluorescent tag can indeed impede polyQ expansion behavior in cells.
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Figure 1: Workflow diagram for the analysis of the effect of fluorescent protein
tag on the aggregation and toxicity of polyQ expansion proteins in yeast.
First, FPs are cloned into yeast expression vectors encoding a galactose-inducible
version of FLAG-tagged Httex1 harboring either 25Q (nontoxic) or 72Q (HDassociated, aggregating and toxic) repeats. Clones are selected and verified by
sequencing and, subsequently, transformed in yeast. Following the induction of
polyQ fusion expression by incubation in galactose-containing media, either spotting
assays on agar plates or growth liquid media can assess the polyQ toxicity. PolyQ
aggregation is analyzed by fluorescence microscopy. A relative expression of the
different constructs is assessed using dot blot.
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Figure 2: Representative growth assay results following the expression of
Httex1 fluorescent fusions in yeast.
Yeast expressing either 25Q or 72Q Httex1 fused to ymsfGFP or yomTagBFP was
cultured in glucose (control) or galactose media (polyQ-induced) overnight and
either (A) spotted on agar plates or (B) incubated further in liquid media to assess
growth under the different conditions. While 72Q-ymsfGFP induces a significant
growth defect, 72Q-yomTagBFP displays a growth phenotype similar to the
nontoxic 25Q counterparts.
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Aggregation of the fluorescent polyQ fusions can be assessed using fluorescence
microscopy. 72Q-ymsGFP displays significant aggregation compared to 25Q. However,
the 72-yomTagBFP fluorescent signal remains diffused throughout the cytoplasm (Figure
3). In most of the cases, it is not recommended to use the same image acquisition settings
(laser power, exposure time) to acquire both 25Q and 72Q images. The aggregates in the
72Q-expressing cells are much brighter than the diffused 25Q signal. Therefore, under
imaging conditions used to acquire 72Q images, the diffused 25Q signal may appear very
weak or not be visible at all. Appropriate acquisition settings should also be applied to
minimize the saturation during the imaging of the 72Q-expressing cells.
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Figure 3: Representative fluorescent images of Httex1 fluorescent fusions in
yeast.
Yeast expressing either 25Q or 72Q Httex1 fused to ymsfGFP or yomTagBFP was
cultured in glucose (control) or galactose media (polyQ-induced) overnight and
imaged with a confocal microscope. While the 72Q-ymsfGFP expression results in
a strong polyQ protein aggregation, 72Q-yomTagBFP displays a diffused
cytoplasmic signal similar to the nontoxic 25Q counterparts.
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Expression levels of the various polyQ fusions could affect toxicity. Detergent-insoluble
amyloids, such as polyQ aggregates, are notoriously difficult to study biochemically and
are not suitable for an analysis by standerd SDS-PAGE. Therefore, dot blots can be
performed to assess protein levels. The inclusion of the FLAG tag at the amino terminus
end of Httex1 allows detection of all the fluorescent fusions simultaneously, despite the
presence of FPs (Figure 4). Alternatively, semi-denaturing detergent agarose gel
electrophoresis (SDD-AGE) can be performed to assess the formation of polyQ
oligomers (Jiang et al., 2017). A detailed protocol and video are available in Halfmann
and Lindquist (Halfmann and Lindquist, 2008).
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Figure 4: Representative dot blot analysis of Httex1 fluorescent fusion
expression in yeast. Yeast expressing 25Q, 46Q, 72Q, or 103Q Httex1 fused to CFP
was cultured in galactose media (polyQ-induced) overnight and processed for dot
blot analysis. Fivefold dilutions of the cell lysates are shown.
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Discussion
In this article, various assays to measure the aggregation of Httex1 polyQ expansions and
their effect on yeast growth were employed as a model to study how different fluorescent
proteins alter their fusion partners in the context of fluorescent reporters. Using a GFP
variant (ymsfGFP) as a positive control, we showed that this detects significant changes
in polyQ toxicity and aggregation between different fluorescent tags and allows for a
direct and rapid comparison of the polyQ-FP fusion performance against GFP-tagged
constructs (Albakri et al., 2018; Jiang et al., 2017).
While the present protocol focuses on fluorescent proteins, various parts of the protocol
could be readily adapted to test the effects of other protein tags. In addition, the present
protocol employs low-copy yeast centromeric vectors that can vary in terms of copy
numbers (generally one to two copies) present in cells (Sikorski and Hieter, 1989). Using
integrative vectors to ensure a uniform expression across experimental conditions could
circumvent this problem. While this protocol has been optimized for use in the W303
background, other S. cerevisiae strains can be employed. However, susceptibility to
polyQ toxicity should be determined using the ymsfGFP-tagged vectors prior to
designing new constructs. In certain cases, it may be appropriate to employ high-copy
(2µ) vectors to generate a significant growth defect. It is also suggested to test multiple
isolates following the yeast transformation with polyQ vectors to avoid selecting
spontaneous suppressors showing a reduced polyQ toxicity. Of note, the W303 yeast
strain (Thomas and Rothstein, 1989) is usually used as it is more sensitive to polyQ
toxicity than other S288C derivatives, such as BY4741/BY4742 (Brachmann et al., 1998),
thus allowing for a wider range of growth phenotypes. Importantly, strains employed for
this assay need to carry the Rnq1 prion protein since rnq1Δ cells do not display polyQ
toxicity and aggregation (Meriin et al., 2002). It is also important to use Httex1 constructs
carrying the amino-terminal FLAG tag and lacking the proline-rich domain. Other
variations of the fusion design may alter toxic phenotypes (Duennwald et al., 2006a).
Finally, the induction of the polyQ fusion expression in galactose-containing media is a
critical step of the protocol (Duennwald, 2013). When transferring cells from glucose- to
galactose-containing media, it is important to wash the cells at least three times with
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sterile water to eliminate all traces of glucose that could contribute to repressing the
induction of the Gal1 promoter (Mumberg et al., 1995). When performing spotting assays,
culturing the cells overnight in galactose media to induce the expression of the fusion can
exacerbate the toxic phenotype of the 72Q fusion and help discriminate changes in
growth across different fusions (Jiang et al., 2017).
As a limitation, previous studies did not observe differential effects between a
nonmonomeric version of CFP (a GFP derivative) and ymsfGFP (Jiang et al., 2017).
Thus, at least for GFP variants, this assay may not be sensitive enough to discriminate
between monomeric and oligomeric variants, highlighting the need to complement the
polyQ toxicity assays with other standard methods, such as the OSER assay (Costantini et
al., 2012) and biochemical analysis (Baird et al., 2000; Laue and Stafford, 1999; Pédelacq
et al., 2002; Pédelacq et al., 2006) that can directly assess oligomerization. Also, it should
be noted that FPs can behave differently in yeast compared to in vitro assays or their
expression in other organisms (Lee et al., 2013).
Collectively, these methods allow researchers to rapidly characterize new FPs and
measure their effect on their fusion partner. In the future, this protocol will enable the
quick screening of new derivatives of previously characterized FPs to identify mutants
that behave similarly to GFP variants, which are still the gold standard measure for FP
reporters. While this protocol focuses on fluorescent proteins, it can easily be adapted to
screen for the effects of other genetically encoded tags, such as SNAP-tag (Keppler et al.,
2003) and SunTag (Tanenbaum et al., 2014).
In conclusion, this protocol provides a rapid and easily scalable assay to enable further
characterization of the new generation of FPs and other genetically encoded tags to guide
research in fusion protein design.
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